Esterases and uses thereof

JP2024545360AInactive Publication Date: 2024-12-05CARBIOS
View PDF 13 Cites 0 Cited by

Patent Information

Application Number
JP2024555266
Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
Priority Date
2021-11-16
Filing Date
2022-11-15
Publication Date
2024-12-05
Estimated Expiration
Not applicable · inactive patent

Smart Images

  • Figure 2024545360000001
    Figure 2024545360000001
  • Figure 2024545360000002
    Figure 2024545360000002
  • Figure 2024545360000003
    Figure 2024545360000003
Patent Text Reader

Abstract

The present invention relates to novel esterases, more particularly to esterase variants having increased activity and / or increased thermostability under acidic conditions compared to the parent esterases of SEQ ID NO: 1, SEQ ID NO: 2, or SEQ ID NO: 3, and their use for degrading polyester-containing materials, such as plastic products. The esterases of the present invention are particularly suitable for degrading polyethylene terephthalate and materials containing polyethylene terephthalate under acidic conditions.
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] The present invention relates to novel esterases, more particularly to esterases which have improved activity and / or heat resistance compared to the parent esterase at a pH of 3-6, preferably at a pH of 5-5.5. The present invention also relates to the use of said novel esterases for degrading polyester-containing materials, such as plastic products. The esterases of the present invention are particularly suitable for degrading polyethylene terephthalate and polyethylene terephthalate-containing materials. [Background technology]

[0002] Esterases can catalyze the hydrolysis of various polymers, such as polyesters. In this context, esterases have shown promising effects in many industrial applications, for example as detergents for dishwashing and laundry applications, as degradative enzymes for the treatment of biomass and food, as biocatalysts in the detoxification of environmental pollutants, or as biocatalysts for the treatment of polyester fabrics in the textile industry. The use of esterases as degradative enzymes for the hydrolysis of polyethylene terephthalate (PET) has been of particular interest. In fact, PET is used in many technical fields, for example in the manufacture of clothing, carpets, or in the form of thermosetting resins for the manufacture of packaging materials or automotive plastics, etc., and as a result, the accumulation of PET in landfills is becoming an increasingly ecological problem.

[0003] Enzymatic degradation of polyesters (especially PET) is considered an interesting solution to reduce the accumulation of plastic and textile waste. In fact, enzymes can promote the hydrolysis of polyester-containing materials (more specifically, plastics and textile products) down to the monomer level. Furthermore, the hydrolyzates (i.e., monomers and oligomers) can be recycled as materials for synthesizing new polymers.

[0004] In this context, several esterases have been identified as candidate degrading enzymes for polyesters, and several variants of such esterases have been developed. Among the esterases, cutinases, also known as cutin hydrolases (EC 3.1.1.74), are of particular interest. Cutinases have been identified from various fungi (PE Kolattukudy in "Lipases", Ed. B. Borg-strom and HL Brockman, Elsevier 1984, pp. 471-504), bacteria, and plant pollen. Recently, metagenomics approaches have identified additional esterases. [Prior art documents] [Patent documents]

[0005] [Patent Document 1] International Publication No. 2014 / 079844 [Patent Document 2] International Publication No. 2015 / 173265 [Patent Document 3] International Publication No. 2017 / 198786 [Patent Document 4] International Publication No. 2020 / 094661 [Patent Document 5] International Publication No. 2020 / 094646 [Patent Document 6] International Publication No. 2021 / 123299 [Patent Document 7] International Publication No. 2021 / 123301 [Patent Document 8] International Publication No. 2021 / 123328 [Patent Document 9] International Publication No. 2013 / 093355 [Patent Document 10] International Publication No. 2016 / 198650 [Patent Document 11] International Publication No. 2016 / 198652 [Patent Document 12] International Publication No. 2019 / 043145

Patent Document 13

Non-Patent Documents

[0006]

Non-Patent Document 1

Non-Patent Document 2

Non-Patent Document 3

Non-Patent Document 4

Non-Patent Document 5

Non-Patent Document 6

Non-Patent Document 7

Non-Patent Document 8

Summary of the Invention

Problems to be Solved by the Invention

[0007] However, there remains a need for esterases with improved activity and / or thermostability compared to known esterases to make the polyester degradation process more efficient, particularly in acidic conditions (i.e., pH 3-6), and thereby more competitive. [Means for solving the problem]

[0008] The present invention provides novel esterases that exhibit increased activity and / or increased thermostability under acidic conditions compared to the parent (i.e., wild-type esterase) having the amino acid sequence set forth in SEQ ID NO: 1. The wild-type esterase corresponds to amino acids 36-293 of the amino acid sequence of a metagenomic cutinase described in Sulaiman et al., Appl Environ Microbiol. March 2012, and designated G9BY57 in SwissProt, and described as having polyester degrading activity. The esterases of the present invention are particularly useful in processes for degrading plastic products, more specifically plastic products including PET.

[0009] In this regard, an object of the present invention is an esterase variant having (i) at least 75%, 80%, 85%, 90%, 95%, 96%, 97%, 98% or 99% identity to the full-length amino acid sequence as set forth in SEQ ID NO:1, and (ii) an amino acid substitution at at least one position corresponding to a residue selected from E141, G171 and V180, and / or R12A / I / M, S13L, A14C / Y, L15Q / G / I / D, A17F / V / Q / D, D18E, R30Y / L / Q / M / N / S / E, G37E / C, Y60H / C / G, T61Y / H / Q / E, S66E / W / D, L67I / E, W69I, R72I / T / L / V, R89E / G / V, F90D / T / H / E / G / P / S / Q / N, Y 92E, P93A, R138L / K / D / E, A127T, W155M / H / E, D158E / I / C, T160C, L202I, N204A, A205M / Q, S and (iv) exhibiting increased thermostability and / or increased polyester degrading activity at a pH of 3 to 6 compared to the esterase of SEQ ID NO: 1.

[0010] Preferably, the esterase comprises at least one substitution selected from S13L, A14C / Y, L15Q / G / I / D, A17F / V / Q / D, F90D / T / H / E / G / P / S / Q / N, Y92E, D158E / I / C, S206V / I / N, F208V / K, A127T, N211F / W, A215S / Y, Q237C / I, and H156D, preferably S13L, A14C / Y, L15Q, A17F / V, F90D / T, Y92E, D158E, S206I / N, F208K, A127T, N211F, A215Y, Q237 I, and H156D, more preferably at least one substitution selected from S13L, A14C / Y, A17F / V, F90D / T, Y92E, D158E, S206I / N, F208K, A127T, N211F, A215Y, Q237I, and H156D, and even more preferably at least one substitution selected from S13L, A14C / Y, A17F / V, F90D / T, Y92E, D158E, S206I, F208K, N211F, A215Y, Q237I, and H156D.

[0011] A further object of the present invention is an esterase variant having (i) at least 80%, 85%, 90%, 95%, 96%, 97%, 98% or 99% identity to the full length amino acid sequence set forth in SEQ ID NO:2, and (ii) at least one of the following amino acid sequences as compared to the amino acid sequence SEQ ID NO:2: E141C / K / R, G171C, V180C, R12A / I / M, S13L, A14C / Y, L15Q / G / I / D, A17F / V / Q / D, D18E, R30Y / L / Q / M / N / S / E, G37E / C, Y60H / C / G, T61Y / H / Q / E, S66E / W / D, L67I / E, W69I, R72I / T / L / V, R89E / G / V, F90D / T / H / E / G / P / S / Q / N, G92E, P93A, R138L / K / D / E, A127T, W155M / H / E, D158E / I / C, T160C, L202I, N204A, A205M / Q, S206V / I / N, M208V / and (iv) exhibiting increased thermostability and / or increased polyester decomposition activity at a pH of 3 to 6 compared to the esterase of SEQ ID NO: 1. Specifically, the esterase further exhibits increased thermostability and / or increased polyester decomposition activity compared to the esterase of SEQ ID NO: 2.

[0012] A further object of the present invention is an esterase variant having (i) at least 80%, 85%, 90%, 95%, 96%, 97%, 98% or 99% identity to the full length amino acid sequence as set forth in SEQ ID NO:3, and (ii) at least one of the following amino acid sequences as compared to the amino acid sequence SEQ ID NO:3: R12A / I / M, A14C / Y, L15Q / G / I / D, A17F / V / Q / D, D18E, R30Y / L / Q / M / N / S / E, G37E / C, Y60H / C / G, T61Y / H / Q / E, S66E / W / D, L67I / E, W69I, R72I / T / L / V, R89E / G / V, F90D / G / V, F90E ... T / H / E / G / P / S / Q / N, P93A, R138L / K / D / E, A127T, W155M / H / E, E158I / C, T160C, L202I, N20 4A / G, A205M / Q, S206V / I / N, M208V / K, A209S / D / E, N211F / W / E, S212T / A / Q, N214T, A215S / and / or an amino acid substitution at at least one position corresponding to a residue selected from Y, I217L / C / V, Y220W / C / T, Q237C / I, F238I / D, L239C, V242I, and L247M, and H156D, and / or an amino acid substitution at at least one position corresponding to a residue selected from E141, G171, and V180, which positions are numbered with reference to the amino acid sequence set forth in SEQ ID NO: 3; (iii) having polyester degrading activity; and (iv) exhibiting increased thermostability and / or increased polyester degrading activity at a pH of 3 to 6 compared to the esterase of SEQ ID NO: 3.Preferably, the substitutions are selected from A17F / V / Q / D, F90D / T / H / E / G / P / S / Q / N, R138L / K / D / E, N204A / G, N211F / W / E, A215S / Y, E158I / C, T160C, G171C, and V180C, more preferably A17F, F90D / T / E / Q / N, R138 / K, N204G, N211E, A215Y, E158C, T160C, G 171C, and V180C, and even more preferably selected from one amino acid substitution or combination of substitutions selected from A17F, F90D / T / E / Q / N, R138K, N204G, E158C+T160C, G171C+V180C, N204G+A17F, F90D+A215Y, F90D+A17F, F90D+A17F+N204G, F90D+A17F+N211E.

[0013] Another object of the invention is to provide a nucleic acid encoding an esterase of the invention. The invention also relates to an expression cassette or expression vector comprising said nucleic acid, and to a host cell comprising said nucleic acid, expression cassette or expression vector.

[0014] The invention also provides compositions comprising an esterase of the invention, a host cell of the invention, or an extract thereof.

[0015] A further object of the present invention is a method for producing an esterase according to the invention, comprising the steps of: (a) culturing a host cell according to the invention under conditions suitable for expression of a nucleic acid encoding an esterase, and optionally (b) recovering the esterase from the cell culture. The object of the present invention is to provide a method comprising the steps of:

[0016] A further object of the present invention is to provide a method for degrading polyesters or polyester-containing materials, comprising the steps of: (a) contacting the polyester with an esterase according to the invention, or a host cell according to the invention, or a composition according to the invention, and optionally (b) recovering the monomers and / or oligomers. The object of the present invention is to provide a method comprising the steps of:

[0017] Advantageously, at least step a) is carried out under acidic conditions, in particular at a pH between 3 and 6, preferably between 5 and 5.5.

[0018] In particular, the present invention provides a method for degrading PET, comprising the steps of contacting PET with at least one esterase of the present invention and, optionally, recovering PET monomers and / or oligomers. Advantageously, at least the step of contacting PET with said esterase of the present invention is carried out under acidic conditions, in particular at a pH of 3 to 6, preferably at a pH of 5 to 5.5.

[0019] The present invention also relates to the use of an esterase according to the invention for degrading PET or plastic products containing PET, said use being advantageously carried out under acidic conditions, in particular at a pH between 3 and 6, preferably at a pH between 5 and 5.5.

[0020] The present invention also relates to polyester-containing materials comprising the esterases or host cells or compositions of the invention.

[0021] The present invention also relates to detergent compositions comprising an esterase or a host cell according to the invention, or a composition comprising an esterase of the invention. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0022] definition The present disclosure will be best understood by reference to the following definitions.

[0023] Here, the terms "peptide", "polypeptide", "protein" and "enzyme" refer to a chain of amino acids linked by peptide bonds, regardless of the number of amino acids forming said chain. Amino acids are represented herein by one-letter or three-letter codes according to the following nomenclature: A: alanine (Ala); C: cysteine ​​(Cys); D: aspartic acid (Asp); E: glutamic acid (Glu); F: phenylalanine (Phe); G: glycine (Gly); H: histidine (His); I: isoleucine (Ile); K: lysine (Lys); L: leucine (Leu); M: methionine (Met); N: asparagine (Asn); P: proline (Pro); Q: glutamine (Gln); R: arginine (Arg); S: serine (Ser); T: threonine (Thr); V: valine (Val); W: tryptophan (Trp); and Y: tyrosine (Tyr).

[0024] The term "esterase" refers to an enzyme belonging to the class of hydrolases classified under EC 3.1.1 according to the enzyme nomenclature, which catalyzes the hydrolysis of esters to acids and alcohols. The term "cutinase" or "cutin hydrolase" refers to an esterase classified under EC 3.1.1.74 according to the enzyme nomenclature, which can catalyze the chemical reaction producing cutin monomers from cutin and water.

[0025] The term "wild-type protein" refers to the non-mutated version of the polypeptide as it occurs in nature, in which case wild-type esterase refers to the esterase having the amino acid sequence set forth in SEQ ID NO:1.

[0026] The term "parent protein" refers to a reference polypeptide, where parent esterase refers to any of the esterases having the amino acid sequence set forth in SEQ ID NO:1, SEQ ID NO:2, or SEQ ID NO:3.

[0027] The terms "mutant" and "variant" refer to a polypeptide derived from SEQ ID NO: 1, which comprises at least one modification or change (i.e., substitution, insertion, and / or deletion) at one or more (e.g., several) positions compared to SEQ ID NO: 1, and which has polyesterolytic activity. In a particular embodiment, the mutant is derived from SEQ ID NO: 2, which corresponds to the amino acid sequence of SEQ ID NO: 1, and has the substitution combination F208M+D203C+S248C+V170I+Y92G+N213P+Q182E compared to SEQ ID NO: 1. In another particular embodiment, the mutant is derived from SEQ ID NO: 3, which corresponds to the amino acid sequence of SEQ ID NO: 1, and has the substitution combination F208M+D203C+S248C+V170I+Y92G+N213P+Q182E+S13L+D158E compared to SEQ ID NO: 1. In other words, a variant derived from SEQ ID NO: 2 or SEQ ID NO: 3 comprises at least one of these substitution combinations compared to SEQ ID NO: 1, as well as one or more additional substitutions. Variants can be obtained by various techniques known in the art.Specifically, examples of techniques for modifying the DNA sequence encoding wild-type protein include, but are not limited to, site-directed mutagenesis, random mutagenesis, and synthetic oligonucleotide construction.Therefore, the terms "modification" and "modification" when used herein with respect to a specific position, mean that the amino acid at this specific position is modified compared to the amino acid at this specific position of wild-type protein.

[0028] "Substitution" means that an amino acid residue is replaced by another amino acid residue. Preferably, the term "substitution" refers to the replacement of an amino acid residue by another amino acid residue selected from the 20 standard naturally occurring amino acid residues, rare naturally occurring amino acid residues (e.g., hydroxyproline, hydroxylysine, allohydroxylysine, 6-N-methyllysine, N-ethylglycine, N-methylglycine, N-ethylasparagine, allo-isoleucine, N-methylisoleucine, N-methylvaline, pyroglutamine, aminobutyric acid, ornithine, norleucine, norvaline), and non-naturally occurring amino acid residues that are often synthetically produced (e.g., cyclohexyl-alanine). Preferably, the term "substitution" refers to the replacement of an amino acid residue by another amino acid residue selected from the 20 standard naturally occurring amino acid residues (G, P, A, V, L, I, M, C, F, Y, W, H, K, R, Q, N, E, D, S, and T). The symbol "+" indicates a combination of substitutions. The following terms are used herein to designate substitutions: L82A indicates that the amino acid residue at position 82 of the parent sequence (leucine, L) is replaced by alanine (A). A121V / I / M indicates that the amino acid residue at position 121 of the parent sequence (alanine, A) is replaced by one of the following amino acids: valine (V), isoleucine (I), or methionine (M). Substitutions can be conservative or non-conservative. Examples of conservative substitutions are found within the groups of basic amino acids (arginine, lysine, and histidine), acidic amino acids (glutamic acid and aspartic acid), polar amino acids (glutamine, asparagine, and threonine), hydrophobic amino acids (methionine, leucine, isoleucine, cysteine, and valine), aromatic amino acids (phenylalanine, tryptophan, and tyrosine), and small amino acids (glycine, alanine, and serine).

[0029] Unless otherwise specified, positions disclosed in this application are numbered with reference to the amino acid sequence set forth in SEQ ID NO:1.

[0030] As used herein, the term "sequence identity" or "identity" refers to the number (or percentage) of matches (identical amino acid residues) between two polypeptide sequences. Sequence identity is determined by comparing sequences when aligned to maximize overlap and identity while minimizing sequence gaps. In particular, sequence identity can be determined using any of a number of mathematical global or local alignment algorithms, depending on the length of the two sequences. Sequences of similar length are preferably aligned using a global alignment algorithm (e.g., the Needleman and Wunsch algorithm; Needleman and Wunsch, 1970), which optimally aligns sequences over their entire length, whereas sequences of substantially different lengths are preferably aligned using a local alignment algorithm (e.g., the Smith and Waterman algorithm (Smith and Waterman, 1981) or the Altschul algorithm (Altschul et al., 1997; Altschul et al., 2005). Alignments to determine percent amino acid sequence identity can be performed using, for example, the following methods: This is accomplished in a variety of ways within the art using computer software available on Internet websites such as http: / / www.ebi.ac.uk / Tools / emboss / . Those skilled in the art can determine the appropriate parameters for measuring alignment, such as any algorithm required to achieve maximum alignment over the entire length of the sequences being compared. For purposes herein, amino acid sequence identity values ​​% refer to values ​​generated using the pairwise sequence alignment program EMBOSS Needle, which uses the Needleman-Wunsch algorithm to generate the optimal global alignment of two sequences, with all search parameters set to default values, i.e., scoring matrix=BLOSUM62, gap open=11, gap extend=1.

[0031] "Polymer" refers to a compound or mixture of compounds having a structure composed of multiple monomers (repeating units) linked by covalent chemical bonds. In the context of the present invention, the term polymer includes natural or synthetic polymers composed of a single type of repeating unit (i.e., homopolymers) or a mixture of different repeating units (i.e., copolymers or heteropolymers). According to the present invention, "oligomer" refers to a molecule containing from 2 to about 20 monomers.

[0032] In the context of the present invention, "polyester-containing material" or "polyester-containing product" refers to a product (e.g., a plastic product) that contains at least one polyester in crystalline, semi-crystalline, or completely amorphous form. In a particular embodiment, polyester-containing material refers to any item made of at least one plastic material, such as plastic sheets, tubes, rods, profiles, shapes, films, chunks, fibers, etc., containing at least one polyester and, optionally, other substances or additives, such as plasticizers, inorganic or organic fillers. In another particular embodiment, polyester-containing material refers to a plastic compound or plastic blend in a molten or solid state that is suitable for making plastic products. In another particular embodiment, polyester-containing material refers to a textile, fabric, or fiber that contains at least one polyester. In another particular embodiment, polyester-containing material refers to a plastic waste or fiber waste that contains at least one polyester. In particular, plastic products refer to industrial products, such as rigid or flexible packaging (bottles, trays, cups, etc.), agricultural films, bags and sacks, disposable goods, etc., carpet scraps, fabrics, textiles, etc. The plastic product may contain additional substances or additives such as plasticizers, inorganic or organic fillers or dyes. In the context of the present invention, the plastic product may contain a mixture of semi-crystalline and / or amorphous polymers and / or additives.

[0033] As used herein, the term "polyester" includes, but is not limited to, polyethylene terephthalate (PET), polytrimethylene terephthalate (PTT), polybutylene terephthalate (PBT), polyethylene isosorbide terephthalate (PEIT), polylactic acid (PLA), polyhydroxyalkanoates (PHA), polybutylene succinate (PBS), polybutylene succinate adipate (PBSA), polybutylene adipate terephthalate (PBAT), polyethylene furanoate (PEF), polycaprolactone (PCL), poly(ethylene adipate) (PEA), polyethylene naphthalate (PEN), and blends / mixtures of these polymers. Polyesters may also include "polyolefin-like" polyesters (preferably "polyethylene-like" polyesters), which correspond to polyolefins (preferably polyethylenes) into which ester segments have been introduced (generally achieved by polycondensation of long-chain α,ω-difunctional monomers), as defined in Lebarbe et al. Green Chemistry Issue 4 2014.

[0034] Novel esterases The present invention provides novel esterases that have improved activity and / or thermostability under acidic conditions, specifically at a pH of 3-6, compared to the parent esterases. More specifically, the inventors have designed novel enzymes that are particularly suitable for use in industrial processes under acidic conditions. The esterases of the present invention are particularly suitable for degrading polyesters, more specifically PET, such as PET-containing materials, specifically plastic products that contain PET. In a specific embodiment, the esterases show both increased activity and increased thermostability under acidic conditions compared to the parent esterases.

[0035] According to the present invention, "acidic conditions" refers to conditions (e.g., medium, solution, etc.) with a pH of 3 to 6. Specifically, "acidic conditions" refers to conditions for carrying out a polyester degradation step, i.e., conditions in which an esterase is contacted with a polyester in a medium having a pH of 3 to 6.

[0036] The esterase of the present invention exhibits higher activity and / or higher thermostability under acidic conditions compared to the parent esterase. Specifically, the esterase of the present invention exhibits higher activity and / or higher thermostability when presented at a pH of 3 to 6 compared to the parent esterase. According to the present invention, this higher activity and / or higher thermostability can be observed at a specific pH of 3 to 6 and / or in a pH range of 3 to 6. Specifically, this higher activity and / or higher thermostability can be observed at least at pH 3, pH 3.5, pH 4, pH 4.5, pH 5, pH 5.2, pH 5.5, and / or pH 6. This higher activity and / or higher thermostability can also be observed in the entire range of pH 3 to 6, the entire range of pH 4 to 6, the entire range of pH 4.5 to 6, the entire range of pH 5 to 6, the entire range of pH 5.5 to 6, the entire range of pH 5 to 5.5, the entire range of pH 5 to 5.2, and the entire range of pH 5.2 to 5.5.

[0037] It is therefore an object of the present invention to provide esterases which show higher activity at a pH between 3 and 6 compared to esterases having the amino acid sequence set forth in the parent esterase at the same pH. In the context of the present invention, the parent esterase may be any of the esterases of SEQ ID NO: 1, SEQ ID NO: 2 or SEQ ID NO: 3.

[0038] Specifically, the inventors have identified certain amino acid substitutions in SEQ ID NO:1 that advantageously increase the activity of the esterase on polymers, specifically polyesters, more specifically polyethylene terephthalate (PET), under acidic conditions.

[0039] In the context of the present invention, the term "high activity" or "high degradation activity" refers to a higher ability of the esterase to degrade and / or adsorb the same polyester under given conditions (e.g., temperature, pH, concentration) compared to the ability of the parent esterase to degrade and / or adsorb the same polyester. Specifically, the esterase of the present invention has increased PET degradation activity. Such an increase may be at least 10% higher than the PET degradation activity of the parent esterase, and preferably at least 20%, 30%, 40%, 50%, 60%, 70%, 80%, 90%, 100%, 110%, 120%, 130% or higher. Specifically, degradation activity refers to depolymerization activity resulting in polyester monomers and / or oligomers, which may be further recovered and optionally reused. In the context of the present invention, the esterases exhibit a higher degradation activity at at least a pH between 3 and 6 compared to the degradation activity of the parent esterase at the same pH. Preferably, the esterases exhibit a higher activity at least at a pH between 4 and 6, preferably at a pH between 5 and 6, more preferably at a pH between 5 and 5.5, even more preferably at pH 5.2.

[0040] The "degradation activity" of an esterase may be evaluated by a person skilled in the art according to methods known in the art. For example, the degrading activity may be evaluated by measuring the depolymerization activity rate of a specific polymer, measuring the decomposition rate of a solid polymeric compound dispersed in an agar plate, or measuring the depolymerization activity rate of a polymer in a reactor. Specifically, the degrading activity may be evaluated by measuring the "specific degrading activity" of an esterase. The "specific degrading activity" of an esterase for PET corresponds to the PET μmol / min hydrolyzed or the equivalent amount of TA generated mg / hr per mg of esterase during the initial period of the reaction (i.e., the first 24 hours), and is determined from the linear portion of the hydrolysis curve of the reaction, such a curve being established by several samplings performed at various times during the first 24 hours. As another example, the "degradation activity" may be evaluated by measuring the rate and / or yield of oligomers and / or monomers released under appropriate conditions of temperature, pH, and buffer when a polymer or a plastic product containing a polymer is contacted with a degrading enzyme after a specified period of time (e.g., 24 hours, 48 ​​hours, or 72 hours).

[0041] The ability of an enzyme to adsorb to a substrate can be assessed by one of skill in the art according to methods known in the art. For example, the ability of an enzyme to adsorb to a substrate can be measured from a solution containing the enzyme, which has been pre-incubated with the substrate under suitable conditions.

[0042] The inventors have also identified target amino acids in the parent esterase that can be advantageously modified to improve the stability (i.e., improve thermostability) of the corresponding esterase under acidic conditions and at elevated temperatures (advantageously at temperatures between 50°C and 90°C, preferably at temperatures above 60°C, and more preferably at temperatures above 65°C).

[0043] Therefore, the object of the present invention is to provide a novel esterase that exhibits high thermostability at pH 3 to 6 compared to that of an esterase having an amino acid sequence described in the parent esterase.

[0044] In the context of the present invention, the term "high thermostability" refers to the increased ability of an esterase to resist changes in its chemical and / or physical structure at elevated temperatures, specifically temperatures between 50° C. and 90° C., as compared to the parent esterase. In certain embodiments, the thermostability of the esterase is improved under acidic conditions at temperatures between 50° C. and 90° C., between 50° C. and 80° C., between 50° C. and 75° C., between 50° C. and 70° C., between 50° C. and 65° C., between 55° C. and 90° C., between 55° C. and 80° C., between 55° C. and 75° C., between 55° C. and 70° C., between 55° C. and 65° C., between 60° C. and 90° C., between 60° C. and 80° C., between 60° C. and 75° C., between 60° C. and 70° C., between 60° C. and 65° C., between 65° C. and 90° C., between 65° C. and 80° C., between 65° C. and 75° C., between 65° C. and 70° C., as compared to the thermostability of the parent esterase. Specifically, the thermostability of the present esterases is improved under acidic conditions compared to the thermostability of the parent esterase at temperatures between 40° C. and 80° C., between 50° C. and 72° C., between 55° C. and 60° C., between 50° C. and 55° C., and between 60° C. and 72° C. In certain embodiments, the thermostability of the present esterases is improved compared to the thermostability of the parent esterase at temperatures between at least 50° C. and 65° C. In the context of the present invention, temperatures are given to + / - 1° C.

[0045] Specifically, thermostability may be assessed by evaluation of the melting temperature (Tm) of the esterase. In the context of the present invention, "melting temperature" refers to the temperature at which half of the enzyme population under consideration is unfolded or misfolded. Typically, the esterases of the present invention exhibit an increase in Tm of about 0.8°C, 1°C, 2°C, 3°C, 4°C, 5°C, 10°C, or more at a pH of 3-6 compared to the Tm of the parent esterase. Specifically, at a pH of 3-6, the esterases of the present invention may have an extended half-life at temperatures between 50°C and 90°C compared to the parent esterase. Specifically, the esterase of the present invention may have an extended half-life at temperatures of 50° C. to 90° C., 50° C. to 80° C., 50° C. to 75° C., 50° C. to 70° C., 50° C. to 65° C., 55° C. to 90° C., 55° C. to 80° C., 55° C. to 75° C., 55° C. to 70° C., 55° C. to 65° C., 60° C. to 90° C., 60° C. to 80° C., 60° C. to 75° C., 60° C. to 70° C., 60° C. to 65° C., 65° C. to 90° C., 65° C. to 80° C., 65° C. to 75° C., 65° C. to 70° C., at a pH of 3 to 6, compared to the parent esterase. Advantageously, the esterase of the present invention has an extended half-life at temperatures of at least 50° C. to 60° C. at a pH of 3 to 6, compared to the parent esterase.

[0046] In the context of the present invention, the esterase of the present invention exhibits high thermostability at least at a pH of 3 to 6, as compared to an esterase having the amino acid sequence set forth in SEQ ID NO: 1, SEQ ID NO: 2, or SEQ ID NO: 3 (i.e., the parent esterase). Preferably, the esterase exhibits high thermostability at least at a pH of 4 to 6, preferably at a pH of 5 to 6, more preferably at a pH of 5 to 5.5, and even more preferably at pH 5.2.

[0047] The melting temperature (Tm) of esterase can be evaluated by those skilled in the art according to methods known in the art. For example, DSF can be used to quantify the change in thermal denaturation temperature of esterase, thereby determining the Tm of this esterase. Alternatively, Tm can be evaluated by analyzing protein folding using circular dichroism. Preferably, Tm is measured using DSF or circular dichroism, as shown in the experimental section. In the context of the present invention, comparison of Tm is performed with Tm measured under the same conditions (e.g. pH, nature and amount of polyester, etc.).

[0048] Alternatively, thermostability may be assessed by measuring the esterase and / or polyester depolymerization activity of the esterase after incubation at various temperatures and comparing it to the esterase and / or polyester depolymerization activity of the parent esterase. The ability to perform multiple polyester depolymerization assays at various temperatures may also be evaluated. A rapid and informative test may consist of evaluating the ability of the esterase to degrade solid polyester compounds dispersed in agar plates after incubation at various temperatures by halo diameter measurements.

[0049] According to the invention, these esterases of the invention further exhibit higher polyesterolytic activity and / or higher thermostability in acidic conditions than in basic conditions compared to the enzymes of SEQ ID NO:1, SEQ ID NO:2 or SEQ ID NO:3 (i.e., the parent esterases). In the context of the present invention, "basic conditions" refers to conditions (e.g., medium, solution, etc.) at a pH above 7, preferably at a pH between 7 and 9. In particular, these esterases are efficient and stable compared to the parent esterases at a pH between 3 and 6, in particular at a pH between 4 and 6, 5 and 6, 5 and 5.5, at a pH above 7, in particular at a pH between 7 and 9.

[0050] Therefore, an object of the present invention is an esterase variant, which (i) has at least 75%, 80%, 85%, 90%, 95%, 96%, 97%, 98% or 99% identity to the full-length amino acid sequence as set forth in SEQ ID NO:1, and (ii) has an amino acid substitution at at least one position corresponding to a residue selected from E141, G171 and V180, and / or R12A / I / M, S13L, A14C / Y, L15Q / G / I / D, A17F / V / Q / D, D18E, R30Y / L / Q / M / N / S / E, G37E / C, Y60H / C / G, T61Y / H / Q / E, S66E / W / D, L67I / E, W69I, R72I / T / L / V, R89E / G / V, F90D / T / H / E / G / P / S / Q / N, Y 92E, P93A, R138L / K / D / E, A127T, W155M / H / E, D158E / I / C, T160C, L202I, N204A, A205M / Q, S and (iv) exhibiting increased thermostability and / or increased polyester degrading activity at a pH of 3 to 6 compared to the esterase of SEQ ID NO: 1.

[0051] In one embodiment, the esterase exhibits a higher specific decomposition activity and / or a higher PET depolymerization yield after a defined period of time (e.g., after 24 hours, 48 ​​hours, or 72 hours) compared to the esterase of SEQ ID NO:1.

[0052] In certain embodiments, the esterase has at least one amino acid substitution at a position corresponding to a residue selected from E141, G171, and V180. Specifically, the esterase includes at least one substitution selected from E141C / K / R, G171C, and V180C.

[0053] According to the invention, the esterase may comprise at least the combination of substitutions at positions G171+V180, and preferably the combination of substitutions G171C+V180C.

[0054] According to the invention, the esterases are: T11, R12, S13, A14, L15, T16, A17, D18, R30, G37, Y60, T61, S66, L67, W69, R72, R89, F90, Y92, P93, A127, R138, W155, T157, D158, P179, Q182, F187, L20 2, N204, A205, S206, F208, A209, N211, S212, N213, N214, A215, I217, S218, V219, Y220, Q237, F238, L239, N241, N243, L247, H156, G135, V167, V170, D203, and S248. It may further comprise one substitution at at least one position, preferably R12, S13, A14, L15, A17, D18, R30, G37, Y60, T61, S66, L67, W69, R72, R89, F90, Y92, P93, R138, A127, W155, D158, T160, L202, N204, A20 5, S206, F208, A209, N211, S212, N213, N214, A215, I217, Y220, Q237, F238, L239, V242, L247, H156, G135, V167, V170, D203, and S248. Preferably, the esterase is selected from the group consisting of T11E, R12D / A / N / Q / I / M, S13E / L, A14D / E / C / Y, L50Q / G / I / D, T16E, A17T / V / Q / F / D, D18E, R30Y / L / Q / M / N / S / E, G37E / C, Y60H / C / G, T61S / Y / H / Q / E / V, S66E / W / D, L67I / E, W69I, R72I / T / L / V, R89E / G / V, F90G / P / S / T / A / Y / H / Q / N / D / E, Y92D / E / G, P93A, A127T , R138L / K / D / E, W155M / A / H / E, T157S, D158E / I, P179D / E, Q182D / E, F187Y / I, L202I, N204D / A / E / G, A205M / D / Q, S206D / E / V / I / N, F208V / G / N / K / R / I / A / Q / L / S / M / T / W / E, A209S / D / E, N211F / D / W / Y, S212T / A / Q / F, N213P / L / D, N214D / T, A215N / S / Y, I217L / C / V, S218A, V219I,and may further comprise at least one substitution selected from Y220M / W / C / T / F, Q237C / D / I, F238I / D / E, L239C, N241E / D, N243E / D, L247T / M, H156D, G135A, V167Q / T, V170I, D203C / E / R / K and S248C, preferably R1 2A / I / M, S13L, A14C / Y, L15Q / G / I / D, A17F / V / Q / D, D18E, R30Y / L / Q / M / N / S / E, G37E / C, Y60H / C / G, T61S / Y / H / Q / E, S66E / W / D, L67I / E, W69I, R72I / T / L / V, R89E / G / V, F90D / T / H / E / G / P / S / Q / N, Y92E, P93A, R138L / K / E, A127T, W155M / H / E, D158E / I / C, T160C, L202 I, N204A, A205M / Q, S206V / I / N, F208V / K, A209S / D / E, N211F / W, S212T / A / Q, N213L, N2 14T, A215S / Y, I217L / C / V, Y220W / C / T, Q237C / I, F238I / D, L239C, V242I, L247M, H156D, F187I, G135A, V167Q / T, V170I, D203C / E / R / K, and S248C.

[0055] According to the invention, the esterase may further comprise a substitution at position D203 (preferably selected from D203K / R) and at least amino acid residue S248, as in the parent esterase (i.e. the esterase of SEQ ID NO:1).

[0056] According to the invention, the esterase may comprise at least one combination of substitutions at positions selected from E141+D158, E141+T160, and E141+R138, preferably at least one combination of substitutions selected from E141C / K / R+D158E / I / C, E141C / K / R+T160C, and E141C / K / R+R138E / D, more preferably at least one combination of substitutions selected from E141C+D158C, E141C+T160C, and E141C+R138E.

[0057] In a particular embodiment, the amino acid sequence of the esterase consists of the amino acid sequence set forth in SEQ ID NO: 1 with one to three substitutions at positions selected from E141, G171, and V180, preferably with one or two substitutions at positions selected from G171 and V180. Specifically, the amino acid sequence of the esterase consists of the amino acid sequence set forth in SEQ ID NO: 1 with one to three substitutions selected from E141C / K / R, G171C, and V180C, preferably with one or two substitutions selected from G171C and V180C.

[0058] In another particular embodiment, the amino acid sequence of the esterase consists of the amino acid sequence set forth in SEQ ID NO:1, having one combination of substitutions at positions selected from G171+V180, E141+D158, E141+T160, and E141+R138, preferably having one combination of substitutions selected from G171C+V180C, E141C / K / R+D158E / I / C, E141C / K / R+T160C, and E141C / K / R+R138E / D, more preferably having one combination of substitutions selected from G171C+V180C, E141C+D158C, E141C+T160C, and E141C+R138E.

[0059] In another particular embodiment, the esterase variants have the following amino acid sequence as compared to the amino acid sequence SEQ ID NO:1: R12A / I / M, S13L, A14C / Y, L15Q / G / I / D, A17F / V / Q / D, D18E, R30Y / L / Q / M / N / S / E, G37E / C, Y60H / C / G, T61Y / H / Q / E, S66E / W / D, L67I / E, W69I, R72I / T / L / V, R89E / G / V, F90D / T / H / E / G / P / S / Q / N, Y92E, P93A, R138L / K / D / E, A127T, W1 and at least one amino acid substitution selected from 55M / H / E, D158E / I / C, T160C, L202I, N204A, A205M / Q, S206V / I / N, F208V / K, A209S / D / E, N211F / W, S212T / A / Q, N213L, N214T, A215S / Y, I217L / C / V, Y220W / C / T, Q237C / I, F238I / D, L239C, V242I, L247M, and H156D.

[0060] Specifically, the esterase is R12A / I / M, S13L, A14C / Y, L15Q / G / I / D, A17F / V / Q / D, D18E, R30Y / L / Q / M / N / S / E, G37E / C, Y60H / C / G, T61Y / H / Q / E, S66E / W / D, L67I / E, W69I, R72I / T / L / V, R89E / G / V, F90D / T / H / E / G / P / S / Q / N, Y92E, P93A, R138L, A12 and at least one substitution selected from: 7T, W155M / H / E, D158E / I, L202I, N204A, A205M / Q, S206V / I / N, F208V / K, A209S / D / E, N211F / W, S212T / A / Q, N213L, N214T, A215S / Y, I217L / C / V, Y220W / C / T, Q237C / I, F238I / D, L239C, V242I, L247M, and H156D.

[0061] In a preferred embodiment, the esterase comprises at least one substitution selected from S13L, A14C / Y, L15Q / G / I / D, A17F / V / Q / D, F90D / T / H / E / G / P / S / Q / N, Y92E, D158E / I / C, S206V / I / N, F208V / K, A127T, N211F / W, A215S / Y, Q237C / I, and H156D, preferably S13L, A14C / Y, L15Q, A17F / V, F90D / T, Y92E, D158E, S206I / N, F208K, A127T, N211F, A215Y, Q237C / I, and H156D. 37I, and H156D, more preferably at least one substitution selected from S13L, A14C / Y, A17F / V, F90D / T, Y92E, D158E, S206I / N, F208K, A127T, N211F, A215Y, Q237I, and H156D, and even more preferably at least one substitution selected from S13L, A14C / Y, A17F / V, F90D / T, Y92E, D158E, S206I, F208K, N211F, A215Y, Q237I, and H156D.

[0062] In one embodiment, the amino acid sequence of the esterase is R12A / I / M, S13L, A14C / Y, L15Q / G / I / D, A17F / V / Q / D, D18E, R30Y / L / Q / M / N / S / E, G37E / C, Y60H / C / G, T61Y / H / Q / E, S66E / W / D, L67I / E, W69I, R72I / T / L / V, R89E / G / V, F90D / T / H / E / G / P / S / Q / N, Y92E, P93A, R 138L / K / D / E, A127T, W155M / H / E, D158E / I / C, T160C, L202I, N204A, A205M / Q, S206V / I / N, F208V / K, A209S / D / E, N211 From F / W, S212T / A / Q, N213L, N214T, A215S / Y, I217L / C / V, Y220W / C / T, Q237C / I, F238I / D, L239C, V242I, L247M and H156D The amino acid sequence includes 1 to 42 substitutions selected from the group consisting of R12A / I / M, S13L, A14C / Y, L15Q / G / I / D, A17F / V / Q / D, D18E, R30Y / L / Q / M / N / S / E, G37E / C, Y60H / C / G, T61Y / H / Q / E, S66E / W / D, L67I / E, W69I, R72I / T / L / V, R89E / G / V, F90D / T / H / E / G / P / S / Q / N, Y92E, P93A, R138 and H156D.

[0063] In one embodiment, the amino acid sequence of the esterase is R12A / I / M, S13L, A14C / Y, L15Q / G / I / D, A17F / V / Q / D, D18E, R30Y / L / Q / M / N / S / E, G37E / C, Y60H / C / G, T61Y / H / Q / E, S66E / W / D, L67I / E, W69I, R72I / T / L / V, R89E / G / V, F90D / T / H / E / G / P / S / Q / N, Y92E, P93A, R138L / K / L, R14L / K / L, R ...4L / K / L, R14L / K / L, R14L / K / L, R14L / K / L, R14L / K / L, R14L / K / L, R14L / K / L, R14L / K / L, R14L / K / L, R14L / K / L, R14L / K / L, R14L / K / L, R14L / K / L, R14L / K / L, R14L / K / L, R14L / K / L, R14L / K / L 1 to 42 substitutions selected from D / E, A127T, W155M / H / E, D158E / I / C, T160C, L202I, N204A, A205M / Q, S206V / I / N, F208V / K, A209S / D / E, N211F / W, S212T / A / Q, N213L, N214T, A215S / Y, I217L / C / V, Y220W / C / T, Q237C / I, F238I / D, L239C, V242I, L247M, and H156D and preferably R12A / I / M, S13L, A14C / Y, L15Q / G / I / D, A17F / V / Q / D, D18E, R30Y / L / Q / M / N / S / E, G37E / C, Y60H / C / G, T61Y / H / Q / E, S66E / W / D, L67I / E, W69I, R72I / T / L / V, R89E / G / V, F90D / T / H / E / G / P / S / Q / N, Y92E, P93A, R138L, A127T, W155M / H / E, D The amino acid sequence is as set forth in SEQ ID NO:1, having 1 to 41 substitutions selected from 158E / I, L202I, N204A, A205M / Q, S206V / I / N, F208V / K, A209S / D / E, N211F / W, S212T / A / Q, N213L, N214T, A215S / Y, I217L / C / V, Y220W / C / T, Q237C / I, F238I / D, L239C, V242I, L247M and H156D.

[0064] In one embodiment, the amino acid sequence of the esterase is R12A / I / M, S13L, A14C / Y, L15Q / G / I / D, A17F / V / Q / D, D18E, R30Y / L / Q / M / N / S / E, G37E / C, Y60H / C / G, T61Y / H / Q / E, S66E / W / D, L67I / E, W69I, R72I / T / L / V, R89E / G / V, F90D / T / H / E / G / P / S / Q / N, Y92E, P93A, R138L / Q / M, R14L / Q / M, R ... A single position selected from K / D / E, A127T, W155M / H / E, D158E / I / C, T160C, L202I, N204A, A205M / Q, S206V / I / N, F208V / K, A209S / D / E, N211F / W, S212T / A / Q, N213L, N214T, A215S / Y, I217L / C / V, Y220W / C / T, Q237C / I, F238I / D, L239C, V242I, L247M, and H156D. and preferably R12A / I / M, S13L, A14C / Y, L15Q / G / I / D, A17F / V / Q / D, D18E, R30Y / L / Q / M / N / S / E, G37E / C, Y60H / C / G, T61Y / H / Q / E, S66E / W / D, L67I / E, W69I, R72I / T / L / V, R89E / G / V, F90D / T / H / E / G / P / S / Q / N, Y92E, P93A, R138L, A127T, W155M / H / E , D158E / I, L202I, N204A, A205M / Q, S206V / I / N, F208V / K, A209S / D / E, N211F / W, S212T / A / Q, N213L, N214T, A215S / Y, I217L / C / V, Y220W / C / T, Q237C / I, F238I / D, L239C, V242I, L247M and H156D.

[0065] According to the present invention, the esterase has at least 75%, 80%, 85%, 90%, 95%, 96%, 97%, 98% or 99% identity to the full-length amino acid sequence set forth in SEQ ID NO:1, has at least one of the substitutions listed above, and may further include one substitution at at least one position selected from E141, G171, V180, preferably at least one substitution selected from E141C / K / R, G171C, and V180C.This esterase is T11, R12, S13, A14, T16, A17, T61, F90, Y92, W155, T157, P179, Q182, F187, D203, N204, A205, S206, F208, N211, S212, N213, N214, A215, S218, V129, Y220, Q and / or at least one substitution at a position selected from T11E / M, R12D / N / Q / E / F, S13E, A14E / D, T16E, A17T, A24R, T61V, A6 2D, F90A / Y, Y92G / D, W155A, T157S, P179D / E, Q182D / E, F187Y / I, D203C / K / R, N204D / E / G, A205D, S206D / E, F208W / G / N / R / I / A / Q / L / S / M / T / E, N211D / Y / E, S212F, N213P / D, N214D, A215N, S218A, V129I, Y220M / F, Q237D, F238E, N241E / D, N243E / D, L247T, G135A, V167Q / T, V170I, and S248C, more preferably at least one substitution selected from A14E, F90A and S248C, and even more preferably, may further comprise at least one substitution selected from F90A Y92G, Q182D / E, D203C / K / R, N204G, F208W / G / N / R / I / A / Q / L / S / M / T / E, N211D / E, N213P, V219I, V170I, and S248C.

[0066] The object of the present invention is also an esterase variant, which (i) has at least 75%, 80%, 85%, 90%, 95%, 96%, 97%, 98% or 99% identity to the full length amino acid sequence set forth in SEQ ID NO:1, and (ii) has at least one of the following amino acid sequences as compared to the amino acid sequence SEQ ID NO:1: E141C / K / R, G171C, V180C, R12A / I / M, S13L, A14C / Y, L15Q / G / I / D, A17F / V / Q / D, D18E, R30Y / L / Q / M / N / S / E, G37E / C, Y60H / C / G, T61Y / H / Q / E, S66E / W / D, L67I / I / M, G3 ...I / M, G37I / I / I / M, G37I / I / I / M, G37I / I / I / M, G37I / I / I / I, G37I / I / I / I, G37I / I / I / I, G37I / I / I / I, G37I / I / E, W69I, R72I / T / L / V, R89E / G / V, F90D / T / H / E / G / P / S / Q / N, Y92E, P93A, R138L / K / D / E, A127T, W155M / H / E, D158E / I / C, T160C, L202I, N204A, A205M / Q, S206V / I / N, F208V / K, and (iv) exhibiting increased thermostability and / or increased polyester degrading activity at a pH of 3 to 6 compared to the esterase of SEQ ID NO: 1.

[0067] According to the invention, the esterase is selected from the group consisting of S13L, A14C / Y, L15Q / G / I / D, A17F / V / Q / D, F90D / T / H / E / G / P / S / Q / N, Y92E, D158E / I / C, S206V / I / N, F208V / K, A127T, N211F / W, A215S / Y, Q237C / I, H156D, R12A / I / M, D18E, L67I / E, R72I / T / L / V, P93A, R138L, L239C, L202I, A209S, S212 T / A / Q, N213L, F238D, R30Y / L / Q / M / N / S / E, G37E / C, Y60H / C / G, T61Y / H / Q / E, S66E / W / D, R89E / G / V, and W155M / H, and preferably S13L, A14C / Y, L15Q, A17F / V, F90D / T / H / E / G / P / S / Q / N, Y92E, D158E, S206I / N, F208K, A127T, N211W / F, A215Y and at least one substitution selected from Q237I, H156D, R30Y / L / Q / M / N / S / E, G37E / C, Y60H / C / G, T61Y / H / Q / E, S66E / W / D, R89E / G / V, and W155M / H, and more preferably S13L, A14C / Y, A17F / V, F90 D / T, Y92E, D158E, S206I / N, F208K, A127T, N211W / F, A215Y, Q237I, H156D, R12I / M , L15Q, R72T, S212A, N213L, R30Y / L / Q / M / S / E, G37E, Y60H / C / G, T61Y / H / Q / E, S66E / and W155M / H, and even more preferably, at least one substitution selected from S13L, A14C / Y, A17F / V, F90D / T / H / E / G / P / S / Q / N, Y92E, D158E, S206I, F208K, N211W / F, A215Y, Q237I, H156D, R72T, S212A, N213L, R30Y / L / Q / M / S / E, G37E, Y60H / C / G, T61Y / H / Q / E, S66E / W / D, R89E / G / V, and W155M / H.

[0068] Specifically, the esterase is R12A / I / M, S13L, A14C / Y, L15Q / G / I / D, A17F / V / Q / D, D18E, R30Y / L / Q / M / N / S / E, G37E / C, Y60H / C / G, T61Y / H / Q / E, S66E / W / D, L67I / E, W69I, R72I / T / L / V, R89E / G / V, F90D / T / H / E / G / P / S / Q / N, Y92E, P93A, R138L, A12 and at least one substitution selected from: 7T, W155M / H / E, D158E / I, L202I, N204A, A205M / Q, S206V / I / N, F208V / K, A209S / D / E, N211F / W, S212T / A / Q, N213L, N214T, A215S / Y, I217L / C / V, Y220W / C / T, Q237C / I, F238I / D, L239C, V242I, L247M, and H156D.

[0069] In one embodiment, the esterase is selected from the group consisting of 12A / I / M, A14C / Y, L15Q / D, A17V / Q / F, D18E, L67I / E, R72I / T / L / V, P93A, R138L, L239C, L202I, S206V, A209S, S212T / A / Q, N213L, F238D, Q237C / I, R30Y / L / Q / M / N / S / E, G37E / C, Y60H / C / G, T61Y / H / Q / E, S66E / W, / D, R89E / G / V, F90G / P / S / T / H / Q / N / D / E, Y92E, W155M / H, and N211W / F, preferably R12I / M, A14C, L15Q, A17Q, L67I, R72T / L, P93A, S212A / Q, N213L, Q237C / I, R30Y / L / Q / M / N / S / E, G37E / C, Y60H / C / G, T61Y / H / Q / E, and at least one substitution selected from S66E / W / D, R89E / G / V, F90G / P / S / T / H / Q / N / D / E, W155M / H, and N211W / F, more preferably R12I / M, L15Q, R72T, S212A, N213L, R30Y / L / Q / M / S / E, G37E, Y60H / C / G, T61Y / H / Q / E, S66E / W / D, R89E / G / V, F90G / P / S / T / H / Q / N / D / E, W155M / H, and N211W / F. and N / D / E, W155M / H, and N211W / F, and even more preferably, R72T, S212A, N213L, R30Y / L / Q / M / S / E, G37E, Y60H / C / G, T61Y / H / Q / E, S66E / W / D, R89E / G / V, F90G / P / S / T / H / Q / N / D / E, W155M / H, and N211W / F.

[0070] Preferably, the esterase comprises at least one substitution selected from S13L, A14C / Y, L15Q / G / I / D, A17F / V / Q / D, F90D / T / H / E / G / P / S / Q / N, Y92E, D158E / I / C, S206V / I / N, F208V / K, A127T, N211F / W, A215S / Y, Q237C / I, and H156D, preferably S13L, A14C / Y, L15Q, A17F / V, F90D / T, Y92E, D158E, S206I / N, F208K, A127T, N211F, A215Y, Q237 I, and H156D, more preferably at least one substitution selected from S13L, A14C / Y, A17F / V, F90D / T, Y92E, D158E, S206I / N, F208K, A127T, N211F, A215Y, Q237I, and H156D, and even more preferably at least one substitution selected from S13L, A14C / Y, A17F / V, F90D / T, Y92E, D158E, S206I, F208K, N211F, A215Y, Q237I, and H156D. In another preferred embodiment, the esterase comprises at least one substitution selected from S13L, L15Q, A17F, F90D, and D158E, preferably at least one substitution selected from S13L, A17F, and F90D.

[0071] According to an embodiment, the esterase is selected from S13L, A14C / Y, L15Q / G / I / D, A17F / V / Q / D, F90D / T / H / E / G / P / S / Q / N, Y92E, D158E / I / C, S206V / I / N, F208V / K, A127T, N211F / W, A215S / Y, Q237C / I, and H156D, preferably selected from S13L, L15Q, A17F, F90D, and D158E, more preferably selected from Preferably, the amino acid sequence includes at least one substitution selected from S13L, A17F, and F90D, and at least one combination of substitutions selected from F208M+D203C+S248C+V170I+Y92G+N213P+Q182E, or F208M+D203K+V170I+Y92G+N213P+Q182E, preferably the combination of substitutions F208M+D203C+S248C+V170I+Y92G+N213P+Q182E.

[0072] According to the invention, the esterase may comprise at least two substitutions selected from S13L, A14C / Y, L15Q / G / I / D, A17F / V / Q / D, F90D / T / H / E / G / P / S / Q / N, D158E / I / C, A215S / Y, Q237C / I, and H156D, preferably at least two substitutions selected from S13L, A14C / Y, L15Q, A17F / V, F90D / T, D158E, A215Y, Q237I, and H156D, more preferably at least two substitutions selected from S13L, A14Y, L15Q, A17F / V, F90D, D158E, A215Y, Q237I, and H156D.

[0073] In one embodiment, the esterase is selected from the group consisting of S13L, A14C / Y, L15Q / G / I / D, A17F / V / Q / D, F90D / T / H / E / G / P / S / Q / N, Y92E, D158E / I / C, F208V / K, N211F / W, A215S / Y, Q237C / I, Q182E+A127T, H156D, R12A / I / M, D18E, L67I / E, R72I / T / and at least one substitution or combination of substitutions selected from L / V, P93A, R138L, L239C, L202I, S206V, A209S, S212T / A / Q, N213L, F238D, R30Y / L / Q / M / N / S / E, G37E / C, Y60H / C / G, T61Y / H / Q / E, S66E / W / D, R89E / G / V, and W155M / H, preferably For S13L, A14C, L15Q, A17F / Q, F90D / T / H / E / G / P / S / Q / N, Y92E, D158E, F208K, N211F / W, A215Y, Q237C / I, Q182E+A127T, H156D, R12I / M, L67I, R72T / L, P93A, S212A / Q, N213L, R30Y / L / Q / M / N / S / E, G37E / C, Y and comprising at least one substitution or combination of substitutions selected from 60H / C / G, T61Y / H / Q / E, S66E / W / D, R89E / G / V, and W155M / H, and exhibiting higher polyester degradation activity than the esterase of SEQ ID NO: 1 at a pH of 4 to 6, preferably at a pH of 5 to 6, more preferably at a pH of 5 to 5.5, and even more preferably at pH 5.2.

[0074] According to an embodiment, the esterase comprises at least one substitution selected from S13L, A14C / Y, L15Q / G / I / D, A17F / V / Q / D, F90D / T / H / E / G / P / S / Q / N, Y92E, D158E / I / C, S206V / I / N, F208V / K, A127T, N211F / W, A215S / Y, Q237C / I, and H156D, preferably S13L, A14C / Y, L15Q, The esterase comprises at least one substitution selected from A17F / V, F90D / T, Y92E, D158E, S206I / N, F208K, A127T, N211F, A215Y, Q237I, and H156D, and exhibits higher polyester decomposition activity and / or higher thermostability at a pH of 4 to 6, preferably at a pH of 5 to 6, more preferably at a pH of 5 to 5.5, and even more preferably at pH 5.2, compared to the esterase of SEQ ID NO: 1.

[0075] According to one embodiment, the esterase comprises at least the substitution H156D and exhibits increased PET depolymerization yields after 24 hours and / or 48 hours compared to the esterase of SEQ ID NO:1.

[0076] In one embodiment, the esterase comprises at least one substitution or combination of substitutions selected from S13L, A14C, A17F, F90D / T, Y92E, F208K, N211F, A215Y, and Q237I, and exhibits increased specific cleavage activity compared to the esterase of SEQ ID NO:1.

[0077] According to an embodiment, the esterase is selected from the group consisting of R12A / I / M, A14C / Y, L15Q / D, A17V / Q / F, D18E, L67I / E, R72I / T / L / V, P93A, R138L, L239C, L202I, S206V, A209S, S212T / A / Q, N213L, F238D, Q237C / I, R30Y / L / Q / M / N / S / E, G37E / C, Y60H / C / G, T61Y / H / Q / E, S66E / W / D, R89E / G / V, F90G / P / S / T / H / Q / N / D / E, Y92E, W155M / H, and N211W / F, preferably R12I / M, A14C, L15Q, A17Q, L67I, R72T / L, P93A, S212A / Q, N213L, Q237C / I, R30Y / L / Q / M / N / S / E, G37E / C, Y60H / C / G, T61Y / H / Q / E, S66E / W / D, and at least one substitution selected from R89E / G / V, F90G / P / S / T / H / Q / N / D / E, W155M / H, and N211W / F, more preferably R12I / M, L15Q, R72T, S212A, N213L, R30Y / L / Q / M / S / E, G37E, Y60H / C / G, T61Y / H / Q / E, S66E / W / D, R89E / G / V, F90G / P / S / T / H / Q / N / D / E, W155M / H, and and N211W / F, and even more preferably comprising at least one substitution selected from R72T, S212A, N213L, R30Y / L / Q / M / S / E, G37E, Y60H / C / G, T61Y / H / Q / E, S66E / W / D, R89E / G / V, F90G / P / S / T / H / Q / N / D / E, W155M / H, and N211W / F, and having a higher PET depolymerization yield after 24 hours compared to SEQ ID NO:1.

[0078] In another embodiment, the esterase comprises at least one substitution or combination of substitutions selected from S13L, A14C / Y, L15Q / G / I / D, A17F / V / Q / D, F90D / T / H / E / G / P / S / Q / N, Y92E, D158E / I / C, F208V / K, N211F / W, A215S / Y, Q237C / I, Q182E+A127T, and H156D, preferably S13L, A14C, L15Q, A17F, F90D / T, Y92E, D158E, F208K, N211F, A215Y, Q237I, Q182E+A127T, and H156D. The esterase comprises at least one substitution or a combination of substitutions selected from 2E+A127T, and H156D, more preferably at least one substitution or a combination of substitutions selected from S13L, A14C, A17F, F90D / T, Y92E, F208K, N211F, A215Y, Q237I, and H156D, and exhibits higher polyester degradation activity than the esterase of SEQ ID NO: 1 at a pH of 4 to 6, preferably at a pH of 5 to 6, more preferably at a pH of 5 to 5.5, and even more preferably at pH 5.2.

[0079] Specifically, the esterase comprises at least one substitution or combination of substitutions selected from S13L, A14C / Y, L15Q / G / I / D, A17F / V / Q / D, F90D / T / H / E / G / P / S / Q / N, Y92E, D158E / I / C, F208V / K, N211F / W, A215S / Y, Q237C / I, and Q182E+A127T, and preferably S13L, A14C, L15Q, A17F, F90D / T, Y92E, D158E, F208K, N211F, A215Y, and Q237I. , Q182E+A127T, and H156D, more preferably at least one substitution or combination of substitutions selected from S13L, A14C, A17F, F90D / T, Y92E, F208K, N211F, A215Y, and Q237I, and exhibits a higher specific hydrolysis activity than the esterase of SEQ ID NO: 1 at a pH of 4 to 6, preferably at a pH of 5 to 6, more preferably at a pH of 5 to 5.5, and even more preferably at pH 5.2.

[0080] In another particular embodiment, the esterase comprises at least the substitution H156D and exhibits increased PET depolymerization yields after 48 hours compared to the esterase of SEQ ID NO:1 at a pH of 4-6, preferably at a pH of 5-6, more preferably at a pH of 5-5.5, and even more preferably at pH 5.2.

[0081] According to the present invention, the esterase may contain at least one substitution selected from S13L, D158E / I / C, F90D / T / H / E / G / P / S / Q / N, Q237C / I, A14C / Y, A17F / V / Q / D, D158E, and S206V / I / N, preferably at least one substitution selected from S13L, D158E, N204G, F90D, Q237I, A14Y, A17V, D158E, and S206I / N, more preferably selected from A14Y, A17V, D158E, and S206I, and exhibits high thermostability compared to the esterase of SEQ ID NO: 1 at a pH of 4 to 6, preferably at a pH of 5 to 6, more preferably at a pH of 5 to 5.5, and even more preferably at pH 5.2.

[0082] Advantageously, the esterase of the present invention exhibits higher polyester decomposition activity and / or higher thermostability in the pH range of 3 to 6 compared to the esterase of SEQ ID NO: 1. Specifically, the esterase of the present invention exhibits higher polyester decomposition activity and / or higher thermostability in the pH ranges of 3 to 6, 4 to 6, 5 to 6, 5 to 5.5, 5.2 to 5.5, 5.5 to 6, and 5 to 5.2 compared to the esterase of SEQ ID NO: 1. According to the present invention, the designation of a pH range includes the upper and lower limits of said range.

[0083] In one embodiment, the esterase of the present invention further exhibits higher thermostability and / or higher polyester decomposition activity at a pH of 6 to 10, preferably at a pH of 6.5 to 9, more preferably at a pH of 6.5 to 8, and even more preferably at pH 8, compared to the esterase of SEQ ID NO:1.

[0084] Specifically, the present esterase comprises at least one substitution selected from S13L, A14C / Y, L15Q / G / I / D, D158E / I / C, S206V / I / N, and N211F / W, preferably comprises at least one substitution selected from S13L, A14Y, L15Q, D158E, S206N, and N211F, more preferably comprises the substitution N211F, and exhibits higher heat resistance and / or higher polyester decomposition activity at a pH of 3 to 6, specifically at a pH of 5 to 5.5, compared to the esterase of SEQ ID NO: 1, and further exhibits higher heat resistance and / or higher polyester decomposition activity at a pH of 6 to 10, preferably at a pH of 6.5 to 9, more preferably at a pH of 6.5 to 8, and even more preferably at pH 8, compared to the esterase of SEQ ID NO: 1.

[0085] For example, the esterase contains at least one substitution selected from S13L, A14Y, L15Q, S206N, and N211F, preferably contains the substitution N211F, and exhibits higher polyester decomposition activity at a pH of 3 to 6, specifically at a pH of 5 to 5.5, compared to the esterase of SEQ ID NO: 1, and further exhibits higher polyester decomposition activity at a pH of 6 to 10, preferably at a pH of 6.5 to 9, more preferably at a pH of 6.5 to 8, and even more preferably at pH 8, compared to the esterase of SEQ ID NO: 1.

[0086] Alternatively, or in addition, the esterase contains at least the substitution D158E and exhibits higher heat resistance at a pH of 3 to 6, specifically at a pH of 5 to 5.5, compared to the esterase of SEQ ID NO:1, and further exhibits higher heat resistance at a pH of 6 to 10, preferably at a pH of 6.5 to 9, more preferably at a pH of 6.5 to 8, and even more preferably at pH 8, compared to the esterase of SEQ ID NO:1.

[0087] According to the invention, the esterase comprises at least one of the substitutions listed above and is selected from the group consisting of T11, R12, S13, A14, T16, A17, T61, F90, Y92, W155, T157, P179, Q182, F187, D203, N204, A205, S206, F208, N211, S212, N213, N214, A215, S218, V129, Y220, Q237, F238, N241, N243, and may further comprise a substitution at at least one position corresponding to a residue selected from L247, G135, V167, V170, and S248, preferably T11E / M, R12D / N / Q / E / F, S13E / D, A14E / D, T16E, A17T, A24R, T61V, A62D, F90A / Y, Y92G / D, W155A, T157S, P179D / E, Q182D / E, F187Y / I, D203C / K / R, N20 and may further comprise at least one substitution selected from 4D / E / G, A205D, S206D / E, F208W / G / N / R / I / A / Q / L / S / M / T / E, N211D / Y / E, S212F, N213P / D, N214D, A215N, S218A, V129I, Y220M / F, Q237D, F238E, N241E / D, N243E / D, L247T, G135A, V167Q / T, V170I, and S248C. , preferably further comprising at least one substitution selected from S13E / D, A14E / D, A17T, F90A / Y, Y92D / G, Q182D / E, D203C / K / R, N204D / E / G, S206D / E, F208W / G / N / R / I / A / Q / L / S / M / T / E, N211D / Y / E, N213P, A215N, V219I, Q237D, G135A, V167Q / T, V170I, and S248C.

[0088] According to the invention, the esterase may further comprise a substitution at position D203, preferably selected from D203K / R, and at least amino acid residue S248 as in the parent esterase.

[0089] In a particular embodiment, the esterase comprises the substitution S13L and at least one additional substitution selected from A14C / E / Y, L15Q / G / I / D, A17F / V / Q / D, F90D / T / H / E / G / P / S / Q / N, D158E / I / C, N204D / E / G, N211F / W / D / Y / E, A215S / Y, and Q237C / I, preferably selected from A14E, L15Q, A17F / V, F90D, D158E, N204G, N211E, A215Y, and Q237I. More preferably, the esterase comprises at least a combination of substitutions selected from S13L+D158E / I / C, preferably the combination of substitutions S13L+D158E.

[0090] According to the invention, the esterase may further comprise at least two substitutions at positions selected from Y92, G135, V167, V170, Q182, D203, F208, N213, and S248, and preferably at least three, four, or five substitutions. In certain embodiments, the esterase variant comprises at least two substitutions selected from Y92A / G / P / N / Q / T / F / C / D, G135A, V167Q / T, V170I, Q182E / D, D203E / R / K / C, F208W / I / L / G / S / N / A / R / T / H / M / E / Q / Y, N213D / E / R / K / P, and S248C, preferably selected from F208I / L / M / T, D203C / K / R, S248C, V170I, Y92G, G135A, V167Q, Q182E, and N213P, and preferably comprises at least three, four, five substitutions.

[0091] For example, the esterase further comprises the combination of substitutions at positions D203+S248, and preferably further comprises the combination of substitutions D203C+S248C.

[0092] In another example, the esterase may further comprise a combination of substitutions at least at positions F208+D203+S248, preferably selected from F208I / L / M / T+D203C+S248C. In one embodiment, the esterase comprises a combination of substitutions at least at positions F208+D203+S248 and one or two substitutions at positions selected from Y92, G135, V167, V170, Q182, and N213. Specifically, the esterase comprises at least a combination of substitutions selected from F208I / L / M / T+D203C+S248C and one substitution selected from Y92A / G / P / N / Q / T / F / C / D, G135A, V167Q / T, V170I, Q182E / D, and N213D / E / R / K / P, preferably Y92G, G135A, V167Q, V170I, Q182E, and N213P.

[0093] In another example, the esterase may further comprise a combination of substitutions at least at positions F208+D203, preferably selected from F208I / L / M / T+D203K / R. In one embodiment, the esterase comprises a combination of substitutions at least at positions F208+D203 and one or two substitutions at positions selected from Y92, G135, V167, V170, Q182, and N213. In particular, the esterase comprises at least the combination of substitutions F208I / L / M / T+D203K / R and one substitution selected from Y92A / G / P / N / Q / T / F / C / D, G135A, V167Q / T, V170I, Q182E / D and N213D / E / R / K / P, preferably selected from Y92G, G135A, V167Q, V170I, Q182E and N213P. Advantageously, in said embodiment, the esterase comprises at least the amino acid residue S248, like the parent esterase.

[0094] Non-repeatable waveforms are D203C + S248C and F208W / I / L / G / S / N / A / R / T / H / M / E / Q / Y + D203C + S248C、F208W / I / L / G / S / N / A / R / T / H / M / E / Q / Y + D203C + S248C + V170I、F208W / I / L / G / S / N / A / R / T / H / M / E / Q / Y + D203C + S248C + V170I + Y92A / G / P / N / Q / T / F / C / D、F208W / I / L / G / S / N / A / R / T / H / M / E / Q / Y + D203C + S248C + V170I + Y92A / G / P / N / Q / T / F / C / D + N213D / E / R / K / P、F208W / I / L / G / S / N / A / R / T / H / M / E / Q / Y + D203C + S248C + V170I + Y92A / G / P / N / Q / T / F / C / D + N213D / E / R / K / P + Q182D / E、F208W / I / L / G / S / N / A / R / T / H / M / E / Q / Y + D203K / R、F208W / I / L / G / S / N / A / R / T / H / M / E / Q / Y + D203K / R + V170I、F208W / I / L / G / S / N / A / R / T / H / M / E / Q / Y + D203K / R + V170I + Y92A / G / P / N / Q / T / F / C / D V170I + Y92A / G / P / N / Q / T / F / C / D + N213D / E / R / K / P、F208W / I / L / G / S / N / A / R / T / H / M / E / Q / Y + D203K / R + V170I + Y92A / G / P / N / Q / T / F / C / D + N213D / E / R / K / P+ Q182D / E is a smooth and 1-inch wavelength based on the D203C + S248C、F208W / I / L / G / S / N / A / R / T / H / M / E / Q / Y + D203C + S248C V170I、F208W / I / L / G / S / N / A / R / T / H / M / E / Q / Y + D203C + S248C + V170I +Y92A / G / P / N / Q / T / F / C / D, F208W / I / L / G / S / N / A / R / T / H / M / E / Q / Y + D203C + S248C + V170I + Y92A / G / P / N / Q / T / F / C / D + N213P, F208W / I / L / G / S / N / A / R / T / H / M / E / Q / Y + D203C + S248C + V170I + Y92A / G / P / N / Q / T / F / C / D + N213P + and more preferably at least one combination of substitutions selected from D203C+S248C, F208I / L / M / T+D203C+S248C, F208I / L / M / T+D203C+S248C+V170I, F208I / L / M / T+D203C+S248C+V170I+Y92G, F208I / L / M / T+D203C+S248C+V170I+Y92G+N213P, F208I / It may further comprise at least one combination of substitutions selected from: L / M / T+D203C+S248C+V170I+Y92G+N213P+Q182E, and even more preferably, it may further comprise at least one combination of substitutions selected from: F208M+D203C+S248C+V170I+Y92G+N213P+Q182E, or F208I+D203C+S248C+V170I+Y92G+N213P+Q182E.

[0095] In one embodiment, the esterase comprises at least one combination of substitutions selected from E141C+T160C, E141C+D158E / I / C, G171C+V180C, R138D / E+E141C / K / R, and D158E / I / C+T160C, preferably at least one combination of substitutions selected from E141C+T160C, E141C+D158C, G171C+V180C, R138D / E+E141C / K / R, and D158C+T160C.

[0096] According to the invention, the esterase is selected from S13L, A14C / Y, L15Q / G / I / D, A17F / V / Q / D, F90D / T / H / E / G / P / S / Q / N, D158E / I / C, A215S / Y and Q237C / I, preferably selected from S13L, A14C / Y, L15Q, A17F / V, F90D / T, D158E, A215Y and Q237I, more preferably selected from S13L, A14Y, L15Q, A17F / V, F90D, D158E, A215Y and Q237I, and preferably selected from D203C + S248C, F208W / I / L / G / S / N / A / R / T / H / M / E / Q / Y + D203C + S248C, F208W / I / L / G / S / N / A / R / T / H / M / E / Q / Y + D203C + S248C + V170I, F208W / I / L / G / S / N / A / R / T / H / M / E / Q / Y + D203C + S248C + V170I + Y92A / G / P / N / Q / T / F / C / D, F208W / I / L / G / S / N / A / R / T / H / M / E / Q / Y + D203C + S248C + V170I + Y92A / G / P / N / Q / T / F / C / D + N213D / E / R / K / P, F208W / I / L / G / S / N / A / R / T / H / M / E / Q / Y + D203C + S248C + V170I + Y92A / G / P / N / Q / T / F / C / D + N213D / E / R / K / P + Q182D / E, F208W / I / L / G / S / N / A / R / T / H / M / E / Q / Y + D203K / R, F208W / I / L / G / S / N / A / R / T / H / M / E / Q / Y + D203K / R + V170I, F208W / I / L / G / S / N / A / R / T / H / M / E / Q / Y + D203K / R + V170I + Y92A / G / P / N / Q / T / F / C / D, F208W / I / L / G / S / N / A / R / T / H / M / E / Q / Y + D203K / R + V170I + Y92A / G / P / N / Q / T / F / C / D + N213D / E / R / K / P, F208W / I / L / G / S / N / A / R / T / H / M / E / Q / Y + D203K / R + V170I + Y92A / G / P / N / Q / T / F / C / D + N213D / E / R / K / P +Selected from Q182D / E, preferably D203C + S248C, F208W / I / L / G / S / N / A / R / T / H / M / E / Q / Y + D203C + S248C, F208W / I / L / G / S / N / A / R / T / H / M / E / Q / Y + D203C + S248C + V170I, F208W / I / L / G / S / N / A / R / T / H / M / E / Q / Y + D203C + S248C + V170I + Y92A / G / P / N / Q / T / F / C / D, F208W / I / L / G / S / N / A / R / T / H / M / E / Q / Y + D203C + S248C + V170I + Y92A / G / P / N / Q / T / F / C / D + N213D / E / R / K / P, F208W / I / L / G / S / N / A / R / T / H / M / E / Q / Y + D203C + S248C + V170I + Y92A / G / P / N / Q / T / F / C / D + N213D / E / R / K / P + Q182D / E, more preferably selected from D203C+S248C, F208I / L / M / T+D203C+S248C, F208I / L / M / T+D203C+S248C+V170I, F208I / L / M / T+D203C+S248C+V170I+Y92G, F208I / L / M / T+D203C+S248 C+V170I+Y92G+N213P, F208I / L / M / T+D203C+S248C+V170I+Y92G+N213P+Q182E, and even more preferably F208M+D203C+S248C+V170I+Y92G+N213P+Q182E.

[0097] Specifically, this esterase is selected from S13L, L15Q / G / I / D, A17F / V / Q / D, F90D / T / H / E / G / P / S / Q / N, D158E / I / C, A215S / Y, and Q237C / I, preferably at least one substitution selected from S13L, L15Q, A17F / V, F90D, D158E, A215Y, and Q237I, and D203C + S248C, F208W / I / L / G / S / N / A / R / T / H / M / E / Q / Y + D203C + S248C, F208W / I / L / G / S / N / A / R / T / H / M / E / Q / Y + D203C + S248C + V170I, F208W / I / L / G / S / N / A / R / T / H / M / E / Q / Y + D203C + S248C + V170I + Y92A / G / P / N / Q / T / F / C / D, F208W / I / L / G / S / N / A / R / T / H / M / E / Q / Y + D203C + S248C + V170I + Y92A / G / P / N / Q / T / F / C / D + N213D / E / R / K / P, F208W / I / L / G / S / N / A / R / T / H / M / E / Q / Y + D203C + S248C + V170I + Y92A / G / P / N / Q / T / F / C / D + N213D / E / R / K / P + Q182D / E, F208W / I / L / G / S / N / A / R / T / H / M / E / Q / Y + D203K / R, F208W / I / L / G / S / N / A / R / T / H / M / E / Q / Y + D203K / R + V170I, F208W / I / L / G / S / N / A / R / T / H / M / E / Q / Y + D203K / R + V170I + Y92A / G / P / N / Q / T / F / C / D, F208W / I / L / G / S / N / A / R / T / H / M / E / Q / Y + D203K / R + V170I + Y92A / G / P / N / Q / T / F / C / D + N213D / E / R / K / P, F208W / I / L / G / S / N / A / R / T / H / M / E / Q / Y + D203K / R + V170I + Y92A / G / P / N / Q / T / F / C / D + N213D / E / R / K / P + Q182D / E, and is preferably D203C + S248C, F208W / I / L / G / S / N / A / R / T / H / M / E / Q / Y + D203C +S248C, F208W / I / L / G / S / N / A / R / T / H / M / E / Q / Y + D203C + S248C + V170I, F208W / I / L / G / S / N / A / R / T / H / M / E / Q / Y + D203C + S248C + V170I + Y92A / G / P / N / Q / T / F / C / D, F208W / I / L / G / S / N / A / R / T / H / M / E / Q / Y + D203C + S248C + V170I + Y92A / G / P / N / Q / T / F / C / D + N213D / E / R / K / P, F208W / I / L / G / S / N / A / R / T / H / M / E / Q / Y + D203C + S248C + V170I + Y92A / G / P / N / Q / T / F / C / D + N213D / E / R / K / P + Q182D / E, more preferably selected from D203C+S248C, F208I / L / M / T+D203C+S248C, F208I / L / M / T+D203C+S248C+V170I, F208I / L / M / T+D203C+S248C+V170I+Y92G, F208I / L / M / T+D203C+S248C+V170I+Y92G+N213P, F208I / L / M / T+D203C+S248C+V and comprising at least one combination of substitutions selected from 170I+Y92G+N213P+Q182E, and even more preferably F208M+D203C+S248C+V170I+Y92G+N213P+Q182E, and exhibiting higher polyester degradation activity compared to the esterase of SEQ ID NO: 1 at a pH of 4 to 6, preferably at a pH of 5 to 6, more preferably at a pH of 5 to 5.5, and even more preferably at pH 5.2.

[0098] Available from S13L, A14C / Y, A17F / V / Q / D / F90D / T / H / E / G / P / S / Q / N / D158E / I / C / Q 237C / I must be S13L, A14Y, A17F, F90D The D158E and the Q237I are the same as the 1 and the D203C + S248C、F208W / I / L / G / S / N / A / R / T / H / M / E / Q / Y + D203C + S248C、F208W / I / L / G / S / N / A / R / T / H / M / E / Q / Y + D203C + S248C + V170I、F208W / I / L / G / S / N / A / R / T / H / M / E / Q / Y + D203C + S248C + V170I + Y92A / G / P / N / Q / T / F / C / D + S248C + V170I + Y92A / G / P / N / Q / T / F / C / D + N213D / E / R / K / P、F208W / I / L / G / S / N / A / R / T / H / M / E / Q / Y + D203C + S248C + V170I + Y92A / G / P / N / Q / T / F / C / D + N213D / E / R / K / P + Q182D / E、F208W / I / L / G / S / N / A / R / T / H / M / E / Q / Y + D203K / R、F208W / I / L / G / S / N / A / R / T / H / M / E / Q / Y + D203K / R + V170I、F208W / I / L / G / S / N / A / R / T / H / M / E / Q / Y + D203K / R + V170I + Y92A / G / P / N / Q / T / F / C / D、F208W / I / L / G / S / N / A / R / T / H / M / E / Q / Y + D203K / R + V170I + Y92A / G / P / N / Q / T / F / C / D + N213D / E / R / K / P、F208W / I / L / G / S / N / A / R / T / H / M / E / Q / Y + D203K / R + V170I + Y92A / G / P / N / Q / T / F / C / D + N213D / E / R / K / P + Q182D / E is free-standing D203C + S248C F208W / I / L / G / S / N / A / R / T / H / M / E / Q / Y + D203C +S248C, F208W / I / L / G / S / N / A / R / T / H / M / E / Q / Y + D203C + S248C + V170I, F208W / I / L / G / S / N / A / R / T / H / M / E / Q / Y + D203C + S248C + V170I + Y92A / G / P / N / Q / T / F / C / D, F208W / I / L / G / S / N / A / R / T / H / M / E / Q / Y + D203C + S248C + V170I + Y92A / G / P / N / Q / T / F / C / D + N213D / E / R / K / P, F208W / I / L / G / S / N / A / R / T / H / M / E / Q / Y + D203C + S248C + V170I + Y92A / G / P / N / Q / T / F / C / D + N213D / E / R / K / P + Q182D / E, more preferably selected from D203C+S248C, F208I / L / M / T+D203C+S248C, F208I / L / M / T+D203C+S248C+V170I, F208I / L / M / T+D203C+S248C+V170I+Y92G, F208I / L / M / T+D203C+S248C+V170I+Y92G+N213P, F208I / L / M / T+D203C+S248C+ and at least one combination of substitutions selected from V170I+Y92G+N213P+Q182E, and even more preferably selected from F208M+D203C+S248C+V170I+Y92G+N213P+Q182E, and exhibits high heat resistance compared to the esterase of SEQ ID NO: 1 at a pH of 4 to 6, preferably at a pH of 5 to 6, more preferably at a pH of 5 to 5.5, and even more preferably at pH 5.2.

[0099] F208W / I / L / G / S / N / A / R / T / H / M / E / Q / Y + D203C + S203C + V270C + YG+D + N213P + Q182D / E + F90D、F208W / I / L / G / S / N / A / R / T / H / M / E / Q / Y + D203C + S248C + V170I + Y92G / D + N213P + Q182D / E + S13L、F208W / I / L / G / S / N / A / R / T / H / M / E / Q / Y + D203C + S248C + V170I + Y92G / D + N213P + Q182D / E + L15Q、F208W / I / L / G / N / M / E / H / H / Y D203C + S248C + V170I + Y92G / D + N213P + Q182D / E + A17F、F208W / I / L / G / S / N / A / R / T / H / M / E / Q / Y + D203C + S248C + V170ID + Y921 / E / Q / E + Q21+D + N213P + N213P D158E、F208W / I / L / G / S / N / A / R / T / H / M / E / Q / Y + D203C + S248C + V170I + Y92G / D + N213P + Q182D / E + S13L + A14E、F208W / I / L / G / S / N / A / R / T / H / M / E / Q / Y + D203C + S248C + V170I + Y92G / D + N213P + Q182D / E + S13L + L15Q、F208W / I / L / G / S / N / A / R / T / H / M / E / Q / Y + D203C + S248C + V170I + Y92G / D + N213P + Q182D / E + S13L + A17F / V、F208W / I / L / G / S / N / A / R / T / H / M / E / Q / Y + D203C + S248C + V170I + Y92G / D + N213P + Q182D / E + S13L + D158E、F208W / I / L / G / S / N / A / R / T / H / M / E / Q / Y + D203C + S248C + V170I + Y92G / D + N213P + Q182D / E + S13L + N204G、F208W / I / L / G / S / N / A / R / T / H / M / E / Q / Y + D203C+ S248C + V170I + Y92G / D + N213P + Q182E + A14Y, F208W / I / L / G / S / N / A / R / T / H / M / E / Q / Y + D203K / R + V170I + Y92G / D + N213P + Q182E + F90D, F208W / I / L / G / S / N / A / R / T / H / M / E / Q / Y + D203K / R + V170I + Y92G / D + N213P + Q182D / E + S13L, F208W / I / L / G / S / N / A / R / T / H / M / E / Q / Y + D203K / R + V170I + Y92G / D + N213P + Q182D / E + L15Q, F208W / I / L / G / S / N / A / R / T / H / M / E / Q / Y + D203K / R + V170I + Y92G / D + N213P + Q182D / E + A17F, F208W / I / L / G / S / N / A / R / T / H / M / E / Q / Y + D203K / R + V170I + Y92G / D + N213P + Q182D / E + D158E, F208W / I / L / G / S / N / A / R / T / H / M / E / Q / Y + D203K / R + V170I + Y92G / D + N213P + Q182D / E + S13L + A14E, F208W / I / L / G / S / N / A / R / T / H / M / E / Q / Y + D203K / R + V170I + Y92G / D + N213P + Q182D / E + S13L + L15Q, F208W / I / L / G / S / N / A / R / T / H / M / E / Q / Y + D203K / R + V170I + Y92G / D + N213P + Q182D / E + S13L + A17F / V, F208W / I / L / G / S / N / A / R / T / H / M / E / Q / Y + D203K / R + V170I + Y92G / D + N213P + Q182D / E + S13L + D158E, F208W / I / L / G / S / N / A / R / T / H / M / E / Q / Y + D203K / R + V170I + Y92G / D + N213P + Q182D / E + S13L + N204G and F208W / I / L / G / S / N / A / R / T / H / M / E / Q / Y + D203K / R + V170I + Y92G / D + N213P +Q182E + A14Y is a strong and smooth range and the range of the 1 is available This is F208W / I / L / G / S / N / A / R / T / H / M / E / Q / Y + D203C + S248C + V170I + Y92G / D + N213P + Q182E + F90D + F208W / I / L / G / S / N / A / R / T / H / M / E / Q / Y + D203C + S248C + V170I + Y92G / D + N213P + Q182D / E + S13L、F208W / I / L / G / S / N / A / R / T / H / M / E / Q / Y + D203C + S248C + V170I + Y92G / D + N213P + Q182D / E + L15Q D203C + S248C + V170I + Y92G / D + N213P + Q182D / E + A17F、F208W / I / L / G / S / N / A / R / T / H / M / E / Q / Y+ D158E、F208W / I / L / G / S / N / A / R / T / H / M / E / Q / Y + D203C + S248C + V170I + Y92G / D + N213P + Q182D / E + S13L + A14E、F208W / I / L / G / S / N / A / R / T / H / M / E / Q / Y+D203C+S248C+V170I+Y92G / D+N213P+Q182D / E+S13L+ L15Q、F208W / I / L / G / S / N / A / R / T / H / M / E / Q / Y + D203C + S248C + V170I + Y92G / D + N213P + Q182D / E + S13L + A17F / V、F208W / I / L / G / S / N / A / R / T / H / M / E / Q / Y+D203C+S248C+V170I+Y92G / D+N213P+Q182D / E+S13L+ D158E、F208W / I / L / G / S / N / A / R / T / H / M / E / Q / Y + D203C + S248C + V170I + Y92G / D + N213P + Q182D / E + S13L +N204G and F208W / I / L / G / S / N / A / R / T / H / M / E / Q / Y + D203C + S248C + V170I + Y92G / D + N213P + Q182E + A14Y, more preferably F208I / L / M / T + D203C + S248C + V170I + Y92G / D + N213P + Q182E + F90D, F208I / L / M / T + D203C + S248C + V170I + Y92G / D + N213P + Q182E + S13L, F208I / L / M / T + D203C + S248C + V170I + Y92G / D + N213P + Q182E + A14Y. Q182E + L15Q, F208I / L / M / T + D203C + S248C + V170I + Y92G / D + N213P + Q182E + A17F, F208I / L / M / T + D203C + S248C + V170I + Y92G / D + N213P + Q182E + D158E, F208I / L / M / T + D203C + S248C + V170I + Y92G / D + N213P + Q182E + S13L + A14E, F208I / L / M / T + D203C + S248C + V170I + Y92G / D + N213P + Q182E + S13L + L15Q, F208I / L / M / T + D203C + S248C + V170I + Y92G / D + N213P + Q182E + S13L + A17F / V, F208I / L / M / T + D203C + S248C + V170I + Y92G / D + N213P + Q182E + S13L + D158E, F208I / L / M / T + D203C + S248C + V170I + Y92G / D + N213P + Q182E + S13L + N204G and F208I / L / M / T + D203C + S248C + V170I + Y92G / D + N213P + Q182E+ A14Y, and even more preferably F208M + D203C + S248C + V170I + Y92G + N213P +Q182E + F90D, F208M + D203C + S248C + V170I + Y92G + N213P + Q182E + S13L, F208M + D203C + S248C + V170I + Y92G + N213P + Q182E + L15Q, F208M + D203C + S248C + V170I + Y92G + N213P + Q182E + A17F, F208M + D203C + S248C + V170I + Y92G + N213P + Q182E + D158E, F208M + D203C + S248C + V170I + Y92G + N213P + Q182E + S13L + A14E, F208M + D203C + S248C + V170I + Y92G + N213P + Q182E + S13L + L15Q, F208M + D203C + S248C + V170I + Y92G + N213P + Q182E + S13L + A17F / V, F208M + D203C + S248C + V170I + Y92G + N213P + Q182E + S13L + D158E, F208M + D203C + S248C + V170I + Y92G + N213P + Q182E + S13L + N204G, F208M + D203C + S248C + V170I + Y92G + It comprises at least one combination of substitutions selected from N213P + Q182E + A14Y.

[0100] According to the invention, the esterase has at least 75%, 80%, 85%, 90%, 95%, 96%, 97%, 98%, or 99% identity to the full-length amino acid sequence set forth in SEQ ID NO:1 and has at least one combination of substitutions selected from F208G / N / R / I / A / Q / L / S / M / T / E+D203C+S248C+V170I+Y92G / D+N213P+Q182D / E+S13L+D158E / I, and F208G / N / R / I / A / Q / L / S / M / T / E+D203K / R+V170I+Y92G / D+N213P+Q182D / E+S13L+D158E / I. Preferably, this substitution combination is selected from F208I / L / M / T+D203C+S248C+V170I+Y92G+N213P+Q182E+S13L+D158E and F208I / L / M / T+D203K / R+V170I+Y92G+N213P+Q182E+S13L+D158E, more preferably selected from F208I / L / M / T+D203C+S248C+V170I+Y92G+N213P+Q182E+S13L+D158E. In a particular embodiment, the esterase is selected from F208G / N / R / I / A / Q / L / S / M / T / E+D203C+S248C+V170I+Y92G / D+N213P+Q182D / E+S13L+D158E / I and F208G / N / R / I / A / Q / L / S / M / T / E+D203K / R+V170I+Y92G / D+N213P+Q182D / E+S13L+D158E / I, more preferably F208I / L / M / T+D203C+S24 and F208I / L / M / T+D203K / R+V170I+Y92G+N213P+Q182E+S13L+D158E, more preferably F208I / L / M / T+D203C+S248C+V170I+Y92G+N213P+Q182E+S13L+D158E.In one embodiment, the esterase is selected from F208G / N / R / I / A / Q / L / S / M / T / E+D203C+S248C+V170I+Y92G / D+N213P+Q182D / E+S13L+D158E / I and F208G / N / R / I / A / Q / L / S / M / T / E+D203K / R+V170I+Y92G / D+N213P+Q182D / E+S13L+D158E / I, preferably F208I / L / M / T+D203C+S248C+V17 The amino acid sequence of the present invention is selected from the amino acid sequence set forth in SEQ ID NO: 1, having a combination of substitutions selected from the following: 0I+Y92G+N213P+Q182E+S13L+D158E, and F208I / L / M / T+D203K / R+V170I+Y92G+N213P+Q182E+S13L+D158E, and more preferably selected from the following: F208I / L / M / T+D203C+S248C+V170I+Y92G+N213P+Q182E+S13L+D158E.

[0101] According to the present invention, the esterase has at least F208G / N / R / I / A / Q / L / S / M / T / E+D203C+S248C+V170I+Y92G / D+N213P+Q182D / E+S13L+D158E / I and F208G / N / R / I / A / Q / L / S / M / T / E+D203K / R+V170I+Y92G / D+N213P+Q182D / E+S13L+D158E / I and at least one substitution selected from A14C / E / Y, L15Q / G / I / D, A17F / V / Q / D, F90D / T / H / E / G / P / S / Q / N, N204D / E / G, A215S / Y, and Q237C / I. Preferably, the esterase comprises at least a combination of substitutions selected from F208I / L / M / T+D203C+S248C+V170I+Y92G+N213P+Q182D / E+S13L+D158E, and F208I / L / M / T+D203K / R+V170I+Y92G+N213P+Q182D / E+S13L+D158E, and at least one substitution selected from A14E, A17F / V, F90D, N204G, N211E, A215Y, and Q237I. More preferably, the esterase comprises at least a combination of substitutions selected from F208I / L / M / T+D203C+S248C+V170I+Y92G+N213P+Q182D / E+S13L+D158E and at least one substitution selected from A14E, A17F, F90D, N204G, N211E, A215Y, and Q237I.

[0102] These are F208G / N / R / I / A / Q / L / S / M / T / E + D203C + S248C + V170I + Y92G / D + N213P + Q182D / E + S13L + D158E / I、F208G / N / R / I / A / Q / L / S / M / T / E + D203C + S248C + V170I + Y92G / D + N213P + Q182D / E + S13L + D158E / I、F208G / N / R / I / A / Q / L / S / M / T / E + D203C + S248C + V170I + Y92G / D + N213P + Q182D / E + S13L + D158E / I + A17F / V / Q / D、F208G / N / R / I / A / Q / L / S / M / T / E + D203C + S248C + V170I + Y92G / D + N213P + Q182D / E + S13L + D158E / I + N204G、F208G / N / R / I / A / Q / L / S / M / T / E+D203C+S248C+V170I+Y92G / D+N213P+Q182D / E+S13L+D158E / I+ A215Y、F208G / N / R / I / A / Q / L / S / M / T / E+D203C+S248C+V170I+Y92G / D+N213P+Q182D / E+S13L+D158E / I+ F90D / T / H / E / G / P / S / Q / N、F208G / N / R / I / A / Q / L / S / M / T / E + D203C + S248C + V170I + Y92G / D + N213P + Q182D / E + S13L + D158E / I + A215Y+ A17F / V / Q / D、F208G / N / R / I / A / Q / L / S / M / T / E+D203C+S248C+V170I+Y92G / D+N213P+Q182D / E+S13L+D158E / I+N204G+ A17F / V / Q / D、F208G / N / R / I / A / Q / L / S / M / T / E + D203C + S248C + V170I + Y92G / D + N213P + Q182D / E + S13L + D158E / I + F90D / T / H / E / G / P / S / Q / N+A215Y、F208G / N / R / I / A / Q / L / S / M / T / E + D203C + S248C + V170I + Y92G / D + N213P + Q182D / E + S13L + D158E / I + F90D / T / H / E / G / P / S / Q / N + A17F / V / Q / D、 F208G / N / R / I / A / Q / L / S / M / T / E + D203C + S248C + V170I + Y92G / D + N213P + Q182D / E + S13L + D158E / I + F90D / T / H / E / G / P / S / Q / N + A17F / V / Q / D + N204G、F208G / N / R / I / A / Q / L / S / M / T / E + D203C + S248C + V170I + Y92G / D + N213P + Q182D / E + S13L + D158E / I + F90D / T / H / E / G / P / S / Q / N + A17F / V / Q / D + Q237I、F208G / N / R / I / A / Q / L / S / M / T / E + D203C + S248C + V170I + Y92G / D + N213P + Q182D / E + S13L + D158E / I + F90D / T / H / E / G / P / S / Q / N + A17F / V / Q / D + N211E、F208G / N / R / I / A / Q / L / S / M / T / E + D203C + S248C + V170I + Y92G / D + N213P + Q182D / E + S13L + D158E / I + F90D / T / H / E / G / P / S / Q / N + A17F / V / Q / D + N204G + Q237C / D / I、F208G / N / R / I / A / Q / L / S / M / T / E + D203C + S248C + V170I + Y92G / D + N213P + Q182D / E + S13L + D158E / I + F90D / T / H / E / G / P / S / Q / N + A17F / V / Q / D + N211E + Q237C / D / I、F208G / N / R / I / A / Q / L / S / M / T / E + D203C + S248C + V170I + Y92G / D + N213P + Q182D / E + S13L + D158E / I + F90D / T / H / E / G / P / S / Q / N + A17F / V / Q / D + N211E +N204G、F208G / N / R / I / A / Q / L / S / M / T / E + D203C + S248C + V170I + Y92G / D + N213P + Q182D / E + S13L + D158E / I + F90D / T / H / E / G / P / S / Q / N + A17F / V / Q / D + N211E + N204G + Q237I、F208G / N / R / I / A / Q / L / S / M / T / E + D203K / R + V170I + Y92G / D + N213P + Q182D / E + S13L + D158E / I、F208G / N / R / I / A / Q / L / S / M / T / E + D203K / R + V170I + Y92G / D + N213P + Q182D / E + S13L + D158E / I、F208G / N / R / I / A / Q / L / S / M / T / E + D203K / R + V170I + Y92G / D + N213P + Q182D / E + S13L + D158E / I + A17F / V / Q / D、F208G / N / R / I / A / Q / L / S / M / T / E + D203K / R + V170I + Y92G / D + N213P + Q182D / E + S13L + D158E / I + N204G、F208G / N / R / I / A / Q / L / S / M / T / E + D203K / R + V170I + Y92G / D + N213P + Q182D / E + S13L + D158E / I + A215Y、F208G / N / R / I / A / Q / L / S / M / T / E + D203K / R + V170I + Y92G / D + N213P + Q182D / E + S13L + D158E / I + F90D / T / H / E / G / P / S / Q / N、F208G / N / R / I / A / Q / L / S / M / T / E + D203K / R + V170I + Y92G / D + N213P + Q182D / E + S13L + D158E / I + A215Y + A17F / V / Q / D、F208G / N / R / I / A / Q / L / S / M / T / E + D203K / R + V170I + Y92G / D + N213P + Q182D / E + S13L + D158E / I + N204G + A17F / V / Q / D、F208G / N / R / I / A / Q / L / S / M / T / E + D203K / R +V170I + Y92G / D + N213P + Q182D / E + S13L + D158E / I + F90D / T / H / E / G / P / S / Q / N + A215Y、F208G / N / R / I / A / Q / L / S / M / T / E + D203K / R + V170I + Y92G / D + N213P + Q182D / E + S13L + D158E / I + F90D / T / H / E / G / P / S / Q / N + A17F / V / Q / D、 F208G / N / R / I / A / Q / L / S / M / T / E + D203K / R + V170I + Y92G / D + N213P + Q182D / E + S13L + D158E / I + F90D / T / H / E / G / P / S / Q / N + A17F / V / Q / D + N204G、F208G / N / R / I / A / Q / L / S / M / T / E + D203K / R + V170I + Y92G / D + N213P + Q182D / E + S13L + D158E / I + F90D / T / H / E / G / P / S / Q / N + A17F / V / Q / D + Q237I、F208G / N / R / I / A / Q / L / S / M / T / E + D203K / R + V170I + Y92G / D + N213P + Q182D / E + S13L + D158E / I + F90D / T / H / E / G / P / S / Q / N + A17F / V / Q / D + N211E、F208G / N / R / I / A / Q / L / S / M / T / E + D203K / R + V170I + Y92G / D + N213P + Q182D / E + S13L + D158E / I + F90D / T / H / E / G / P / S / Q / N + A17F / V / Q / D + N204G + Q237C / D / I、F208G / N / R / I / A / Q / L / S / M / T / E + D203K / R + V170I + Y92G / D + N213P + Q182D / E + S13L + D158E / I + F90D / T / H / E / G / P / S / Q / N + A17F / V / Q / D + N211E + Q237C / D / I、F208G / N / R / I / A / Q / L / S / M / T / E + D203K / R + V170I + Y92G / D + N213P + Q182D / E + S13L + D158E / I + F90D / T / H / E / G / P / S / Q / N+ A17F / V / Q / D + N211E + N204G、F208G / N / R / I / A / Q / L / S / M / T / E + D203K / R + V170I + Y92G / D + N213P + Q182D / E + S13L + D158E / I + F90D / T / H / E / G / P / S / Q / N + A17F / V / Q / D + N211E + N204G + Q237I is a 100-year-old manufacturer This is F208G / N / R / I / A / Q / L / S / M / T / E + D203C + S248C + V170I + Y92G / D + N213P + Q182D / E + S13L + D158E / I、F208G / N / R / I / A / Q / L / S / M / T / E + D203C + S248C + V170I + Y92G / D + N213P + Q182D / E + S13L + D158E / I + F90D / T / H / E / G / P / S / Q / N + A17F / V / Q / D Q182D / E + S13L + D158E / I + F90D / T / H / E / G / P / S / Q / N + A17F / V / Q / D + N204G、F208G / N / R / I / A / Q / L / S / M / T / E + D203C + S248C + V170I + Y92G / D + N213P + Q182D / E + S13L + D158E / I + F90D / T / H / E / G / P / S / Q / N + A17F / V / Q / D + Q237I、F208G / N / R / I / A / Q / L / S / M / T / E + D203C + S248C + V170I + Y92G / D + N213P + Q182D / E + S13L + D158E / I + F90D / T / H / E / G / P / S / Q / N + A17F / V / Q / D + N211E、F208G / N / R / I / A / Q / L / S / M / T / E + D203C + S248C + V170I + Y92G / D + N213P + Q182D / E + S13L + D158E / I + F90D / T / H / E / G / P / S / Q / N + A17F / V / Q / D + N204G+Q237C / D / I、F208G / N / R / I / A / Q / L / S / M / T / E + D203C + S248C + V170I + Y92G / D + N213P + Q182D / E + S13L + D158E / I + F90D / T / H / E / G / P / S / Q / N+ A17F / V / Q / D+N211E+Q237C / D / I、F208G / N / R / I / A / Q / L / S / M / T / E+D203C+S248C+V170I+Y92G / D+N213P+Q182D / E+S13L+D158E / I+ F90D / T / H / E / G / P / S / Q / N + A17F / V / Q / D + N211E + N204G、F208G / N / R / I / A / Q / L / S / M / T / E + D203C + S248C + V170I + Y92G / D + N213P + Q182D / E + S13L + D158E / I + F90D / T / H / E / G / P / S / Q / N + A17F / V / Q / D + N211E + N204G + Q237I is a 1-inch or 1000 sq. ft. F208I / L / M / T + D203C + S248C + V170I + Y92G / D + N213P + Q182D / E + S13L + D158E / I D158E / I、F208I / L / M / T + D203C + S248C + V170I + Y92G / D + N213P + Q182D / E + S13L + D158E / I + A17F / V / Q / D Y92G / D + N213P + Q182D / E + S13L + D158E / I + N204G、F208I / L / M / T + D203C + S248C + V170I + Y92G / D + N213P + Q182D / E + S13L + D158E / I+ A215Y、F208I / L / M / T+D203C+S248C+V170I+Y92G / D+N213P+Q182D / E+S13L+D158E / I + F90D / T / H / E / G / P / S / Q / N、F208I / L / M / T + D203C + S248C + V170I + Y92G / D + N213P + Q182D / E + S13L + D158E / I + A215Y + A17F / V / Q / D、F208I / L / M / T + D203C + S248C + V170I + Y92G / D + N213P + Q182D / E + S13L + D158E / I + N204G + A17F / V / Q / D、F208I / L / M / T + D203C + S248C + V170I + Y92G / D + N213P + Q182D / E + S13L + D158E / I + F90D / T / H / E / G / P / S / Q / N + A215Y、F208I / L / M / T + D203C + S248C + V170I + Y92G / D + N213P + Q182D / E + S13L + D158E / I + F90D / T / H / E / G / P / S / Q / N + A17F / V / Q / D、 F208I / L / M / T + D203C + S248C + V170I + Y92G / D + N213P + Q182D / E + S13L + D158E / I + F90D / T / H / E / G / P / S / Q / N + A17F / V / Q / D + N204G、F208I / L / M / T + D203C + S248C + V170I + Y92G / D + N213P + Q182D / E + S13L + D158E / I + F90D / T / H / E / G / P / S / Q / N + A17F / V / Q / D + Q237I、F208I / L / M / T + D203C + S248C + V170I + Y92G / D + N213P + Q182D / E + S13L + D158E / I + F90D / T / H / E / G / P / S / Q / N + A17F / V / Q / D + N211E、F208I / L / M / T + D203C + S248C + V170I + Y92G / D + N213P + Q182D / E + S13L + D158E / I + F90D / T / H / E / G / P / S / Q / N + A17F / V / Q / D + N204G + Q237C / D / I、F208I / L / M / T + D203C + S248C +V170I + Y92G / D + N213P + Q182D / E + S13L + D158E / I + F90D / T / H / E / G / P / S / Q / N + A17F / V / Q / D + N211E + Q237C / D / I, F208I / L / M / T + D203C + S248C + V170I + Y92G / D + N213P + Q182D / E + S13L + D158E / I + F90D / T / H / E / G / P / S / Q / N + A17F / V / Q / D + N211E + N204G, F208I / L / M / T + D203C + S248C + V170I + Y92G / D + N213P + Q182D / E and even more preferably, the combination of substitutions selected from F208M + D203C + S248C + V170I + Y92G + N213P + Q182E + S13L + D158E, F208M + D203C + S248C + V170I + Y92G + N213P + Q182E + S13L + D158E + A17F, F208M + D203C + S248C + V170I + Y92G + N213P + Q182E + S13L + D158E + A17F, F208M + D203C + S248C + V170I + Y92G + N213P + Q182E + S13L + D158E + N204G, F208M + D203C + S248C + V170I + Y92G + N213P + Q182E + S13L + D158E + A215Y, F208M + D203C + S248C + V170I + Y92G + N213P + Q182E + S13L + D158E + F90D, F208M + D203C + S248C + V170I + Y92G + N213P + Q182E + S13L + D158E + A215Y + A17F, F208M + D203C + S248C + V170I + Y92G + N213P + Q182E + S13L + D158E + N204G + A17F, F208M + D203C + S248C + V170I + Y92G + N213P +Q182E + S13L + D158E + F90D + A215Y, F208M + D203C + S248C + V170I + Y92G + N213P + Q182E + S13L + D158E + F90D + A17F, F208M + D203C + S248C + V170I + Y92G + N213P + Q182E + S13L + D158E + F90D + A17F + N204G, F208M + D203C + S248C + V170I + Y92G + N213P + Q182E + S13L + D158E + F90D + A17F + Q237I, F208M + D203C + S248C + V170I + Y92G + N213P + Q182E + S13L + D158E + F90D + A17F + N211E, F208M + D203C + S248C + V170I + Y92G + N213P + Q182E + S13L + D158E + F90D + A17F + N204G + Q237I, F208M + D203C + S248C + V170I + Y92G + N213P + Q182E + S13L + D158E + F90D + A17F + N211E + Q237I, F208M + D203C + S248C + V170I + Y92G + N213P + Q182E + S13L + D158E + F90D + A17F + N211E + N204G, F208M + D203C + S248C + V170I + Y92G + N213P + Q182E + S13L + D158E + F90D + A17F + N211E + N204G + Q237I.

[0103] In certain embodiments, the amino acid sequence of the esterase is: F208M + D203C + S248C + V170I + Y92G + N213P + Q182E + S13L + D158E, F208M + D203C + S248C + V170I + Y92G + N213P + Q182E + S13L + D158E + A17F, F208M + D203C + S248C + V170I + Y92G + N213P + Q182E + S13L + D158E + N204G, F208M + D203C + S248C + V170I + Y92G + N213P + Q182E + S13L + D158E + A215Y, F208M + D203C + S248C + V170I + Y92G + N213P + Q182E + S13L + D158E + F90D, F208M + D203C + S248C + V170I + Y92G + N213P + Q182E + S13L + D158E + A215Y + A17F, F208M + D203C + S248C + V170I + Y92G + N213P + Q182E + S13L + D158E + N204G + A17F, F208M + D203C + S248C + V170I + Y92G + N213P + Q182E + S13L + D158E + F90D + A215Y, F208M + D203C + S248C + V170I + Y92G + N213P + Q182E + S13L + D158E + F90D + A17F, F208M + D203C + S248C + V170I + Y92G + N213P + Q182E + S13L + D158E + F90D + A17F + N204G, F208M + D203C + S248C + V170I + Y92G + N213P + Q182E + S13L + D158E + F90D + A17F + Q237I, F208M + D203C + S248C + V170I + Y92G + N213P + Q182E + S13L + D158E + F90D + A17F +N211E, F208M + D203C + S248C + V170I + Y92G + N213P + Q182E + S13L + D158E + F90D + A17F + N204G + Q237I, F208M + D203C + S248C + V170I + Y92G + N213P + Q182E + S13L + D158E + F90D + A17F + N211E + Q237I, F208M + D203C + S248C + V170I + Y92G + N213P + Q182E + S13L + D158E + F90D + A17F + N211E + N204G, and F208M + D203C + S248C + V170I + Y92G + N213P + Q182E + S13L + D158E + F90D + A17F + N211E + N204G + Q237I.

[0104] In one embodiment, the amino acids of the esterase are E141C / K / R, G171C, V180C, R12A / I / M, S13L, A14C / Y, L15Q / G / I / D, A17F / V / Q / D, D18E, R30Y / L / Q / M / N / S / E, G37E / C, Y60H / C / G, T61Y / H / Q / E, S66E / W / D, L67I / E, W69I, R72I / T / L / V, R89E / G / V, F90D / T / H / E / G / P / S / Q / N, Y92E, P93A, R138L / K / D / E, A127T, W155M / H / E, D158E / I / C, T160C, L202I, N204A, A205M / Q, S206V / I / N, F208V / K, A209S / D / E, N211F / W, S212T / A / Q, N213L, N214T, A215S / Y, I217L / C / V, Y220W / C / T, Q237C / I, F238I / D, L239C, V242I, L247M, and H156D, preferably R12A / I / M, S13L, A14C / Y, L15Q / G / I / D, A17F / V / Q / D, D18E, R30Y / L / Q / M / N / S / E, G37E / C, Y60H / C / G, T61Y / H / Q / E, S66E / W / D, L67I / E, W69I, R72I / T / L / V, R89E / G / V, F90D / T / H / E / G / P / S / Q / N, Y92E, P93A , R138L, A127T, W155M / H / E, D158E / I, L202I, N204A, A205M / Q, S206V / I / N, F208K, A209S / D / E, N211F / W, S212T / A / Q, N213L, N214T, A215S / Y, I217L / C / V, Y220W / C / T, Q237C / I, F238I / D, L239C, V242I, L247M, and H156.

[0105] In one embodiment, the amino acid sequence of the esterase is E141C / K / R, G171C, V180C, R12A / I / M, S13L, A14C / Y, L15Q / G / I / D, A17F / V / Q / D, D18E, R30Y / L / Q / M / N / S / E, G37E / C, Y60H / C / G, T61Y / H / Q / E, S66E / W / D, L67I / E, W69I, R72I / T / L / V, R89E / G / V, F90D / T / H / E / G / P / S / Q / N, Y92 E, P93A, R138L / K / D / E, A127T, W155M / H / E, D158E / I / C, T160C, L202I, N204A, A205M / Q, S206V / I / N, F208V / K, A209S / D / E, N21 Selected from 1F / W, S212T / A / Q, N213L, N214T, A215S / Y, I217L / C / V, Y220W / C / T, Q237C / I, F238I / D, L239C, V242I, L247M, and H156D. and preferably R12A / I / M, S13L, A14C / Y, L15Q / G / I / D, A17F / V / Q / D, D18E, R30Y / L / Q / M / N / S / E, G37E / C, Y60H / C / G, T61Y / H / Q / E, S66E / W / D, L67I / E, W69I, R72I / T / L / V, R89E / G / V, F90D / T / H / E / G / P / S / Q / N, Y92E, P93A, R138L, A127T, W155M The present invention is directed to a method for treating a pulmonary artery disease comprising administering to a patient a pulmonary artery disease (PAD) comprising administering to said patient an amino acid sequence as set forth in SEQ ID NO: 1, which has 1 to 41 amino acid substitutions selected from among / H / E, D158E / I, L202I, N204A, A205M / Q, S206V / I / N, F208K, A209S / D / E, N211F / W, S212T / A / Q, N213L, N214T, A215S / Y, I217L / C / V, Y220W / C / T, Q237C / I, F238I / D, L239C, V242I, L247M, and H156.

[0106] In another embodiment, the amino acid sequence of the esterase is E141C / K / R, G171C, V180C, R12A / I / M, S13L, A14C / Y, L15Q / G / I / D, A17F / V / Q / D, D18E, R30Y / L / Q / M / N / S / E, G37E / C, Y60H / C / G, T61Y / H / Q / E, S66E / W / D, L67I / E, W69I, R72I / T / L / V, R89E / G / V, F90D / T / H / E / G / P / S / Q / N ... 92E, P93A, R138L / K / D / E, A127T, W155M / H / E, D158E / I / C, T160C, L202I, N204A, A205M / Q, S206V / I / N, F208V / K, A209S / D / E, Select from N211F / W, S212T / A / Q, N213L, N214T, A215S / Y, I217L / C / V, Y220W / C / T, Q237C / I, F238I / D, L239C, V242I, L247M and H156D and preferably has a single amino acid substitution such as R12A / I / M, S13L, A14C / Y, L15Q / G / I / D, A17F / V / Q / D, D18E, R30Y / L / Q / M / N / S / E, G37E / C, Y60H / C / G, T61Y / H / Q / E, S66E / W / D, L67I / E, W69I, R72I / T / L / V, R89E / G / V, F90D / T / H / E / G / P / S / Q / N, Y92E, P93A, R138L, A127T, W155M and H156D, D158E / I, L202I, N204A, A205M / Q, S206V / I / N, F208K, A209S / D / E, N211F / W, S212T / A / Q, N213L, N214T, A215S / Y, I217L / C / V, Y220W / C / T, Q237C / I, F238I / D, L239C, V242I, L247M, and H156D.

[0107] Preferably, the esterase exhibits at least one amino acid residue selected from S130, D175, H207, C240, or C275, as the parent esterase of SEQ ID NO:1, i.e. the esterase of the invention is not modified at one, two, three etc. or all of these positions.

[0108] In particular, the esterase may exhibit, like the parent esterase, at least the amino acids S130, D175 and H207 which form the catalytic site of the esterase, and / or the amino acids C240 ​​and C275 which form disulfide bonds. Preferably, the esterase, like the parent esterase, comprises at least a combination of amino acid residues selected from S130+D175+H207, C240+C275 and S130+D175+H207+C240+C275, more preferably, like the parent esterase, the combination S130+D175+H207+C240+C275.

[0109] A further object of the present invention is an esterase variant having (i) at least 80%, 85%, 90%, 95%, 96%, 97%, 98% or 99% identity to the full length amino acid sequence set forth in SEQ ID NO:2, and (ii) at least one of the following amino acid sequences as compared to the amino acid sequence SEQ ID NO:2: E141C / K / R, G171C, V180C, R12A / I / M, S13L, A14C / Y, L15Q / G / I / D, A17F / V / Q / D, D18E, R30Y / L / Q / M / N / S / E, G37E / C, Y60H / C / G, T61Y / H / Q / E, S66E / W / D, L67I / E, W69I, R72I / T / L / V, R89E / G / V, F90D / T / H / E / G / P / S / Q / N, G92E, P93A, R138L / K / D / E, A127T, W155M / H / E, D158E / I / C, T160C, L202I, N204A, A205M / Q, S206V / I / N, M208V / and (iv) exhibiting increased thermostability and / or increased polyester degrading activity at a pH of 3 to 6 compared to the esterase of SEQ ID NO: 1.

[0110] The amino acid sequence set forth in SEQ ID NO:2 corresponds to the amino acid sequence of SEQ ID NO:1 with the substitution combination F208M+D203C+S248C+V170I+Y92G+N213P+Q182E compared to SEQ ID NO:1.

[0111] In particular, the esterase comprises the amino acid sequence set forth in SEQ ID NO:2 and at least one substitution selected from S13L, A14C / Y, L15Q / G / I / D, A17F / V / Q / D, F90D / T / H / E / G / P / S / Q / N, D158E / I / C, A215S / Y, and Q237C / I, preferably selected from S13L, A14C / Y, L15Q, A17F / V, F90D / T, D158E, A215Y, and Q237I, more preferably selected from S13L, A14Y, L15Q, A17F / V, F90D, D158E, A215Y, and Q237I, even more preferably selected from S13L, L15Q, A17F, F90D, and D158E.

[0112] In one embodiment, the esterase variant has the following amino acid sequence as compared to the amino acid sequence of SEQ ID NO:2: E141C / K / R, G171C, V180C, R12A / I / M, S13L, A14C / Y, L15Q / G / I / D, A17F / V / Q / D, D18E, R30Y / L / Q / M / N / S / E, G37E / C, Y60H / C / G, T61Y / H / Q / E, S66E / W, S67E / H, S67E / W ... / D, L67I / E, W69I, R72I / T / L / V, R89E / G / V, F90D / T / H / E / G / P / S / Q / N, G92E, P93A , R138L / K / D / E, A127T, W155M / H / E, D158E / I / C, T160C, L202I, N204A, A205M / Q, S the esterase of SEQ ID NO: 1 has 1 to 45 amino acid substitutions selected from 206V / I / N, M208V / K, A209S / D / E, N211F / W, S212T / A / Q, P213L, N214T, A215S / Y, I217L / C / V, Y220W / C / T, Q237C / I, F238I / D, L239C, V242I, L247M and H156D, the positions being numbered with reference to the amino acid sequence set forth in SEQ ID NO: 2, has polyester degrading activity, and exhibits higher thermostability and / or higher polyester degrading activity at a pH of 3 to 6 compared to the esterase of SEQ ID NO: 1.

[0113] Specifically, the esterase comprises 1 to 8 substitutions selected from S13L, A14C / Y, L15Q / G / I / D, A17F / V / Q / D, F90D / T / H / E / G / P / S / Q / N, D158E / I / C, A215S / Y, and Q237C / I, preferably comprises 1 to 8 substitutions selected from S13L, A14C / Y, L15Q, A17F / V, F90D / T, D158E, A215Y, and Q237I, more preferably comprises 1 to 8 substitutions selected from S13L, A14Y, L15Q, A17F / V, F90D, D158E, A215Y, and Q237I. In particular, the esterase comprises two substitutions selected from S13L, A14C / Y, L15Q / G / I / D, A17F / V / Q / D, F90D / T / H / E / G / P / S / Q / N, D158E / I / C, A215S / Y, and Q237C / I, preferably comprises two substitutions selected from S13L, A14C / Y, L15Q, A17F / V, F90D / T, D158E, A215Y, and Q237I, more preferably comprises the two substitutions S13L and D158E.

[0114] In one embodiment, the esterase variant has the following amino acids compared to SEQ ID NO:2: E141C / K / R, G171C, V180C, R12A / I / M, S13L, A14C / Y, L15Q / G / I / D, A17F / V / Q / D, D18E, R30Y / L / Q / M / N / S / E, G37E / C, Y60H / C / G, T61Y / H / Q / E, S66E / W / D, L67I / E, W69I, R72I / T / L / V, R89E / G / V, F90D / T / L / V, R89E / G ... H / E / G / P / S / Q / N, G92E, P93A, R138L / K / D / E, A127T, W155M / H / E, D158E / I / C, T160C, L202I, N204A, A205M / Q, S206V / I / N, M2 08V / K, A209S / D / E, N211F / W, S212T / A / Q, P213L, N214T, A215S / Y, I217L / C / V, Y220W / C / T, Q237C / I, F238I / D, L239C, V242I The esterase has the amino acid sequence set forth in SEQ ID NO: 2 and has 1 to 45 amino acid substitutions selected from L247M and H156D, the positions being numbered with reference to the amino acid sequence set forth in SEQ ID NO: 2, has polyester decomposition activity, and exhibits higher heat resistance and / or higher polyester decomposition activity at a pH of 3 to 6 compared to the esterase of SEQ ID NO: 1.

[0115] Specifically, the esterase has 1 to 8 substitutions selected from S13L, A14C / Y, L15Q / G / I / D, A17F / V / Q / D, F90D / T / H / E / G / P / S / Q / N, D158E / I / C, A215S / Y, and Q237C / I, preferably has 1 to 8 substitutions selected from S13L, A14C / Y, L15Q, A17F / V, F90D / T, D158E, A215Y, and Q237I, more preferably has 1 to 8 substitutions selected from S13L, A14Y, L15Q, A17F / V, F90D, D158E, A215Y, and Q237I, and has the amino acid sequence set forth in SEQ ID NO: 2.

[0116] Specifically, the esterase has an amino acid sequence as set forth in SEQ ID NO:2, with two substitutions selected from S13L, A14C / Y, L15Q / G / I / D, A17F / V / Q / D, F90D / T / H / E / G / P / S / Q / N, D158E / I / C, A215S / Y, and Q237C / I, preferably with two substitutions selected from S13L, A14C / Y, L15Q, A17F / V, F90D / T, D158E, A215Y, and Q237I, more preferably with two substitutions S13L and D158E.

[0117] Preferably, the esterase, like the parent esterase (i.e., in the amino acid sequence set forth in SEQ ID NO: 2), comprises at least the amino acids S130, D175, and H207 which form the catalytic site of the esterase, and / or the amino acids C240 ​​and C275 which form disulfide bonds. Preferably, the esterase, like the parent esterase, comprises at least a combination of amino acid residues selected from S130+D175+H207, C240+C275, and S130+D175+H207+C240+C275.

[0118] According to the present invention, the esterase further exhibits higher thermostability and / or higher polyester decomposition activity compared to the esterase of SEQ ID NO:2 at a pH of 3 to 6, preferably at a pH of 5 to 5.5.

[0119] A further object of the present invention is an esterase variant having (i) at least 80%, 85%, 90%, 95%, 96%, 97%, 98% or 99% identity to the full length amino acid sequence set forth in SEQ ID NO:3, and (ii) the amino acid sequence R12A / I / M, A14C / Y, L15Q / G / I / D, A17F / V / Q / D, D18E, R30Y / L / Q / M / N / S / E, G37E / C, Y60H / C / G, T61Y / H / Q / E, S66E / W / D, L67I / E, W69I, R72I / T / L / V, R89E / G / V, F90D / T / H / E / G / P / S / Q / N, P93A, R138L / K / D / E, A127T, W155M / H / E, E158I / C, T160C, L202I, N204A / G , A205M / Q, S206V / I / N, F208V / K, A209S / D / E, N211F / W / E, S212T / A / Q, N214T, A215S / Y, I217L / C / V, Y220W / C / T, Q237C / I, F238I / D, L239C, V242I, L247M, and H156D, and / or an amino acid substitution at at least one position corresponding to a residue selected from E141, G171, and V180 compared to the amino acid sequence SEQ ID NO:3, said positions being numbered with reference to the amino acid sequence set forth in SEQ ID NO:3; (iii) having polyester degrading activity; and (iv) exhibiting increased thermostability and / or increased polyester degrading activity at a pH of 3 to 6 compared to the esterase of SEQ ID NO:3.

[0120] The amino acid sequence set forth in SEQ ID NO:3 corresponds to the amino acid sequence of SEQ ID NO:1, but has the following substitution combination compared to SEQ ID NO:1: F208M+D203C+S248C+V170I+Y92G+N213P+Q182E+S13L+D158E.

[0121] In the context of the present invention, a variant of the esterase of SEQ ID NO: 3 having at least 80%, 85%, 90%, 95%, 96%, 97%, 98% or 99% identity to the full length amino acid sequence set out in SEQ ID NO: 3 always contains the same residue combination G92+P213+E182+L13 as the parent esterase, as in SEQ ID NO: 3. In other words, this residue combination is not affected by any changes in the sequence within the abovementioned % identity.

[0122] In certain embodiments, the variant of the esterase of SEQ ID NO: 3 further comprises one or several combinations of the following residues: E158, M208, C203, C248, and I170. In some embodiments, the variant further comprises a combination of residues selected from M208+C203+C248, C203+C248, M208+C203+C248+I170, C203+C248+I170, M208+E158, M208+C203+C248+E158, M208+C203+C248+I170+E158.

[0123] According to the present invention, the esterase may further exhibit higher heat resistance and / or higher polyester decomposition activity at a pH of 3 to 6 compared to the esterase of SEQ ID NO: 1. Preferably, the esterase exhibits higher heat resistance and / or higher polyester decomposition activity compared to the esterase of SEQ ID NO: 3, and optionally exhibits higher heat resistance and / or higher polyester decomposition activity at a pH of 4 to 6, preferably at a pH of 5 to 6, more preferably at a pH of 5 to 5.5, specifically at pH 5.2, compared to the esterase of SEQ ID NO: 1.

[0124] In addition, the esterase exhibits higher heat resistance and / or higher polyester decomposition activity compared to the esterase of SEQ ID NO: 3, and optionally exhibits higher heat resistance and / or higher polyester decomposition activity compared to the esterase of SEQ ID NO: 1 at temperatures of 50°C to 90°C, preferably at temperatures of 50°C to 72°C, and more preferably at temperatures of 50°C to 65°C.

[0125] Specifically, the esterase is R12A / I / M, A14C / Y, L15Q / G / I / D, A17F / V / Q / D, D18E, R30Y / L / Q / M / N / S / E, G37E / C, Y60H / C / G, T61Y / H / Q / E, S66E / W / D, L67I / E, W69I, R72I / T / L / V, R89E / G / V, F90D / T / H / E / G / P / S / Q / N, P93A, R138L / K / D / E, A127T, W155 M / H / E, E158I / C, T160C, L202I, N204A / G, A205M / Q, S206V / I / N, F208V / K, A209S / D / E, N211F / W / E, S212T / A / Q, N214T, Select from A215S / Y, I217L / C / V, Y220W / C / T, Q237C / I, F238I / D, L239C, V242I, L247M, H156D, E141C / K / R, G171C, and V180C. and preferably at least one substitution selected from A17F / V / Q / D, F90D / T / H / E / G / P / S / Q / N, R138L / K / D / E, N204A / G, N211F / W / E, A215S / Y, E158 / I / C, T160C, G171C, and V180C, more preferably A17F, F90D / T / E / Q / N, R138K, N204G, N211E, A215Y, E 158C, T160C, G171C, and V180C, and even more preferably, at least one substitution selected from A17F, F90D / T / E / Q / N, R138K, N204G, E158C+T160C, G171C+V180C, N204G+A17F, F90D+A215Y, F90D+A17F, F90D+A17F+N204G, F90D+A17F+N211E.

[0126] In one embodiment, the esterase variants have the following amino acid sequence as compared to the amino acid sequence SEQ ID NO:3: R12A / I / M, A14C / Y, L15Q / G / I / D, A17F / V / Q / D, D18E, R30Y / L / Q / M / N / S / E, G37E / C, Y60H / C / G, T61Y / H / Q / E, S66E / W / D, L67I / E, W69I, R72I / T / L / V, R89E / G / V, F90D / T / H / E / G / P / S / Q / N, P93A, R138L / K / D / E, A127T, W155M / H / E, E158I The compound includes 1 to 43 amino acid substitutions selected from among / C, T160C, L202I, N204A / G, A205M / Q, S206V / I / N, F208V / K, A209S / D / E, N211F / W / E, S212T / A / Q, N214T, A215S / Y, I217L / C / V, Y220W / C / T, Q237C / I, F238I / D, L239C, V242I, L247M, H156D, E141C / K / R, G171C, and V180C.

[0127] In one embodiment, the esterase variants have the following amino acid sequence as compared to the amino acid sequence of SEQ ID NO:3: R12A / I / M, A14C / Y, L15Q / G / I / D, A17F / V / Q / D, D18E, R30Y / L / Q / M / N / S / E, G37E / C, Y60H / C / G, T61Y / H / Q / E, S66E / W / D, L67I / E, W69I, R72I / T / L / V, R89I / T / L / V, R90I / T / L / V, R10I / T / L / V, R11I / T / L / V, R12I / T / L / V, R13I / T / L / V, R14I / T / L / V, R15I / T / L / V, R17 ... E / G / V, F90D / T / H / E / G / P / S / Q / N, P93A, R138L / K / D / E, A127T, W155M / H / E, E158I / C , T160C, L202I, N204A / G, A205M / Q, S206V / I / N, F208V / K, A209S / D / E, N211F / W / E, 3, having 1 to 43 amino acid substitutions selected from S212T / A / Q, N214T, A215S / Y, I217L / C / V, Y220W / C / T, Q237C / I, F238I / D, L239C, V242I, L247M, H156D, E141C / K / R, G171C and V180C, wherein the positions are numbered with reference to the amino acid sequence set forth in SEQ ID NO: 3, and has polyester decomposition activity, and exhibits higher thermostability and / or higher polyester decomposition activity at a pH of 3 to 6 compared to the esterase of SEQ ID NO: 3.

[0128] In another embodiment, the esterase comprises 1 to 10 substitutions selected from A17F / V / Q / D, F90D / T / H / E / G / P / S / Q / N, R138L / K / D / E, N204A / G, N211F / W / E, A215S / Y, E158I / C, T160C, G171C, and V180C, preferably 1 to 10 substitutions selected from A17F, F90D / T / E / Q / N, R138 / K, N204G, N211E, A215Y, E158C, T160C, G171C, and V180C.

[0129] Specifically, the esterase has the amino acid sequence set forth in SEQ ID NO: 3, having 1 to 10 substitutions selected from A17F / V / Q / D, F90D / T / H / E / G / P / S / Q / N, R138L / K / D / E, N204A / G, N211F / W / E, A215S / Y, E158I / C, T160C, G171C, and V180C, preferably A17F, F90D / T / E / Q / N, R138 / K, N204G, N211E, A215Y, E158C, T160C, G171C, and V180C.

[0130] Advantageously, said esterase exhibits a higher specific decomposition activity and / or a higher PET depolymerization yield compared to the esterase of SEQ ID NO:3.

[0131] In one embodiment, the esterase comprises at least one amino acid substitution selected from A17F / V / Q / D, F90D / T / H / E / G / P / S / Q / N, R138L / K / D / E, N204A / G, N211F / W / E, A215S / Y, preferably comprises at least one amino acid substitution selected from A17F, F90D / E / Q / N, R138K, N204G, N211E, A215Y, more preferably comprises at least one amino acid substitution selected from A17F, F90D / E / Q / N, R138K, and N204G, and exhibits a higher specific hydrolysis activity compared to the esterase of SEQ ID NO:3.

[0132] In another embodiment, the esterase comprises at least one amino acid substitution selected from F90D / T / H / E / G / P / S / Q / N, preferably comprises at least the substitution F90T, and exhibits a higher PET depolymerization yield after 24 hours compared to the esterase of SEQ ID NO:3.

[0133] In one embodiment, the esterase comprises at least one amino acid substitution selected from A17F / V / Q / D, N204A / G, E158I / C, T160C, G171C, and V180C, preferably comprises at least one amino acid substitution selected from A17F, N204G, E158C, T160C, G171C, and V180C, more preferably comprises at least one substitution or combination of substitutions selected from N204G, N204G+A17F, E158C+T160C, G171C+V180C, and exhibits increased thermostability compared to the esterase of SEQ ID NO:3.

[0134] In an embodiment, the esterase is A215S / Y + A17F / V / Q / D, N204A / G + A17F / V / Q / D, F90D / T / H / E / G / P / S / Q / N + A215S / Y, F90D / T / H / E / G / P / S / Q / N + A17F / V / Q / D, F90D / T / H / E / G / P / S / Q / N + A17F / V / Q / D + N204A / G, F90D / T / H / E / G / P / S / Q / N + A17F / V / Q / D + Q237C / I, F90D / T / H / E / G / P / S / Q / N + A17F / V / Q / D + N211F / W / E, F90D / T / H / E / G / P / S / Q / N + A17F / V / Q / D + N204A / G + Q237C / I, F90D / T / H / E / G / P / S / Q / N + A17F / V / Q / D + N211F / W / E + Q237C / I, F90D / T / H / E / G / P / S / Q / N + A17F / V / Q / D + N211F / W / E + N204A / G, E158E / I / C + T160C and G171C + and V180C, preferably selected from A215Y+A17F, N204G+A17F, F90D+A215Y, F90D+A17F, F90D+A17F+N204G, F90D+A17F+Q237I, F90D+A17F+N211E, F90D+A17F+N204G+Q237I, F90D+A17F+N211E+Q237I, F90D+A17F+N211E+N204G, E158C+T160C, and G171C+V180C. and more preferably at least one substitution combination selected from N204G+A17F, F90D+A215Y, F90D+A17F, F90D+A17F+N204G, F90D+A17F+N211E, E158C+T160C, and G171C+V180C, and exhibits high thermostability compared to the esterase of SEQ ID NO: 3 at a pH of 4 to 6, preferably at a pH of 5 to 6, more preferably at a pH of 5 to 5.5, and even more preferably at pH 5.2.

[0135] Preferably, the esterase, like the parent esterase (i.e., in the amino acid sequence set forth in SEQ ID NO: 3), comprises at least amino acids S130, D175, and H207 forming the catalytic site of the esterase, and / or amino acids C240 ​​and C275 forming disulfide bonds. Preferably, the esterase, like the parent esterase, comprises at least a combination of amino acid residues selected from S130+D175+H207, C240+C275, and S130+D175+H207+C240+C275. In addition, the esterase, like the parent esterase, further comprises at least one of the amino acid residues selected from C203, C248, I170, G92, P213, E182, and L13, and E158. In a preferred embodiment, the esterase comprises at least the amino acids S130, D175, H207, C240, C275, C203, C248, I170, G92, P213, E182, L13, and E158, as in the parent esterase, and preferably comprises at least the amino acids S130, D175, H207, C240, C275, G92, P213, E182, and L13. More preferably, the esterase comprises at least the combination S130+D175+H207+C240+C275+G92+P213+E182+L13.

[0136] In a preferred embodiment, the esterase exhibits higher heat resistance and / or higher polyester decomposition activity compared to the esterase of SEQ ID NO: 3 at a pH of 4 to 6, preferably at a pH of 5 to 6, more preferably at a pH of 5 to 5.5, preferably at pH 5.2, and at a temperature of 50°C to 60°C, preferably at a temperature of 50°C to 72°C, more preferably at a temperature of 50°C to 65°C.

[0137] According to the present invention, the esterase can further exhibit higher heat resistance and / or higher polyester decomposition activity compared to the esterase of SEQ ID NO: 1 at a pH of 4 to 6, preferably at a pH of 5 to 6, more preferably at a pH of 5 to 5.5, preferably at pH 5.2, and at a temperature of 50°C to 90°C, preferably at a temperature of 50°C to 72°C, more preferably at a temperature of 50°C to 65°C.

[0138] Polyester decomposition activity of this variant The object of the present invention is to provide novel enzymes having esterase activity. In a particular embodiment, the enzymes of the present invention exhibit cutinase activity.

[0139] In a particular embodiment, the esterase of the present invention has polyester degradation activity, preferably polyethylene terephthalate (PET) degradation activity, and / or polybutylene adipate terephthalate (PBAT) degradation activity, and / or polycaprolactone (PCL) degradation activity, and / or polybutylene succinate (PBS) degradation activity, more preferably polyethylene terephthalate (PET) degradation activity, and / or polybutylene adipate terephthalate (PBAT) degradation activity. Even more preferably, the esterase of the present invention has polyethylene terephthalate (PET) degradation activity.

[0140] Advantageously, the esterase of the present invention exhibits polyester decomposition activity in the temperature range of 20°C to 90°C, preferably in the temperature range of 30°C to 90°C, more preferably in the temperature range of 40°C to 90°C, more preferably in the temperature range of 50°C to 90°C, and even more preferably in the temperature range of 60°C to 90°C. Specifically, the esterase of the present invention exhibits polyester decomposition activity in the temperature range of 65°C to 90°C, 65°C to 85°C, 65°C to 80°C, 70°C to 90°C, 70°C to 85°C, and 70°C to 80°C. Specifically, the esterase of the present invention exhibits polyester decomposition activity at a temperature of 40°C to 80°C, preferably at a temperature of 50°C to 72°C, and more preferably at a temperature of 50°C to 65°C. In one embodiment, the esterase of the present invention exhibits polyester decomposition activity at a temperature of 55°C to 60°C, 50°C to 55°C, 55°C to 65°C, 60°C to 72°C, and 60°C to 70°C. In certain embodiments, the esterase exhibits polyesterolytic activity at least at 50° C., 54° C., 60° C., 65° C., 68° C., or 70° C. Advantageously, polyesterolytic activity is still measurable at temperatures between 55° C. and 70° C. Within the context of the present invention, temperatures are given to + / - 1° C.

[0141] According to the present invention, the esterase of the present invention has a high polyester decomposition activity at a given temperature, more preferably at a temperature of 40° C. to 90° C., more preferably at a temperature of 50° C. to 90° C., compared with the parent esterase of SEQ ID NO: 1, SEQ ID NO: 2, or SEQ ID NO: 3. Advantageously, the esterase of the present invention has a high polyester decomposition activity in the entire temperature range of 40° C. to 90° C., 40° C. to 80° C., 40° C. to 70° C., 50° C. to 70° C., 54° C. to 70° C., 55° C. to 70° C., 60° C. to 70° C., 65° C. to 75° C., 65° C. to 80° C., and 65° C. to 90° C., compared with the parent esterase of SEQ ID NO: 1, SEQ ID NO: 2, or SEQ ID NO: 3. Specifically, the esterase of the present invention exhibits a high polyester decomposition activity at a temperature of 40° C. to 80° C., preferably at a temperature of 50° C. to 72° C., more preferably at a temperature of 50° C. to 65° C. In certain embodiments, the esterase of the invention exhibits high polyester degradation activity at temperatures between 55° C. and 60° C., between 50° C. and 55° C., between 55° C. and 65° C., between 60° C. and 72° C., between 60° C. and 70° C. More specifically, the esterase of the invention exhibits high polyester degradation activity at least at 50° C., 54° C., 60° C., 65° C., or 68° C., preferably at 54° C. or 60° C. Advantageously, the esterase has at least 5% higher polyester degradation activity than the parent esterase of SEQ ID NO:1, SEQ ID NO:2, or SEQ ID NO:3, and preferably has at least 10%, 20%, 50%, 100% or higher polyester degradation activity.

[0142] In a preferred embodiment, the esterase has a polyesterolytic activity at 54°C that is at least 5% greater than the polyesterolytic activity of the parent esterase of SEQ ID NO:1, SEQ ID NO:2, or SEQ ID NO:3, and preferably has at least 10%, 20%, 50%, 100% or more polyesterolytic activity at 54°C.

[0143] In another preferred embodiment, the esterase has a polyesterolytic activity at 60°C that is at least 5% greater than the polyesterolytic activity of the parent esterase of SEQ ID NO:1, SEQ ID NO:2, or SEQ ID NO:3, and preferably has at least 10%, 20%, 50%, 100% or more polyesterolytic activity at 60°C.

[0144] Specifically, the esterase may have a polyester degradation activity over the full temperature range of 54°C to 60°C that is at least 5% higher than the polyester degradation activity of the parent esterase of SEQ ID NO:1, SEQ ID NO:2, or SEQ ID NO:3, and preferably has a polyester degradation activity over the full temperature range of 54°C to 60°C that is at least 10%, 20%, 50%, 100% or higher.

[0145] According to the present invention, the esterase of the present invention can exhibit measurable polyester decomposition activity at least in the ranges of pH 3 to 6, pH 4 to 6, pH 4.5 to 6, pH 5 to 6, pH 5.5 to 6, pH 5 to 5.5, pH 5 to 5.2, pH 5.2 to 5.5, pH 4 to 5.5, pH 4.5 to 5.5, and pH 5 to 5.5, preferably in the pH range of 5 to 5.2, and more preferably at pH 5.2.

[0146] The present esterase may further exhibit measurable polyester decomposition activity in the pH ranges of 6.5 to 10, 7 to 9.5, 7 to 9, 7.5 to 8.5, 6 to 9, 6.5 to 9, and 6.5 to 8. Preferably, the present esterase further exhibits measurable polyester decomposition activity at pH 8.

[0147] Nucleic acids, expression cassettes, vectors, host cells It is a further object of the present invention to provide a nucleic acid encoding an esterase as defined above.

[0148] As used herein, "nucleic acid", "nucleic acid sequence", "polynucleotide", "oligonucleotide" and "nucleotide sequence" refer to a sequence of deoxyribonucleotides and / or ribonucleotides. Nucleic acids can be DNA (cDNA or gDNA), RNA, or mixtures thereof. Nucleic acids can be in single-stranded or double-stranded form, or mixtures thereof. Nucleic acids can be of recombinant, artificial, and / or synthetic origin and can contain modified nucleotides, including, for example, modified bonds, modified purine or pyrimidine bases, or modified sugars. The nucleic acids of the invention can be in isolated or purified form and can be produced, isolated, and / or manipulated by techniques known per se in the art (e.g., cloning and expression of cDNA libraries, amplification, enzymatic synthesis, or recombinant techniques). Nucleic acids can also be synthesized in vivo by known chemical synthesis techniques, for example as described in Belousov (1997) Nucleic Acids Res. 25:3440-3444.

[0149] The present invention also encompasses nucleic acids that hybridize under stringent conditions to nucleic acids encoding esterases as defined above. Preferably, such stringent conditions include incubation of the hybridization filter in 2×SSC / 0.1% SDS for about 2.5 hours at about 42° C., followed by washing the filter four times for 15 minutes in 1×SSC / 0.1% SDS at 65° C. Protocols used are described in references such as Sambrook et al. (Molecular Cloning: a Laboratory Manual, Cold Spring Harbor Press, Cold Spring Harbor NY (1988)) and Ausubel (Current Protocols in Molecular Biology (1989)).

[0150] The present invention also encompasses a nucleic acid encoding an esterase of the present invention, wherein the sequence of said nucleic acid, or at least a portion of said nucleic acid, has been engineered using optimized codon usage.

[0151] Alternatively, the nucleic acid according to the invention can be deduced from the sequence of the esterase according to the invention and the codon usage can be adapted depending on the host cell in which the nucleic acid is transcribed. These steps can be carried out according to methods known to those skilled in the art, some of which are described in the reference manual Sambrook et al. (Sambrook et al., 2001).

[0152] The nucleic acids of the present invention may further comprise additional nucleotide sequences, such as regulatory regions (i.e., promoters, enhancers, silencers, terminators, signal peptides, etc.) that can be used to cause or regulate expression of the polypeptide in a selected host cell or host system.

[0153] The present invention further relates to an expression cassette comprising a nucleic acid according to the invention operably linked to one or more control sequences directing the expression of said nucleic acid in a suitable host cell.

[0154] The term "expression", as used herein, refers to all steps involved in the production of a polypeptide, including, but not limited to, transcription, post-transcriptional modification, translation, post-translational modification, and secretion.

[0155] The term "expression cassette" refers to a nucleic acid construct that includes a coding region (ie, a nucleic acid of the invention) and an operably linked regulatory region (ie, one or more control sequences).

[0156] Typically, the expression cassette comprises or consists of the nucleic acid of the present invention operably linked to a control sequence, such as a transcription promoter and / or a transcription terminator. The control sequence may comprise a promoter recognized by the host cell or an in vitro expression system for the expression of the nucleic acid encoding the esterase of the present invention. The promoter comprises a transcription control sequence that mediates the expression of the enzyme. The promoter may be any polynucleotide that exhibits transcriptional activity in the host cell, such as mutated promoters, truncated promoters, and hybrid promoters, and may be obtained from a gene encoding an extracellular or intracellular polypeptide, either homologous or heterologous to the host cell. The control sequence may also be a transcription terminator, which is recognized by the host cell to terminate transcription. The terminator is operably linked to the 3' end of the nucleic acid encoding the esterase. Any terminator that functions in the host cell may be used in the present invention. Typically, the expression cassette comprises or consists of the nucleic acid of the present invention operably linked to a transcription promoter and a transcription terminator.

[0157] The present invention also relates to a vector comprising a nucleic acid or an expression cassette as defined above.

[0158] As used herein, the term "vector" or "expression vector" refers to a DNA or RNA molecule containing an expression cassette of the present invention that is used as a vehicle to introduce recombinant genetic material into a host cell. The main types of vectors are plasmids, bacteriophages, viruses, cosmids, and artificial chromosomes. The vector itself is generally a DNA sequence consisting of an insert (heterologous nucleic acid sequence, transgene) and a larger sequence that serves as the "backbone" of the vector. The purpose of a vector to transfer genetic information to a host is typically to isolate, multiply, or express the insert in a target cell. Vectors called expression vectors (expression constructs) are specifically adapted for the expression of heterologous sequences in a target cell and generally have a promoter sequence that drives the expression of a heterologous sequence that encodes a polypeptide. Generally, the regulatory elements present in an expression vector include a transcription promoter, a ribosome binding site, a terminator, and an operator that is optionally present. Preferably, an expression vector also contains an origin of replication for autonomous replication in a host cell, a selectable marker, a limited number of useful restriction enzyme sites, and the potential for high copy number. Examples of expression vectors are cloning vectors, modified cloning vectors, specially designed plasmids and viruses. Expression vectors that provide suitable levels of polypeptide expression in various hosts are known in the art. The choice of vector typically depends on the compatibility of the vector with the host cell into which it must be introduced. Preferably, the expression vector is a linear or circular double-stranded DNA molecule.

[0159] Another object of the present invention is to provide a host cell comprising a nucleic acid, an expression cassette or a vector as described above. The present invention therefore relates to the use of a nucleic acid, an expression cassette or a vector according to the invention for transforming, transfecting or transducing a host cell. The choice of vector typically depends on the compatibility of the vector with the host cell into which it must be introduced.

[0160] According to the invention, the host cell may be transformed, transfected or transduced in a transient or stable manner. The expression cassette or vector of the invention is introduced into the host cell so that the cassette or vector is maintained as a chromosomal integrant or as a self-replicating extrachromosomal vector. The term "host cell" also encompasses any progeny of a parent host cell that is not identical to the parent host cell due to mutations that occur during replication. The host cell may be any cell useful for the production of the variants of the invention, for example, prokaryotic or eukaryotic. Prokaryotic host cells may be any gram-positive or gram-negative bacteria. The host cell may also be a eukaryotic cell, such as a yeast cell, a fungal cell, a mammalian cell, an insect cell, or a plant cell. In certain embodiments, the host cell is selected from the group of Escherichia coli, Bacillus, Streptomyces, Trichoderma, Aspergillus, Saccharomyces, Pichia, Vibrio, or Yarrowia.

[0161] The nucleic acid, expression cassette, or expression vector of the invention may be introduced into a host cell by any method known to those skilled in the art (e.g., electroporation, conjugation, transduction, competent cell transformation, protoplast transformation, protoplast fusion, biological "gene gun" transformation, PEG-mediated transformation, lipid-assisted transformation or transfection, chemically mediated transfection, lithium acetate-mediated transformation, liposome-mediated transformation).

[0162] Optionally, multiple copies of the nucleic acid, cassette or vector of the invention may be inserted into the host cell to increase production of the variant.

[0163] In certain embodiments, the host cell is a recombinant microorganism. The present invention allows for the engineering of microorganisms with improved ability to degrade polyester-containing materials. For example, the sequences of the present invention may be used to complement wild-type strains of fungi or bacteria already known to be capable of degrading polyesters to improve and / or increase the performance of the strains.

[0164] Production of esterase Another object of the invention is to provide a method for producing an esterase of the invention, comprising expressing a nucleic acid encoding the esterase, and optionally recovering the esterase.

[0165] Specifically, the present invention relates to an in vitro method for producing an esterase of the invention, comprising the steps of: (a) contacting a nucleic acid, cassette, or vector of the invention with an in vitro expression system; and (b) recovering the esterase produced. In vitro expression systems are known to those of skill in the art and are commercially available.

[0166] Preferably, the method comprises the steps of: (a) culturing a host cell containing a nucleic acid encoding an esterase of the invention under conditions suitable for expression of said nucleic acid; and optionally (b) recovering the esterase from the cell culture. Includes.

[0167] Advantageously, the host cell is a recombinant Bacillus, a recombinant E. coli, a recombinant Aspergillus, a recombinant Trichoderma, a recombinant Streptomyces, a recombinant Saccharomyces, a recombinant Pichia, a recombinant Vibrio, or a recombinant Yarrowia.

[0168] The host cells are cultured in a nutrient medium suitable for production of the polypeptide using methods known in the art. For example, the cells can be cultured in shake flask cultures or by small- or large-scale fermentation (e.g., continuous, batch, fed-batch, or solid-state fermentation) in laboratory or industrial fermenters carried out in a suitable medium and under conditions that allow expression and / or isolation of the enzyme. Cultivation is carried out in a suitable nutrient medium obtained from a commercial supplier or prepared according to published compositions (e.g., compositions published in catalogues of the American Type Culture Collection).

[0169] If the esterase is secreted into the nutrient medium, it can be directly recovered from the culture supernatant. Conversely, it can be recovered from cell lysate or after permeabilization. The esterase can be recovered using any method known in the art. For example, the esterase can be recovered from the nutrient medium by conventional procedures (such as, but not limited to, collection, centrifugation, filtration, extraction, spray drying, evaporation, or precipitation). Optionally, the esterase can be partially or completely purified by various procedures known in the art (such as, but not limited to, chromatography (e.g., ion exchange, affinity, hydrophobic, chromatofocusing, and size exclusion), electrophoretic procedures (e.g., preparative isoelectric focusing), differential dissolution (e.g., ammonium sulfate precipitation), SDS-PAGE, or extraction) to obtain a substantially pure polypeptide.

[0170] The esterases can be used directly in purified form, alone or in combination with additional enzymes, to catalyze enzymatic reactions involved in the degradation and / or recycling of polyesters and / or polyester-containing materials (e.g., plastic products containing polyesters). The esterases can be in soluble form or in solid phase. In particular, the esterases can be bound to cell membranes or lipid vesicles, or can be bound to synthetic supports such as glass, plastic, polymers, filters, membranes, etc., in the form of beads, columns, plates, etc.

[0171] composition A further object of the present invention is to provide a composition comprising the esterase or host cell of the present invention, or an extract thereof comprising the esterase. In the context of the present invention, the term "composition" encompasses any type of composition comprising the esterase or host cell of the present invention, or an extract thereof comprising the esterase.

[0172] The composition of the present invention may contain 0.1% to 99.9% by mass of the esterase, preferably 0.1% to 50% by mass, more preferably 0.1% to 30% by mass, and even more preferably 0.1 to 5% by mass of the esterase, based on the total mass of the composition. Alternatively, the composition may contain 5 to 10% by mass of the esterase of the present invention.

[0173] The composition may be in liquid or dry form, for example in powder form, hi some embodiments, the composition is a lyophilizate.

[0174] The composition may further comprise excipients and / or reagents etc. Suitable excipients include: buffers commonly used in biochemistry, pH adjusters, preservatives such as sodium benzoate, sodium sorbate or sodium ascorbate, antiseptics, protectants or stabilizers such as starch, dextrin, gum arabic, salts, sugars such as sorbitol, trehalose or lactose, glycerol, polyethylene glycol, polypropylene glycol, propylene glycol, sequestering agents such as EDTA, reducing agents, amino acids, carriers such as solvents or aqueous solutions, and the like. The composition of the present invention can be obtained by mixing the esterase with one or several excipients.

[0175] In certain embodiments, the composition may comprise 0.1% to 99.9% excipient by weight, preferably 50% to 99.9%, more preferably 70% to 99.9%, and even more preferably 95% to 99.9% of the excipient by weight, based on the total weight of the composition, or alternatively, the composition may comprise 5 to 10% by weight of the excipient.

[0176] The composition may further comprise additional polypeptides exhibiting enzymatic activity. The amount of the esterase of the invention is easily adapted by the skilled artisan depending, for example, on the nature of the polyester to be degraded and / or on the additional enzymes / polypeptides included in the composition.

[0177] The esterase of the present invention may be dissolved in an aqueous medium together with one or several excipients, particularly excipients capable of stabilizing or protecting the polypeptide from degradation. For example, the esterase of the present invention may be dissolved in water together with additional components, such as glycerol, sorbitol, dextrin, starch, glycols, such as propanediol, salts, etc. The resulting mixture may then be dried to obtain a powder. Methods for drying such mixtures are known to those skilled in the art and include, but are not limited to, lyophilisation, freeze-drying, spray drying, supercritical drying, downdraft evaporation, thin layer evaporation, centrifugal evaporation, conveyor drying, fluidized bed drying, drum drying, or any combination thereof.

[0178] The composition may be in powder form and may include the esterase and a stabilizing / solubilizing amount of glycerol, sorbitol or dextrin, such as maltodextrin, and / or cyclodextrin, starch, glycol, such as propanediol, and / or a salt.

[0179] The composition of the present invention may comprise at least one recombinant cell expressing the esterase of the present invention or an extract thereof. "Extract of a cell" refers to any fraction obtained from a cell, such as cell supernatant, cell debris, cell wall, DNA extract, enzyme or enzyme preparation, or any preparation that is essentially free of viable cells and obtained from a cell by chemical, physical, and / or enzymatic treatment. A preferred extract is an enzymatically active extract. The composition of the present invention may comprise one or several recombinant cells of the present invention, or an extract thereof, and optionally one or several additional cells.

[0180] For example, the composition may consist of or comprise the culture medium of a recombinant microorganism that expresses and secretes an esterase of the invention. In certain embodiments, the composition comprises such a culture medium that has been lyophilized.

[0181] Use of esterase It is a further object of the present invention to provide a method of using the esterases of the present invention for degrading and / or recycling polyester or polyester-containing materials under aerobic or anaerobic conditions. The esterases of the present invention are particularly useful for the degradation of PET and PET-containing materials, especially under acidic conditions.

[0182] It is therefore an object of the present invention to use the esterases of the present invention, or corresponding recombinant cells having esterase activity or extracts thereof, or compositions for the enzymatic degradation of polyesters.

[0183] Advantageously, the polyester targeted by the esterase is selected from polyethylene terephthalate (PET), polytrimethylene terephthalate (PTT), polybutylene terephthalate (PBT), polyethylene isosorbide terephthalate (PEIT), polylactic acid (PLA), polyhydroxyalkanoates (PHA), polybutylene succinate (PBS), polybutylene succinate adipate (PBSA), polybutylene adipate terephthalate (PBAT), polyethylene furanoate (PEF), polycaprolactone (PCL), poly(ethylene adipate) (PEA), polyethylene naphthalate (PEN), "polyolefin-like" polyesters, and blends / mixtures of these substances, preferably polyethylene terephthalate.

[0184] In a preferred embodiment, the polyester is PET, and at least the monomers (e.g., monoethylene glycol or terephthalic acid), and / or oligomers (e.g., methyl-2-hydroxyethyl terephthalate (MHET), bis(2-hydroxyethyl) terephthalate (BHET), 1-(2-hydroxyethyl) 4-methyl terephthalate (HEMT), and dimethyl terephthalate (DMT)) are optionally recovered.

[0185] An object of the present invention is also the use of an esterase of the present invention, or a corresponding recombinant cell or extract, or composition thereof, for the enzymatic degradation of at least one polyester of a polyester-containing material, in particular under acidic conditions.

[0186] Another object of the present invention is to provide a method for degrading at least one polyester of a polyester-containing material, which comprises contacting the polyester-containing material with an esterase of the present invention, or a host cell, or an extract or composition thereof, in particular under acidic conditions, whereby at least one polyester of the polyester-containing material is degraded.

[0187] Advantageously, the polyester is depolymerized to monomers and / or oligomers.

[0188] Specifically, the invention provides a method for degrading PET in a PET-containing material by contacting the PET-containing material with an esterase, or host cell, or composition of the invention, preferably under acidic conditions, thereby degrading the PET.

[0189] Advantageously, the at least one polyester is decomposed into repolymerizable monomers and / or oligomers, which can be advantageously recovered for reuse. The recovered monomers and / or oligomers can be used for recycling (e.g., repolymerization of the polyester) or methanation. In a particular embodiment, the at least one polyester is PET, and monoethylene glycol, terephthalic acid, methyl-2-hydroxyethyl terephthalate (MHET), bis(2-hydroxyethyl) terephthalate (BHET), 1-(2-hydroxyethyl) 4-methyl terephthalate (HEMT), and dimethyl terephthalate (DMT) are recovered.

[0190] Preferably, the polyester of the polyester-containing material is completely degraded.

[0191] The time required for degradation of a polyester-containing material may vary depending on the polyester-containing material itself (i.e., the nature and origin of the polyester-containing material, its composition, form, etc.), the type and amount of esterase used, and various process parameters (i.e., temperature, pH, additional agents, etc.) A person skilled in the art can easily adapt the process parameters to the polyester-containing material and the expected degradation time.

[0192] Advantageously, the degradation process is carried out at a temperature between 20°C and 90°C, preferably between 40°C and 90°C, more preferably between 50°C and 70°C. In a particular embodiment, the degradation process is carried out at 60°C. In another particular embodiment, the degradation process is carried out at 65°C. In another particular embodiment, the degradation process is carried out at 70°C. More generally, the temperature is kept below the inactivation temperature, which corresponds to the temperature at which the esterase is inactivated (i.e. the temperature at which the esterase loses more than 80% of its activity compared to its activity at the optimum temperature) and / or the temperature at which the recombinant microorganism no longer synthesizes the esterase. In particular, the temperature is kept below the glass transition temperature (Tg) of the target polyester.

[0193] Advantageously, the process is carried out in a continuous flow process at a temperature that allows the esterase to be used and / or recycled several times.

[0194] According to the present invention, the degradation process is carried out at a pH between 3 and 6, preferably between 4 and 5.5, more preferably between 4.5 and 5.5, even more preferably between 5 and 5.5, in particular at pH 5.2.

[0195] In one embodiment, the degradation process may also be carried out at a pH between 5 and 9, preferably between 6 and 9, more preferably between 6.5 and 9, and even more preferably between 6.5 and 8. In another embodiment, the degradation process is carried out at a pH between 6.5 and 10, preferably between 7 and 9.5, more preferably between 7 and 9, and even more preferably between 7.5 and 8.5.

[0196] The polyester-containing material may be pretreated prior to contact with the esterase to physically alter its structure and increase the contact surface between the polyester and the esterase.

[0197] Another object of the present invention is to provide a method for producing monomers and / or oligomers from a polyester-containing material, comprising exposing the polyester-containing material, in particular under acidic conditions, to an esterase of the present invention, or a corresponding recombinant cell or extract thereof, or a composition, and, optionally, recovering the monomers and / or oligomers.

[0198] The monomers and / or oligomers obtained by depolymerization may be recovered sequentially or continuously. Depending on the starting polyester-containing material, a single type of monomer and / or several different types of monomers and / or oligomers may be recovered.

[0199] The process of the present invention is particularly useful for producing monomers selected from monoethylene glycol and terephthalic acid, and / or oligomers selected from methyl-2-hydroxyethyl terephthalate (MHET), bis(2-hydroxyethyl) terephthalate (BHET), 1-(2-hydroxyethyl) 4-methyl terephthalate (HEMT), and dimethyl terephthalate (DMT) from PET and / or plastic articles containing PET.

[0200] The recovered monomers and / or oligomers may be further purified using any suitable purification method and prepared into a repolymerizable form.

[0201] The recovered repolymerizable monomers and / or oligomers can be reused, for example, to synthesize polyesters. Advantageously, polyesters of the same nature are repolymerized. However, it is possible to mix the recovered monomers and / or oligomers with other monomers and / or oligomers, for example to synthesize new copolymers. Alternatively, the recovered monomers can be used as chemical intermediates for producing new compounds of interest. By way of example, processes for degrading such polyester-containing materials, including the esterases of the invention, are disclosed in WO 2014 / 079844, WO 2015 / 173265, WO 2017 / 198786, WO 2020 / 094661, WO 2020 / 094646, WO 2021 / 123299, WO 2021 / 123301, and WO 2021 / 123328.

[0202] The present invention also relates to a method for surface hydrolysis or surface functionalization of polyester-containing materials, in particular comprising exposing the polyester-containing material to an esterase of the present invention, or a corresponding recombinant cell or extract thereof, or a composition, under acidic conditions. The method of the present invention is particularly useful for increasing the hydrophilicity (i.e., water absorbency) of polyester materials. Such increased hydrophilicity may be of particular interest in textile manufacturing, electronics, and biomedical applications.

[0203] The present invention also relates to a method for treating water, wastewater or sewage, in particular under acidic conditions. In wastewater or sewage treatment applications, the esterases according to the invention can be used to degrade microplastic particles made of polyester (preferably PET), such as polymer filaments, fibers or other types of polyester-based product debris and fragments, preferably PET-based product debris and fragments.

[0204] It is a further object of the present invention to provide a polyester-containing material comprising the esterase of the present invention and / or a recombinant microorganism expressing and excreting said esterase. By way of example, processes for preparing such polyester-containing materials comprising the esterase of the present invention are disclosed in WO 2013 / 093355, WO 2016 / 198650, WO 2016 / 198652, WO 2019 / 043145 and WO 2019 / 043134.

[0205] Therefore, it is an object of the present invention to provide a polyester-containing material comprising the esterase of the present invention, and / or recombinant cells and / or compositions, or extracts thereof, and at least PET. According to an embodiment, the present invention provides a plastic product comprising PET and the esterase of the present invention having PET degrading activity.

[0206] Therefore, another object of the present invention is to provide a polyester-containing material comprising the esterase of the present invention, and / or recombinant cell and / or composition, or extract thereof, and at least PBAT. According to one embodiment, the present invention provides a plastic product comprising PBAT and the esterase of the present invention having PBAT degrading activity.

[0207] Therefore, another object of the present invention is to provide a polyester-containing material comprising the esterase of the present invention, and / or recombinant cells and / or compositions, or extracts thereof, and at least PBS. According to one embodiment, the present invention provides a plastic product comprising PBS and the esterase of the present invention having PBS decomposition activity.

[0208] Therefore, another object of the present invention is to provide a polyester-containing material comprising the esterase of the present invention, and / or recombinant cell and / or composition, or extract thereof, and at least PCL. According to an embodiment, the present invention provides a plastic product comprising PCL and the esterase of the present invention having PCL decomposition activity.

[0209] Classically, the esterase of the present invention may be used in detergent, food, animal feed, paper, textile, and pharmaceutical applications. More specifically, the esterase of the present invention may be used as a component of a detergent composition. Detergent compositions include, but are not limited to, detergent compositions for hand or machine washing, such as laundry additive compositions suitable for pre-treatment of soiled fabrics, and fabric softener compositions added to the rinse, detergent compositions used in general household hard surface cleaning operations, and detergent compositions for hand or machine dishwashing operations. For example, the esterase of the present invention may be used as a detergent additive. Thus, the present invention provides a detergent composition comprising the esterase of the present invention. Specifically, the esterase of the present invention may be used as a detergent additive to reduce pilling and graying effects during textile washing.

[0210] The present invention is also directed to a method of using the esterase of the present invention in animal feed, as well as to feed compositions and feed additives comprising the esterase of the present invention. The terms "feed" and "feed composition" refer to any compound, preparation, mixture, or composition suitable for or intended for ingestion by an animal. The esterase of the present invention may also be used to hydrolyze proteins and to produce hydrolysates containing peptides. Such hydrolysates may be used as feed compositions or feed additives.

[0211] It is a further object of the present invention to provide a method of using the esterase of the present invention in the paper industry. More specifically, the esterase of the present invention can be used to remove stickies from the paper pulp and water pipelines of a paper machine. EXAMPLES

[0212] Example 1 Construction, expression, and purification of esterases - construction The esterase according to the invention was produced using the plasmid construct pET26b-LCC-His, into which the gene encoding the esterase of SEQ ID NO: 1 was cloned and optimized for Escherichia coli expression between the NdeI and XhoI restriction sites. To produce the esterase variants, two site-directed mutagenesis kits were used according to the supplier's recommendations: QuikChange II Site-Directed Mutagenesis Kit (from Santa Clara, California, USA) and QuikChange Lightning Multi Site-Directed from Agilent.

[0213] - Expression and purification of esterases Stellar™ strains (Clontech, California, USA) and E. coli BL21(DE3) (New England Biolabs, Evry, France) were employed in succession to perform cloning and recombinant expression in 50 mL of LB-Miller medium or ZYM autoinduction medium (Studier et al., 2005- Prot. Exp. Pur. 41, 207-234). Induction in LB-Miller medium was carried out at 16°C with 0.5 mM isopropyl β-D-1-thiogalactopyranoside (IPTG, Euromedex, Souffelweyersheim, France). Cultures were stopped by centrifugation (8000 rpm, 20 min at 10°C) in an Avanti J-26 XP centrifuge (Beckman Coulter, Brea, USA). The cells were suspended in 20 mL of Talon buffer (Tris-HCl 20 mM, NaCl 300 mM, pH 8). The cell suspension was then sonicated for 2 min at 30% amplitude (2 sec ON and 1 sec OFF cycles) with an FB 705 sonicator (Fisherbrand, Illkirch, France). The following centrifugation step was then performed: 10000 g in an Eppendorf centrifuge at 10° C. for 30 min. The soluble fraction was collected and subjected to affinity chromatography. This purification step was completed with Talon® Metal Affinity Resin (Clontech, CA, USA). Elution of the protein was performed with a step of Talon buffer supplemented with imidazole. The purified proteins were dialyzed against Talon buffer or sodium acetate buffer (100-300 mM, pH 5.2), then quantified using the Bio-Rad protein assay according to the manufacturer's instructions (Lifescience Bio-Rad, France) and stored at +4°C.

[0214] Example 2 Evaluation of esterase degradation activity The decomposition activity of the esterase was determined and compared with the activity of the esterase of SEQ ID NO:1.

[0215] To assess specific activity, several methodologies were used: (1) Specific activity based on PET hydrolysis and ultra-high performance liquid chromatography (UHPLC) analysis (2) Specific activity based on PET hydrolysis and ultraviolet absorption (UV assay) analysis (3) Degradation activity based on the decomposition of polyester in solid form (4) Decomposition activity based on PET hydrolysis in a reactor of more than 100 mL

[0216] 2.1. Specific activity based on PET hydrolysis and ultra-high performance liquid chromatography (UHPLC) analysis 100 mg of powdered amorphous PET (prepared according to WO 2017 / 198786 to reach a crystallinity of less than 20%) was weighed and introduced into a 100 mL glass bottle. 1 mL of an esterase preparation containing the esterase of SEQ ID NO: 1 (as a reference control) or the esterase of the invention, prepared to 1,727 μM in sodium acetate buffer (100-300 mM, pH 5.2) for measurements in acidic conditions (or 0.69 μM in Talon buffer (Tris-HCl 20 mM, NaCl 0.3 M, pH 8) for basic conditions), was introduced into the glass bottle. Finally, 9 mL or 49 mL of the corresponding buffer (depending on the pH at which the measurements are performed) were added.

[0217] Depolymerization was initiated by incubating each vial at 50°C, 54°C, 60°C, 65°C, 68°C, or 72°C and 150 rpm in a Max Q 4450 incubator (Thermo Fisher Scientific, Inc., Waltham, MA, USA).

[0218] The initial rate of the depolymerization reaction (mg equivalents of TA produced / h) was determined by sampling performed at various times during the first 24 h and analyzed by ultra-high performance liquid chromatography (UHPLC). If necessary, the samples were diluted with 0.1 M potassium phosphate buffer (pH 8). Then, 150 μL of methanol and 6.5 μL of 6 N HCl were added to 150 μL of sample or diluent. After mixing and filtering through a 0.45 μm syringe filter, the samples were loaded onto the UHPLC to monitor the release of terephthalic acid (TA), MHET, and BHET. The chromatographic system used was an Ultimate 3000 UHPLC system (Thermo Fisher Scientific, Inc., Waltham, MA, USA) including a pump module, an autosampler, a column oven thermostat at 25 °C, and a UV detector at 240 nm. The column used was a Discovery® HS C18 HPLC column (150 × 4.6 mm, 5 μm, equipped with a precolumn, Supelco, Bellefonte, USA). TA, MHET, and BHET were dissolved in 1 mM H at 1 mL / min. 2 SO 4 Separation was performed using a gradient of MeOH (30%-90%) in 100 mL of ethanol. Injections were 20 μL of samples. TA, MHET, and BHET were measured according to calibration curves made from commercially available TA and BHET, and in-house synthesized MHET, under the same conditions as the samples. The specific activity of PET hydrolysis (mg equivalents of TA / hour / mg enzyme) was determined in the linear part of the hydrolysis curve of the reaction (i.e., at the beginning of the reaction), and such curves were set by sampling performed at various time points during the first 24, 48, or 72 hours. The equivalent amount of TA corresponds to the sum of the measured TA and the TA contained in the measured MHET and BHET. The measurement of the equivalent amount of TA can also be used to calculate the yield of the PET depolymerization assay at a given time and / or after a defined period (e.g., 24 hours or 48 hours).

[0219] 2.2. Specific Activity Based on PET Hydrolysis and Ultraviolet Absorption (UV Assay) Analysis 100 mg of powdered amorphous PET (prepared according to WO 2017 / 198786 to reach a crystallinity of less than 20%) was weighed and introduced into a 100 mL glass bottle. 1 mL of an esterase preparation containing the esterase of SEQ ID NO: 1 (as a reference control) or the esterase of the invention, prepared to 1,727 μM in sodium acetate buffer (100-300 mM, pH 5.2) for measurements in acidic conditions or 0.69 μM in Talon buffer (Tris-HCl 20 mM, NaCl 0.3 M, pH 8) for measurements in basic conditions, was introduced into the glass bottle. Finally, 9 mL or 49 mL of the corresponding buffer (depending on the pH at which the measurements are performed) were added.

[0220] Depolymerization was initiated by incubating each vial at 50°C, 54°C, 60°C, or 65°C and 150 rpm in a Max Q 4450 incubator (Thermo Fisher Scientific, Inc., Waltham, MA, USA).

[0221] The initial rate of the depolymerization reaction (μmol soluble degradant produced / hour) was determined by sampling performed at various times during the first 24 hours and analyzed by reading the absorbance at 242 nm using an Eon Microplate Spectrophotometer (BioTek, USA). An increase in the absorbance of the reaction mixture in the ultraviolet region of the light spectrum (at 242 nm) indicates the release of soluble TA or its esters (BHET and MHET) from the insoluble PET substrate. The absorbance value at this wavelength can be used to calculate the sum of PET hydrolysis products according to the Lambert-Beer law, and the specific activity of the enzyme is determined as the total equivalent TA produced. The specific activity of PET hydrolysis (μmol soluble product / hour / mg enzyme) was determined in the linear part of the hydrolysis curve of the reaction (i.e., at the beginning of the reaction), and such a curve was set by sampling performed at various times during the first 24, 48, or 72 hours. The equivalent TA measurement can also be used to calculate the yield of the PET depolymerization assay at a given time and / or after a defined period of time (e.g., 24 hours or 48 hours). If necessary, samples were diluted with 0.1 M potassium phosphate buffer (pH 8).

[0222] 2.3. Activity based on the degradation of polyester in solid form Preparation of agar plates was achieved by dissolving 50 mg of PET in hexafluoro-2-propanol (HFIP) and pouring this medium into 250 mL of aqueous solution. After HFIP evaporation at 50° C. under 140 mbar, the solution was mixed with potassium phosphate buffer (pH 8.0), or sodium acetate buffer (pH 5.2), or sodium acetate buffer (pH 5.0) to obtain a final concentration of 1% agar with 0.5 mg / mL of PET and 0.1 M of buffer. Approximately 30 mL of this mixture was used to prepare each plate and stored at 4° C. 1 μL, 5 μL, or 20 μL of enzyme preparation (pure enzyme or cell lysate) was placed in the wells of the agar plates containing PET at pH 8.0, 5.2, or 5.0, respectively.

[0223] The diameter or surface area of ​​the halos formed due to polyester degradation by the wild-type esterase and variants was determined by measuring the diameter of the halos on agar plate photographs using the software Gimp and compared after defined periods (2 to 24 hours) at 40°C, 45°C, 50°C, 55°C, 60°C, 65°C, or 70°C.

[0224] 2.4. Activity based on PET hydrolysis in the reactor 0.69 μmol to 2.07 μmol of purified esterase prepared in 80 mL of 100 mM potassium phosphate buffer (pH 8), or 300 mM sodium acetate buffer (pH 5.0), or 300 mM sodium acetate buffer (pH 5.2), or 300 mM sodium acetate buffer (pH 6.0) was mixed with 20 g of amorphous PET (prepared according to WO 2017 / 198786 to reach a crystallinity of less than 20%) in a 500 mL Minibio bioreactor (Applikon Biotechnology, Delft, The Netherlands). Temperature regulation at 40°C, 45°C, 50°C, 55°C, 60°C, 65°C, or 70°C was performed by water bath immersion and constant agitation was maintained at 250 rpm using a single marine impeller. The pH of the PET depolymerization assay was controlled at pH 5, or pH 5.2, or pH 6, or pH 8 by addition of 6 N NaOH and was guaranteed by a my-Control bio controller system (Applikon Biotechnology, Delft, The Netherlands). Base consumption was recorded during the assay and can be used for characterization of the PET depolymerization assay.

[0225] The final yield of the PET depolymerization assay was determined either by determining the mass of the remaining PET, or by determining the equivalent amount of TA produced, or by base consumption. The mass determination of the remaining PET was evaluated at the end of the reaction by filtering the reaction volume through a 12-15 μm grade 11 ashless filter paper (Dutscher SAS, Brumath, France) and weighing such residue after drying. The determination of the equivalent amount of TA produced was realized using the UHPLC method described in 2.1, and the percentage of hydrolysis was calculated based on the ratio of the molar concentration (TA+MHET+BHET) at a given time to the total amount of TA contained in the initial sample. The PET depolymerization produced acidic monomers that were neutralized with base to be able to maintain the pH in the reactor. The determination of the equivalent amount of TA produced was calculated using the corresponding molar base consumption, and the percentage of hydrolysis was calculated based on the ratio of the molar concentration at a given time of the equivalent amount of TA to the total amount of TA contained in the initial sample.

[0226] result Activity based on the degradation of solid forms of PET under acidic conditions compared to the esterase of SEQ ID NO:1 The activity of the esterases (variants) of the invention was evaluated after 24 hours at 50° C. and pH 5.0 (V1 to V38 and V124) or pH 5.2 (V38 to V93) as shown in Example 2.3.

[0227] The surface area of ​​the halos of the esterases (variants) of the invention was compared to the surface area formed by the wild-type esterase of SEQ ID NO: 1. The variants with a higher surface area compared to the wild-type esterase of SEQ ID NO: 1 (i.e., variants with superior degradative activity compared to the esterase of SEQ ID NO: 1 after a defined period of time) are reported in Table 1 below.

[0228] [Table 1A]

[0229] [Table 1B]

[0230] V1 through V93 and V124 have the exact amino acid sequence of SEQ ID NO:1, except for the substitutions listed in Table 1.

[0231] Interestingly, most of the variants exhibit a halo with a diameter greater than or equal to 110% of the halo diameter of the wild-type esterase of SEQ ID NO: 1. These variants are reported in Table 2 below.

[0232] [Table 2A]

[0233] [Table 2B]

[0234] The variants listed in Table 2 have the exact amino acid sequence of SEQ ID NO:1, except for the substitutions listed in Table 2.

[0235] Specific cleavage activity under acidic conditions compared to the esterase of SEQ ID NO:1 The specific hydrolysis activity of the esterase (variant) of the invention was determined from the linear part of the hydrolysis curve (i.e. at the beginning of the reaction). The specific hydrolysis activity of the esterase of SEQ ID NO: 1 was used as a reference and considered as 100% specific hydrolysis activity. This specific hydrolysis activity was measured at pH 5.2 and 54°C as shown in Example 2.1. The results are summarized in Table 3 below.

[0236] [Table 3]

[0237] Each of the variants listed above has the exact amino acid sequence of SEQ ID NO:1, except for the substitutions listed in Table 3.

[0238] PET depolymerization yield under acidic conditions compared to esterase of SEQ ID NO:1 The PET depolymerization yield of the esterase (variant) of the present invention was further evaluated after 48 hours at pH 5.2 and 50°C. In the context of the present invention, the PET depolymerization yield is used to evaluate the decomposition activity. The results are shown in Table 4 below. The decomposition activity of the esterase of SEQ ID NO: 1 was used as a standard and considered as 100% decomposition activity. The specific decomposition activity was measured as shown in Example 2.2.

[0239] [Table 4]

[0240] Specific cleavage activity under acidic conditions compared to the esterase of SEQ ID NO:2 The specific cleavage activity of further esterases (variants) of the invention is shown in Table 5 below. The variants are based on SEQ ID NO: 2, which corresponds to the esterase of SEQ ID NO: 1 with the substitution combination F208M+D203C+S248C+V170I+Y92G+N213P+Q182E, and have a 4.5-fold higher specific cleavage activity at pH 5.2 and 60° C. compared to the esterase of SEQ ID NO: 1. The specific cleavage activity of the esterase of SEQ ID NO: 2 is used as a reference and is considered as 100% specific cleavage activity. The specific cleavage activity was measured as shown in Example 2.2.

[0241] [Table 5]

[0242] The variants listed above each have the exact amino acid sequence of SEQ ID NO:2, except for the substitutions listed in Table 5.

[0243] Specific cleavage activity under acidic conditions compared to the esterase of SEQ ID NO:3 The specific cleavage activity of further esterases (variants) of the invention is shown in Table 6 below. The variants are based on SEQ ID NO: 3, which corresponds to the esterase of SEQ ID NO: 1 with the substitution combination F208M+D203C+S248C+V170I+Y92G+N213P+Q182E+S13L+D158E and have a 3-fold higher specific cleavage activity at pH 5.2 and 54° C. compared to the esterase of SEQ ID NO: 1. The specific cleavage activity of the esterase of SEQ ID NO: 3 is used as a reference and is considered as 100% specific cleavage activity. The specific cleavage activity was measured as shown in Example 2.2.

[0244] [Table 6]

[0245] The variants listed above each have the exact amino acid sequence of SEQ ID NO:3, except for the substitutions listed in Table 6.

[0246] The degradation activity of further esterases (variants) of the invention after 24 hours is shown in Table 7 below. The degradation activity of the esterase of SEQ ID NO: 3 is used as a reference and is considered as 100% degradation activity after 24 hours. The degradation activity is measured after 24 hours as shown in Example 2.1.

[0247] [Table 7]

[0248] The variants have the exact amino acid sequence of SEQ ID NO:3, except for the substitutions listed in Table 7.

[0249] Specific cleavage activity at pH 8 compared to the esterase of SEQ ID NO:1 The specific lytic activity of the esterase of the present invention was also measured at pH 8.

[0250] The specific degradation activity was measured as described in Example 2.1.

[0251] The specific cleavage activity of the esterase (variants) of the present invention at pH 8 is shown in Table 8 below. The specific cleavage activity of the esterase of SEQ ID NO: 1 is used as a standard and is considered as 100% specific cleavage activity. The specific activity is measured at 65°C as shown in Example 2.1.

[0252] [Table 8]

[0253] The variants listed above each have the exact amino acid sequence of SEQ ID NO:1, except for the substitutions listed in Table 8.

[0254] Example 3 Evaluation of the heat resistance of the esterase of the present invention The thermostability of the esterases of the present invention was determined and compared to that of the esterases of SEQ ID NO:1, SEQ ID NO:2, or SEQ ID NO:3.

[0255] Heat resistance was estimated using various methodologies: (1) Circular dichroism of proteins in solution; (2) the residual esterase activity after incubation of the protein under given conditions of temperature, time, and buffer; (3) the residual polyester depolymerization activity after incubation of the protein under given conditions of temperature, time, and buffer; (4) the ability to degrade a solid polyester compound (e.g., PET, or PBAT, or similar) dispersed in an agar plate after incubation of the protein under given conditions of temperature, time, and buffer; (5) the ability to perform polyester depolymerization assays multiple times under given conditions of temperature, buffer, protein concentration, and polyester concentration; (6) Differential scanning fluorimetry (DSF).

[0256] A detailed protocol for such a method is provided below.

[0257] 3.1 Circular dichroism Circular dichroism (CD) was performed on a Jasco 815 instrument (Easton, USA) to compare the melting temperature (Tm) of the esterase of SEQ ID NO: 1 with that of the esterase of the present invention. Technically, 400 μL of protein sample was prepared at 0.5 mg / mL in defined conditions of pH (Talon buffer (pH 8), sodium acetate buffer 100 mM pH 5 or 5.2) and used for CD. A first scan from 280 to 190 nm was realized to determine the two CD intensity maxima corresponding to the correct folding of the protein. A second scan was then performed from 25 °C to 110 °C with a wave length corresponding to such maximum intensity, providing a specific curve (sigmoidal 3 parameters y=a / (1+e^((x-x0) / b))) that was analyzed by Sigmaplot version 11.0 software to determine the Tm in the case of x=x0. The obtained Tm reflects the thermal resistance of a given protein. The higher the Tm, the more stable the variant is at high temperatures.

[0258] 3.2 Residual esterase activity A 1 mL solution of 40 mg / L (in Talon buffer, or 0.2 M sodium acetate buffer (pH 5.0), or 0.2 M sodium acetate buffer (pH 5.2), or sodium acetate buffer (pH 6.0)) of the esterase of SEQ ID NO: 1 or the esterase of the invention was incubated at various temperatures (40, 50, 60, 65, 70, 75, 80, and 90 °C) for up to 10 days. Samples were taken periodically and diluted 1 to 500 times in 0.1 M potassium phosphate buffer (pH 8.0), or 0.2 M sodium acetate buffer (pH 5.0), or 0.2 M sodium acetate buffer (pH 5.2), or sodium acetate buffer (pH 6.0) to realize the paranitrophenol-butyrate (pNP-B) assay. 20 μL of sample was mixed with 175 μL of 0.1 M potassium phosphate buffer (pH 8.0), or 0.2 M sodium acetate buffer (pH 5.0), or 0.2 M sodium acetate buffer (pH 5.2), or sodium acetate buffer (pH 6.0), and 5 μL of pNP-B solution (40 mM) in 2-methyl-2-butanol. The enzyme reaction was carried out at 30° C. under stirring for 15 min, and the absorbance at 405 nm was obtained by a microplate spectrophotometer (Versamax, Molecular Devices, Sunnyvale, CA, USA). The activity of pNP-B hydrolysis (initial rate expressed in μmol pNPB / min) was determined using a calibration curve prepared in the same buffer and pH conditions as the enzyme assay for liberated paranitrophenol in the linear part of the hydrolysis curve.

[0259] 3.3 Residual polyester depolymerization activity 10 mL of a 40 mg / L solution of the esterase of SEQ ID NO:1 or the esterase of the invention (in Talon buffer, or 0.2 M sodium acetate buffer (pH 5.0), or 0.2 M sodium acetate buffer (pH 5.2), or sodium acetate buffer (pH 6.0)) was incubated at various temperatures (40° C., 50° C., 60° C., 65° C., 70° C., 75° C., 80° C., and 90° C.), respectively, for up to 30 days. Periodically, 1 mL of sample was taken and transferred to a bottle containing 100 mg of amorphous PET (prepared according to WO 2017 / 198786 to reach less than 20% crystallinity) micronized to 250-500 μm and 49 mL of 0.1 M potassium phosphate buffer (pH 8.0), or 0.2 M sodium acetate buffer (pH 5.0), or 0.2 M sodium acetate buffer (pH 5.2), or sodium acetate buffer (pH 6.0), and incubated at 50 °C, 55 °C, 60 °C, 65 °C, or 70 °C. 150 μL of buffer was sampled periodically. If necessary, the sample was diluted with 0.1 M potassium phosphate buffer (pH 8). Then, 150 μL of methanol and 6.5 μL of 6 N HCl were added to the sample or 150 μL of diluent. After mixing and filtering through a 0.45 μm syringe filter, the samples were loaded onto a UHPLC to monitor the release of terephthalic acid (TA), MHET, and BHET. The chromatographic system used was an Ultimate 3000 UHPLC system (Thermo Fisher Scientific, Inc., Waltham, MA, USA) including a pump module, an autosampler, a column oven thermostat at 25° C., and a UV detector at 240 nm. The column used was a Discovery® HS C18 HPLC column (150×4.6 mm, 5 μm, equipped with a precolumn, Supelco, Bellefonte, USA). TA, MHET, and BHET were eluted at 1 mL / min with 1 mM H 2 SO 4Separation was performed using a gradient of MeOH (30%-90%) in 100 mL of ethanol. Injections were 20 μL of sample. TA, MHET, and BHET were measured under the same conditions as the samples according to calibration curves made from commercially available TA and BHET, and from in-house synthesized MHET. The activity of PET hydrolysis (μmol PET hydrolyzed / min, or mg equivalent TA produced / h) was determined in the linear part of the hydrolysis curve, which was set up by sampling performed at various times during the first 24 h. The equivalent TA corresponds to the sum of the measured TA and the TA contained in the measured MHET and BHET.

[0260] 3.4 Degradation of polyester in solid form 1 mL of 40 mg / L solutions of the esterase of SEQ ID NO:1 and the esterase of the present invention (Talon buffer, or 0.1 M potassium phosphate buffer (pH 8.0), or 0.1 M phosphate citrate buffer (pH 6.0), or 0.1 M sodium acetate buffer (pH 5.2)) were incubated at various temperatures (40° C., 50° C., 60° C., 65° C., 70° C., 75° C., 80° C., and 90° C.) for up to 30 days. Periodically, the enzyme preparations were sampled and placed into the wells of the agar plates containing PET. The preparation of the agar plates was achieved by dissolving 50 mg of PET in hexafluoro-2-propanol (HFIP) and pouring this medium into 250 mL of the aqueous solution. After HFIP evaporation at 50° C. under 140 mbar, the solution was mixed with potassium phosphate buffer (pH 8.0), or phosphate citrate buffer (pH 6.0), or sodium acetate buffer (pH 5.2) to obtain a final concentration of 1% agar containing 0.5 mg / mL PET and 0.1 M buffer. Approximately 30 mL of this mixture was used to prepare each plate and stored at 4° C. 1 μL, 5 μL, or 20 μL of the enzyme preparation was placed in the wells of the agar plates containing PET at pH 8.0, 6.0, or 5.2, respectively.

[0261] The diameter or surface area of ​​the halos formed due to polyester degradation by wild-type esterase and the variants of the invention were measured and compared after 2 to 24 hours at 50° C., 55° C., 60° C., 65° C., or 70° C. The half-life of the enzyme at a given temperature corresponds to the time required for the diameter of the halo to decrease by a factor of two.

[0262] 3.5 Multiple depolymerization of polyester The ability of the esterases to perform successive polyester depolymerization assays was evaluated in an enzyme reactor. A Minibio 500 bioreactor (Applikon Biotechnology BV, Delft, The Netherlands) was started with 3 g of amorphous PET (prepared according to WO 2017 / 198786 to reach a crystallinity of less than 20%) and 100 mL of 100 mM sodium acetate buffer (pH 5.0), or 100 mM sodium acetate buffer (pH 5.2), or 100 mM sodium acetate buffer (pH 6.0) containing 3 mg of esterase. Agitation was set at 250 rpm using a marine impeller. The bioreactor was thermostated at 50°C, 55°C, 60°C, 65°C, or 70°C by immersion in an external water bath. The pH was adjusted to 5.0, 5.2, or 6.0 by addition of 3 M NaOH. Various parameters (pH, temperature, stirring, addition of base) were monitored by BioXpert software V2.95. 1.8 g of amorphous PET (prepared according to WO 2017 / 198786 to reach a crystallinity of less than 20%) was added every 20 hours. 500 μL of the reaction medium was sampled periodically.

[0263] The amounts of TA, MHET, and BHET were determined by HPLC as described in Example 2.3. The amount of EG was determined using an Aminex HPX-87K column (Bio-Rad Laboratories, Inc., Hercules, California, United States) thermostated at 65°C. The eluate was diluted with 0.6 mL / min. -1 5 mM K at 2 HPO4 Injections were 20 μL. Ethylene glycol was monitored using a refractometer.

[0264] The percentage of hydrolysis was calculated based on the ratio of the molar concentration (TA+MHET+BHET) at a given time to the total amount of TA contained in the initial sample, or based on the ratio of the molar concentration (EG+MHET+2×BHET) at a given time to the total amount of EG contained in the initial sample. Degradation rates are calculated in mg total free TA per hour or mg total EG per hour.

[0265] The half-life of the enzyme was estimated as the incubation time required to obtain a 50% loss in degradation rate.

[0266] 3.6 Differential Scanning Fluorometry (DSF) DSF was used to evaluate the thermal stability of wild-type protein (SEQ ID NO: 1) and its variants by determining the melting temperature (Tm), the temperature at which half of the protein population is unfolded. To estimate the Tm value, protein samples were prepared at a concentration of 25 μM in buffer A consisting of 100 mM potassium phosphate buffer (pH 8.0). 6 μL of the prepared protein sample was then diluted with 18 μL of buffer A (for measurements at pH 8.0 and Tm evaluation) or with 18 μL of buffer B (for measurements at pH 5.2 and Tm evaluation) consisting of 300 mM sodium acetate (pH 5.09) to a final pH value of 5.2. SYPRO Orange dye 5000× stock solution in DMSO was first diluted 250-fold with water. Protein samples were loaded onto a white clear 96-well PCR plate (Bio-Rad catalog # HSP9601) with each well containing a final volume of 25 μl. The final concentrations of protein and SYPRO Orange dye in each well were 6 μM (0.17 mg / ml) and 10×, respectively. The volumes loaded per well were as follows: 24 μL of 6.25 μM diluted protein solution, and 1 μL of 250× Sypro Orange diluted solution. The PCR plate was then sealed with optical quality sealing tape and spun at 1000 rpm for 1 min at room temperature. DSF experiments were then performed using a CFX96 Real-Time PCR System set to use 450 / 490 excitation and 560 / 580 emission filters. Samples were heated from 25 to 100°C at a rate of 0.3°C / s. A single fluorescence measurement was taken every 0.03 s. Melting points were determined from the peak of the first derivative of the melting curve using Bio-Rad CFX Manager software. As long as the same buffer is used for both the esterases of the invention and the parent esterase, variations in the type of buffer or buffer concentration may be used without affecting the delta Tm between the esterases of the invention and the parent esterase.

[0267] The esterases of SEQ ID NO:1, SEQ ID NO:2, or SEQ ID NO:3 and the esterases of the present invention were then compared based on their Tm values. A ΔTm of 0.8° C. at pH 5.2 and pH 8.0 was considered significant for comparing variants within the same experimental set. Tm values ​​correspond to the average of at least three measurements.

[0268] result Thermostability compared to the esterase of SEQ ID NO:1 under acidic conditions The thermostability of the esterases of the invention was evaluated as shown in Example 3.6. The increase in Tm compared to the esterase of SEQ ID NO: 1 is shown in Table 9 below.

[0269] [Table 9]

[0270] The variants listed above each have the exact amino acid sequence of SEQ ID NO:1, except for the substitutions listed in Table 9.

[0271] Thermostability compared to esterase of SEQ ID NO:1 at pH 8 The Tm of the esterase variants was also evaluated at pH 8. The increase in Tm of the esterases of the present invention compared to the esterase of SEQ ID NO: 1 is shown in Table 10 below.

[0272] [Table 10]

[0273] The variants listed above have the exact amino acid sequence of SEQ ID NO:1, except for the substitutions listed in Table 10.

[0274] Thermostability compared to the esterase of SEQ ID NO:2 under acidic conditions The increase in Tm of the esterases of the present invention compared to the esterase of SEQ ID NO:2 is shown below in Table 11. The esterase of SEQ ID NO:2 has a 17.4°C improvement in Tm compared to the esterase of SEQ ID NO:1.

[0275] [Table 11]

[0276] The variants listed above each have the exact amino acid sequence of SEQ ID NO:2, except for the substitutions listed in Table 11.

[0277] Thermostability compared to the esterase of SEQ ID NO:3 under acidic conditions The increase in Tm of the esterases of the present invention compared to the esterase of SEQ ID NO:3 is shown below in Table 12. The esterase of SEQ ID NO:3 has a 16.3°C improvement in Tm at pH 5.2 compared to the esterase of SEQ ID NO:1.

[0278] [Table 12]

[0279] The variants listed above each have the exact amino acid sequence of SEQ ID NO:3, except for the substitutions listed in Table 12.

Claims

1. 1. An esterase variant, comprising: (i) at least 75%, 80%, 85%, 90%, 95%, 96%, 97%, 98%, or 99% identity to the full-length amino acid sequence set forth in SEQ ID NO:1; and (ii) S13L, R12A / I / M, A14C / Y, L15Q / G / I / D, A17F / V / Q / D, D18E, R30Y / L / Q / M / N / S / E, G37E / C, Y60H / C / G, T61Y / H / Q / E, S66E / W / D, L67I / E, W69I, R72I / T / L / V, R89E / G / V, F90D / T / H / E. At least one amino acid substitution selected from / G / P / S / Q / N, Y92E, P93A, R138L / K / D / E, A127T, W155M / H / E, D158E / I / C, T160C, L202I, N204A, A205M / Q, S206V / I / N, F208V / K, A209S / D / E, N211F / W, S212T / A / Q, N213L, N214T, A215S / Y, I217L / C / V, Y220W / C / T, Q237C / I, F238I / D, L239C, V242I, L247M, and H156D, and / or the amino acid sequence an esterase variant having an amino acid substitution at at least one position corresponding to a residue selected from E141, G171, and V180 compared to SEQ ID NO:1, said positions being numbered with reference to the amino acid sequence set forth in SEQ ID NO:1; (iii) having polyester degrading activity; and (iv) exhibiting increased thermostability and / or increased polyester degrading activity at a pH of 3 to 6 compared to the esterase of SEQ ID NO:

1.

2. The esterases include E141C / K / R, G171C, V180C, R12A / I / M, S13L, A14C / Y, L15Q / G / I / D, A17F / V / Q / D, D18E, R30Y / L / Q / M / N / S / E, G37E / C, Y60H / C / G, T61Y / H / Q / E, S66E / W / D, L67I / E, W69I, R72I / T / L / V, R89E / G / V, F90D / T / H / E / G / P / S / Q / N, Y92E, P93A, R At least one selected from 138L / K / D / E, A127T, W155M / H / E, D158E / I / C, T160C, L202I, N204A, A205M / Q, S206V / I / N, F208V / K, A209S / D / E, N211F / W, S212T / A / Q, N213L, N214T, A215S / Y, I217L / C / V, Y220W / C / T, Q237C / I, F238I / D, L239C, V242I, L247M, and H156D. and preferably R12A / I / M, S13L, A14C / Y, L15Q / G / I / D, A17F / V / Q / D, D18E, R30Y / L / Q / M / N / S / E, G37E / C, Y60H / C / G, T61Y / H / Q / E, S66E / W / D, L67I / E, W69I, R72I / T / L / V, R89E / G / V, F90D / T / H / E / G / P / S / Q / N, Y92E, P93A, R138L, A127T, W15 2. The esterase of claim 1, comprising at least one substitution selected from 5M / H / E, D158E / I, L202I, N204A, A205M / Q, S206V / I / N, F208V / K, A209S / D / E, N211F / W, S212T / A / Q, N213L, N214T, A215S / Y, I217L / C / V, Y220W / C / T, Q237C / I, F238I / D, L239C, V242I, L247M, and H156D.

3. The esterase comprises at least one substitution selected from S13L, A14C / Y, L15Q / G / I / D, A17F / V / Q / D, F90D / T / H / E / G / P / S / Q / N, Y92E, D158E / I / C, S206V / I / N, F208V / K, A127T, N211F / W, A215S / Y, Q237C / I, and H156D, preferably selected from S13L, A14C / Y, L15Q, A17F / V, F90D / T, Y92E, D158E, S206I / N, F208K, A127T, N211F, A215Y, Q237I, and H156D.

2. The esterase of claim 1, comprising at least one substitution selected from the group consisting of S13L, A14C / Y, A17F / V, F90D / T, Y92E, D158E, S206I / N, F208K, A127T, N211F, A215Y, Q237I, and H156D, more preferably comprising at least one substitution selected from the group consisting of S13L, A14C / Y, A17F / V, F90D / T, Y92E, D158E, S206I, F208K, N211F, A215Y, Q237I, and H156D, even more preferably comprising at least one substitution selected from the group consisting of S13L, A14C / Y, A17F / V, F90D / T, Y92E, D158E, S206I, F208K, N211F, A215Y, Q237I, and H156D.

4. The esterase of any one of claims 1 to 3, wherein the esterase exhibits a higher specific decomposition activity and / or a higher PET depolymerization yield after 24 hours compared to the esterase of SEQ ID NO:

1.

5. 5. The esterase of claim 1, wherein the esterase comprises at least the substitution H156D and exhibits a higher PET depolymerization yield after 24 hours compared to the esterase of SEQ ID NO:

1.

6. The esterase according to any one of claims 1 to 5, comprising at least one substitution selected from S13L, A14C, A17F, F90D / T, Y92E, F208K, N211F, A215Y, and Q237I, and exhibiting a higher specific hydrolysis activity compared to the esterase of SEQ ID NO:

1.

7. The esterases include R12A / I / M, A14C / Y, L15Q / D, A17V / Q / F, D18E, L67I / E, R72I / T / L / V, P93A, R138L, L239C, L202I, S206V, A209. S, S212T / A / Q, N213L, F238D, Q237C / I, R30Y / L / Q / M / N / S / E, G37E / C, Y60H / C / G, T61Y / H / Q / E, S66E / W / D, R89E / G / V, F90G / P / S / T / H / Q / N / D / E, Y92E, W155M / H, and N211W / F, preferably R12I / M, A14C, L15Q, A17Q, L67I, R72T / L, P93A, S212A / Q, N213L, Q237C / I, R30Y / L / Q / M / N / S / E, G37E / C, Y60H / C / G, T61Y / H / Q / E, S66E / W / D, R89E / G / V, F90G / P / S / T and at least one substitution selected from R12I / M, L15Q, R72T, S212A, N213L, R30Y / L / Q / M / S / E, G37E, Y60H / C / G, T61Y / H / Q / E, S66E / W / D, R89E / G / V, F90G / P / S / T / H / Q / N / D / E, W155M / H, and N211W / F.

2. The esterase of claim 1, further comprising at least one substitution selected from R72T, S212A, N213L, R30Y / L / Q / M / S / E, G37E, Y60H / C / G, T61Y / H / Q / E, S66E / W / D, R89E / G / V, F90G / P / S / T / H / Q / N / D / E, W155M / H, and N211W / F, and having a higher PET depolymerization yield after 24 hours compared to SEQ ID NO:

1.

8. 8. The esterase of claim 1, further comprising at least two substitutions, preferably at least three, four, five substitutions, at positions selected from Y92, G135, V167, V170, Q182, D203, F208, N213, and S248, preferably selected from F208I / L / M / T, D203C / K / R, S248C, V170I, Y92G, G135A, V167Q, Q182E, and N213P.

9. Specifications are D203C + S248C F208W / I / L / G / S / N / A / R / T / H / M / E / Q / Y + D203C + S248C、F208W / I / L / G / S / N / A / R / T / H / M / E / Q / Y + D203C + S248C + V170I、F208W / I / L / G / S / N / A / R / T / H / M / E / Q / Y + D203C + S248C + V170I + Y92A / G / P / N / Q / T / F / C / D、F208W / I / L / G / S / N / A / R / T / H / M / E / Q / Y + D203C + S248C + V170I + Y92A / G / P / N / Q / T / F / C / D + N213D / E / R / K / P、F208W / I / L / G / S / N / A / R / T / H / M / E / Q / Y + D203C + S248C + V170I + Y92A / G / P / N / Q / T / F / C / D + N213D / E / R / K / P + Q182D / E、F208W / I / L / G / S / N / A / R / T / H / M / E / Q / Y + D203K / R、F208W / I / L / G / S / N / A / R / T / H / M / E / Q / Y + D203K / R + V170I、F208W / I / L / G / S / N / A / R / T / H / M / E / Q / Y + D203K / R + V170I + Y92A / G / P / N / Q / T / F / C / D V170I + Y92A / G / P / N / Q / T / F / C / D + N213D / E / R / K / P、F208W / I / L / G / S / N / A / R / T / H / M / E / Q / Y + D203K / R + V170I + Y92A / G / P / N / Q / T / F / C / D + N213D / E / R / K / P+ Q182D / E is very smooth and only 1 of these ranges are available as D203C + S248C、F208W / I / L / G / S / N / A / R / T / H / M / E / Q / Y + D203C + S248C V170I、F208W / I / L / G / S / N / A / R / T / H / M / E / Q / Y + D203C + S248C + V170I +Y92A / G / P / N / Q / T / F / C / D, F208W / I / L / G / S / N / A / R / T / H / M / E / Q / Y + D203C + S248C + V170I + Y92A / G / P / N / Q / T / F / C / D + N213P, F208W / I / L / G / S / N / A / R / T / H / M / E / Q / Y + D203C + S248C + V170I + Y92A / G / P / N / Q / T / F / C / D + N213P + and further comprising at least one substitution combination selected from the group consisting of D203C+S248C, F208I / L / M / T+D203C+S248C, F208I / L / M / T+D203C+S248C+V170I, F208I / L / M / T+D203C+S248C+V170I+Y92G, F208I / L / M / T+D203C+S248C+V170I+Y92G+N213P, F208I / 9. The esterase according to claim 1, further comprising at least one substitution combination selected from L / M / T+D203C+S248C+V170I+Y92G+N213P+Q182E, and even more preferably F208M+D203C+S248C+V170I+Y92G+N213P+Q182E, or F208I+D203C+S248C+V170I+Y92G+N213P+Q182E.

10. F208W / I / L / G / S / N / A / R / T / H / M / E / Q / Y + D203C + S248C + V170I + Y92G / D + N213P + Q182D / E + F208D F208W / I / L / G / S / N / A / R / T / H / M / E / Q / Y + D203C + S248C + V170I + Y92G / D + N213P + Q182D / E + S13L S248C + V170I + Y92G / D + N213P + Q182D / E + L15Q、F208W / I / L / G / S / N / A / R / T / H / M / E / Q / Y + D203C + S248C + V170I + Y92G / D + N213 + Q122+D + E A17F、F208W / I / L / G / S / N / A / R / T / H / M / E / Q / Y + D203C + S248C + V170I + Y92G / D + N213P + Q182D / E + D158E、F208W / I / L / G / N / M / E / H / H / Y D203C + S248C + V170I + Y92G / D + N213P + Q182D / E + S13L + A14E、F208W / I / L / G / S / N / A / R / T / H / M / E / Q / Y + D203C + S248C + V170I + Y92G / D + Y213+ Q182D / E + S13L + L15Q、F208W / I / L / G / S / N / A / R / T / H / M / E / Q / Y + D203C + S248C + V170I + Y92G / D + N213P + Q182D / E + S13L + A17F / V、F208W / I / L / G / S / N / A / R / T / H / M / E / Q / Y + D203C + S248C + V170I + Y92G / D + N213P + Q182D / E + S13L + D158E、F208W / I / L / G / S / N / A / R / T / H / M / E / Q / Y + D203C + S248C + V170I + Y92G / D + N213P + Q182D / E + S13L + N204G、F208W / I / L / G / S / N / A / R / T / H / M / E / Q / Y + D203C + S248C +V170I + Y92G / D + N213P + Q182E + A14Y, F208W / I / L / G / S / N / A / R / T / H / M / E / Q / Y + D203K / R + V170I + Y92G / D + N213P + Q182E + F90D, F208W / I / L / G / S / N / A / R / T / H / M / E / Q / Y + D203K / R + V170I + Y92G / D + N213P + Q182D / E + S13L, F208W / I / L / G / S / N / A / R / T / H / M / E / Q / Y + D203K / R + V170I + Y92G / D + N213P + Q182D / E + L15Q, F208W / I / L / G / S / N / A / R / T / H / M / E / Q / Y + D203K / R + V170I + Y92G / D + N213P + Q182D / E + A17F, F208W / I / L / G / S / N / A / R / T / H / M / E / Q / Y + D203K / R + V170I + Y92G / D + N213P + Q182D / E + D158E, F208W / I / L / G / S / N / A / R / T / H / M / E / Q / Y + D203K / R + V170I + Y92G / D + N213P + Q182D / E + S13L + A14E, F208W / I / L / G / S / N / A / R / T / H / M / E / Q / Y + D203K / R + V170I + Y92G / D + N213P + Q182D / E + S13L + L15Q, F208W / I / L / G / S / N / A / R / T / H / M / E / Q / Y + D203K / R + V170I + Y92G / D + N213P + Q182D / E + S13L + A17F / V, F208W / I / L / G / S / N / A / R / T / H / M / E / Q / Y + D203K / R + V170I + Y92G / D + N213P + Q182D / E + S13L + D158E, F208W / I / L / G / S / N / A / R / T / H / M / E / Q / Y + D203K / R + V170I + Y92G / D + N213P + Q182D / E + S13L + N204G and F208W / I / L / G / S / N / A / R / T / H / M / E / Q / Y + D203K / R + V170I + Y92G / D + N213P + Q182E +The A14Y is very smooth and the range of the 1 range is smooth This is F208W / I / L / G / S / N / A / R / T / H / M / E / Q / Y + D203C + S248C + V170I + Y92G / D + N213P + Q182E + F90D + F208W / I / L / G / S / N / A / R / T / H / M / E / Q / Y + D203C + S248C + V170I + Y92G / D + N213P + Q182D / E + S13L、F208W / I / L / G / S / N / A / R / T / H / M / E / Q / Y + D203C + S248C + V170I + Y92G / D + N213P + Q182D / E + L15Q D203C + S248C + V170I + Y92G / D + N213P + Q182D / E + A17F、F208W / I / L / G / S / N / A / R / T / H / M / E / Q / Y+ D158E、F208W / I / L / G / S / N / A / R / T / H / M / E / Q / Y + D203C + S248C + V170I + Y92G / D + N213P + Q182D / E + S13L + A14E、F208W / I / L / G / S / N / A / R / T / H / M / E / Q / Y+D203C+S248C+V170I+Y92G / D+N213P+Q182D / E+S13L+ L15Q、F208W / I / L / G / S / N / A / R / T / H / M / E / Q / Y + D203C + S248C + V170I + Y92G / D + N213P + Q182D / E + S13L + A17F / V、F208W / I / L / G / S / N / A / R / T / H / M / E / Q / Y+D203C+S248C+V170I+Y92G / D+N213P+Q182D / E+S13L+ D158E、F208W / I / L / G / S / N / A / R / T / H / M / E / Q / Y + D203C + S248C + V170I + Y92G / D + N213P + Q182D / E + S13L +N204G, F208W / I / L / G / S / N / A / R / T / H / M / E / Q / Y + D203C + S248C + V170I + Y92G / D + N213P + Q182E + A14Y, more preferably F208I / L / M / T + D203C + S248C + V170I + Y92G / D + N213P + Q182E + F90D, F208I / L / M / T + D203C + S248C + V170I + Y92G / D + N213P + Q182E + S13L, F208I / L / M / T + D203C + S248C + V170I + Y92G / D + N213P + Q182E + L15Q, F208I / L / M / T + D203C + S248C + V170I + Y92G / D + N213P + Q182E + A17F, F208I / L / M / T + D203C + S248C + V170I + Y92G / D + N213P + Q182E + D158E, F208I / L / M / T + D203C + S248C + V170I + Y92G / D + N213P + Q182E + S13L + A14E, F208I / L / M / T + D203C + S248C + V170I + Y92G / D + N213P + Q182E + S13L + L15Q, F208I / L / M / T + D203C + S248C + V170I + Y92G / D + N213P + Q182E + S13L + A17F / V, F208I / L / M / T + D203C + S248C + V170I + Y92G / D + N213P + Q182E + S13L + D158E, F208I / L / M / T + D203C + S248C + V170I + Y92G / D + N213P + Q182E + S13L + N204G, F208I / L / M / T + D203C + S248C + V170I + Y92G / D + N213P + Q182E + A14Y, and even more preferably F208M + D203C + S248C + V170I + Y92G + N213P +Q182E + F90D, F208M + D203C + S248C + V170I + Y92G + N213P + Q182E + S13L, F208M + D203C + S248C + V170I + Y92G + N213P + Q182E + L15Q, F208M + D203C + S248C + V170I + Y92G + N213P + Q182E + A17F, F208M + D203C + S248C + V170I + Y92G + N213P + Q182E + D158E, F208M + D203C + S248C + V170I + Y92G + N213P + Q182E + S13L + A14E, F208M + D203C + S248C + V170I + Y92G + N213P + Q182E + S13L + L15Q, F208M + D203C + S248C + V170I + Y92G + N213P + Q182E + S13L + A17F / V, F208M + D203C + S248C + V170I + Y92G + N213P + Q182E + S13L + D158E, F208M + D203C + S248C + V170I + Y92G + N213P + Q182E + S13L + N204G, F208M + D203C + S248C + V170I + Y92G + 10. The esterase according to any one of claims 1 to 9, comprising at least one combination of substitutions selected from N213P + Q182E + A14Y.

11. 11. The esterase according to any one of claims 1 to 10, wherein the esterase as an esterase having an amino acid sequence as set forth in SEQ ID NO:1 comprises at least one amino acid residue selected from S130, D175, H207, C240 ​​or C275, preferably comprises at least one combination of amino acid residues selected from S130+D175+H207, C240+C275 and S130+D175+H207+C240+C275, more preferably comprises the combination S130+D175+H207+C240+C275, as in the parent esterase.

12. The esterase has (i) at least 80%, 85%, 90%, 95%, 96%, 97%, 98%, or 99% identity to the full-length amino acid sequence set forth in SEQ ID NO:2; and (ii) at least one of the following amino acids as compared to the amino acid sequence SEQ ID NO:2: S13L, E141C / K / R, G171C, V180C, R12A / I / M, A14C / Y, L15Q / G / I / D, A17F / V / Q / D, D18E, R30Y / L / Q / M / N / S / E, G37E / C, Y60H / C / G, T61Y / H / Q / E, S66E / W / D, L67I / E, , W69I, R72I / T / L / V, R89E / G / V, F90D / T / H / E / G / P / S / Q / N, G92E, P93A, R138L / K / D / E, A 127T, W155M / H / E, D158E / I / C, T160C, L202I, N204A, A205M / Q, S206V / I / N, M208V / K, A 12. The esterase of any one of claims 1 to 11, comprising at least one amino acid substitution selected from 209S / D / E, N211F / W, S212T / A / Q, P213L, N214T, A215S / Y, I217L / C / V, Y220W / C / T, Q237C / I, F238I / D, L239C, V242I, L247M and H156D, said positions being numbered with reference to the amino acid sequence set forth in SEQ ID NO:2, (iii) having polyesterolytic activity, and (iv) exhibiting increased thermostability and / or increased polyesterolytic activity at a pH of 3 to 6 compared to the esterase of SEQ ID NO:

1.

13. 13. The esterase of claim 12, wherein the esterase variant further exhibits increased thermostability and / or increased polyesterolytic activity compared to the esterase of SEQ ID NO: 2 at a pH between 3 and 6, preferably between 5 and 5.

5.

14. 14. The esterase variant according to any one of claims 1 to 13, wherein the esterase exhibits increased thermostability and / or increased polyester degrading activity compared to the esterase of SEQ ID NO: 1 at a pH between 4 and 6, preferably between 5 and 6, more preferably between 5 and 5.5, preferably at pH 5.2, and at temperatures between 50°C and 90°C, preferably between 50°C and 72°C, more preferably between 50°C and 65°C.

15. 3. An esterase variant, comprising: (i) at least 80%, 85%, 90%, 95%, 96%, 97%, 98%, or 99% identity to the full-length amino acid sequence set forth in SEQ ID NO:3; and (ii) at least one of the following amino acid sequences as compared to the amino acid sequence SEQ ID NO:3: R12A / I / M, A14C / Y, L15Q / G / I / D, A17F / V / Q / D, D18E, R30Y / L / Q / M / N / S / E, G37E / C, Y60H / C / G, T61Y / H / Q / E, S66E / W / D, L67I / E, W69I, R72I / T / L / V, R89E / G / V, F9 0D / T / H / E / G / P / S / Q / N, P93A, R138L / K / D / E, A127T, W155M / H / E, E158I / C, T160C, L202I , N204A / G, A205M / Q, S206V / I / N, M208V / K, A209S / D / E, N211F / W / E, S212T / A / Q, N214T, 3. An esterase variant comprising at least one amino acid substitution selected from A215S / Y, I217L / C / V, Y220W / C / T, Q237C / I, F238I / D, L239C, V242I, L247M, and H156D, and / or an amino acid substitution at at least one position corresponding to a residue selected from E141, G171, and V180, said positions being numbered with reference to the amino acid sequence set forth in SEQ ID NO:3; (iii) having polyesterolytic activity; and (iv) exhibiting increased thermostability and / or increased polyesterolytic activity at a pH of 3 to 6 compared to the esterase of SEQ ID NO:

3.

16. 16. The esterase of claim 15, wherein the esterase comprises the same residue combination G92+P213+E182+L13 as in the parent esterase, as in SEQ ID NO:

3.

17. 17. The esterase of claim 16, further comprising one or several of the following residues E158, M208, C203, C248 and I170 as in the parent esterase, similar to SEQ ID NO: 3, preferably a combination of residues selected from M208+C203+C248, C203+C248, M208+C203+C248+I170, C203+C248+I170, M208+E158, M208+C203+C248+E158, M208+C203+C248+I170+E158.

18. The esterases include R12A / I / M, A14C / Y, L15Q / G / I / D, A17F / V / Q / D, D18E, R30Y / L / Q / M / N / S / E, G37E / C, Y60H / C / G, T61Y / H / Q / E, S66E / W / D, L67I / E, W69I, R72 I / T / L / V, R89E / G / V, F90D / T / H / E / G / P / S / Q / N, P93A, R138L / K / D / E, A127T , W155M / H / E, E158I / C, T160C, L202I, N204A / G, A205M / Q, S206V / I / N, M208 V / K, A209S / D / E, N211F / W / E, S212T / A / Q, N214T, A215S / Y, I217L / C / V, Y220W / C / T, Q237C / I, F238I / D, L239C, V242I, and L247M, H156D, E141C / K / R, G171C, and V180C, and preferably A17F / V / Q / D, F90D / T / H / E / G / P / S / Q / N, R138L / K / D / E, N204A / G, N211F / W / E, A215S / Y, E158I / C, At least one amino acid substitution selected from T160C, G171C, and V180C, more preferably at least one amino acid substitution selected from A17F, F90D / T / E / Q / N, R138K, N204G, N211E, A215Y, E158C, T160C, G171C, and V180C, even ...

18. The esterase of any one of claims 15 to 17, comprising at least one amino acid substitution selected from one amino acid substitution or combination of substitutions selected from 38K, N204G, E158C+T160C, G171C+V180C, N204G+A17F, F90D+A215Y, F90D+A17F, F90D+A17F+N204G, F90D+A17F+N211E.

19. 19. The esterase of any one of claims 15 to 18, wherein the esterase exhibits increased thermostability and / or increased polyester degrading activity compared to the esterase of SEQ ID NO: 3 at a pH between 3 and 6, preferably between 4 and 6, more preferably between 5 and 6, even more preferably between 5 and 5.5, in particular at pH 5.

2.

20. 20. The esterase of any one of claims 15 to 19, wherein the esterase exhibits increased thermostability and / or increased polyester degrading activity compared to the esterase of SEQ ID NO: 3 at temperatures between 50°C and 90°C, preferably between 50°C and 72°C, more preferably between 50°C and 65°C.

21. The esterase according to any one of claims 15 to 20, comprising at least one amino acid substitution selected from A17F / V / Q / D, F90D / T / H / E / G / P / S / Q / N, R138L / K / D / E, N204A / G, N211F / W / E, A215S / Y, preferably comprising at least one amino acid substitution selected from A17F, F90D / E / Q / N, R138K, N204G, N211E, A215Y, more preferably comprising at least one amino acid substitution selected from A17F, F90D / E / Q / N, R138K, and N204G, and exhibiting a higher specific hydrolysis activity compared to the esterase of SEQ ID NO:

3.

22. 22. The esterase of any one of claims 15 to 21, comprising at least one amino acid substitution selected from F90D / T / H / E / G / P / S / Q / N, preferably comprising at least the substitution F90T, and exhibiting a higher PET depolymerization yield after 24 hours compared to the esterase of SEQ ID NO:

3.

23. 22. The esterase according to claim 15, comprising at least one amino acid substitution selected from A17F / V / Q / D, N204A / G, E158I / C, T160C, G171C and V180C, preferably comprising at least one amino acid substitution selected from A17F, N204G, E158C, T160C, G171C and V180C, more preferably comprising at least one substitution or combination of substitutions selected from N204G, N204G+A17F, E158C+T160C, G171C+V180C, and exhibiting increased thermostability compared to the esterase of SEQ ID NO:

3.

24. The esterase is selected from the group consisting of A215S / Y + A17F / V / Q / D, N204A / G + A17F / V / Q / D, F90D / T / H / E / G / P / S / Q / N + A215S / Y, F90D / T / H / E / G / P / S / Q / N + A17F / V / Q / D, F90D / T / H / E / G / P / S / Q / N + A17F / V / Q / D + N204A / G, F90D / T / H / E / G / P / S / Q / N + A17F / V / Q / D + Q237C / I, F90D / T / H / E / G / P / S / Q / N + A17F / V / Q / D + N211F / W / E, F90D / T / H / E / G / P / S / Q / N + A17F / V / Q / D + N204A / G + Q237C / I, F90D / T / H / E / G / P / S / Q / N + A17F / V / Q / D + N211F / W / E + Q237C / I, F90D / T / H / E / G / P / S / Q / N + A17F / V / Q / D + N211F / W / E + N204A / G, E158I / C + T160C and G171C + V180C, preferably A215Y+A17F, N204G+A17F, F90D+A215Y, F90D+A17F, F90D+A17F+N204G, F90D+A17F+Q237I, F90D+A17F+N211E, F90D+A17F+N204G+Q237I, F90D+A17F+N211E+Q237I, F90D+A17F+N211E+N204G, E158 24. The esterase of claim 15, comprising at least one combination of substitutions selected from: C+T160C, and G171C+V180C, more preferably at least one combination of substitutions selected from: N204G+A17F, F90D+A215Y, F90D+A17F, F90D+A17F+N204G, F90D+A17F+N211E, E158C+T160C, and G171C+V180C.

25. 25. The esterase according to any one of claims 15 to 24, wherein the esterase comprises at least one amino acid residue selected from S130, D175, H207, C240 ​​or C275, similar to the esterase having the amino acid sequence set out in SEQ ID NO:1, preferably comprises at least a combination of amino acid residues selected from S130+D175+H207, C240+C275 and S130+D175+H207+C240+C275, more preferably comprises the combination S130+D175+H207+C240+C275, similar to the parent esterase.

26. 26. The esterase variant according to any one of claims 15 to 25, wherein the esterase exhibits increased thermostability and / or increased polyester degrading activity compared to the esterase of SEQ ID NO: 3 at a pH between 4 and 6, preferably between 5 and 6, more preferably between 5 and 5.5, preferably at pH 5.2, and at temperatures between 50°C and 90°C, preferably between 50°C and 72°C, more preferably between 50°C and 65°C.

27. 27. The esterase variant of any one of claims 15 to 26, wherein the esterase further exhibits increased thermostability and / or increased polyester degrading activity compared to the esterase of SEQ ID NO:

1.

28. 28. A nucleic acid encoding an esterase as defined in any one of claims 1 to 27.

29. 29. An expression cassette or expression vector comprising the nucleic acid of claim 28.

30. 30. A host cell comprising a nucleic acid according to claim 28, or an expression cassette or expression vector according to claim 29.

31. 31. A composition comprising an esterase as defined in any one of claims 1 to 27, or a host cell as defined in claim 30, or an extract thereof having esterase activity.

32. 1. A method for degrading polyester or at least one polyester of a polyester-containing material, comprising the steps of: a. contacting said polyester or said polyester-containing material with an esterase as defined in any one of claims 1 to 27, or with a host cell as defined in claim 30, or with a composition as defined in claim 31, and optionally b. Recovering the monomers and / or oligomers The method includes:

33. 33. The method according to claim 32, wherein step (a) is carried out at a pH of from 5 to 11, preferably from 6 to 9, more preferably from 6.5 to 9, even more preferably from 6.5 to 8.

34. 33. The method according to claim 32, wherein step (a) is carried out at a pH between 3 and 6, preferably between 4 and 6, more preferably between 5 and 6, even more preferably between 5 and 5.5, in particular at pH 5.

2.

35. 35. The method according to any one of claims 32 to 34, wherein the polyester is selected from polyethylene terephthalate (PET), polytrimethylene terephthalate (PTT), polybutylene terephthalate (PBT), polyethylene isosorbide terephthalate (PEIT), polylactic acid (PLA), polyhydroxyalkanoates (PHA), polybutylene succinate (PBS), polybutylene succinate adipate (PBSA), polybutylene adipate terephthalate (PBAT), polyethylene furanoate (PEF), polycaprolactone (PCL), poly(ethylene adipate) (PEA), polyethylene naphthalate (PEN), "polyolefin-like" polyesters, and any blend / mixture of at least two of said polyesters, preferably polyethylene terephthalate.

36. 32. A polyester-containing material comprising at least one polyester and at least one esterase as defined in any one of claims 1 to 27, or a host cell as defined in claim 30, or a composition as defined in claim 31.

37. 32. A detergent composition comprising at least one esterase as defined in any one of claims 1 to 27, or a host cell as defined in claim 30, or a composition as defined in claim 31.

Citation Information

Patent Citations

  • Method for preparing a polymer / biological entities blend

    WO2013093355A1

  • Method for recycling plastic products

    WO2014079844A1

  • Process of recycling mixed pet plastic articles

    WO2015173265A1

  • Masterbatch composition comprising a high concentration of biological entities

    WO2016198650A1

  • Biodegradable polyester composition and uses thereof

    WO2016198652A1